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ABSTRACT	
	
																Organogenesis	 of	 the	 ovary	 is	 a	 highly	 orchestrated	 process	 involving	 multiple	
lineage	determinations	of	ovarian	surface	epithelium,	granulosa	cells,	and	theca	cells.	While	
the	 sources	 of	 ovarian	 surface	 epithelium	and	 granulosa	 cells	 are	 known,	 the	 embryonic	
origin(s)	of	theca	stem/progenitor	cells	have	not	been	definitively	identified.	Here	I	show	
that	 theca	 cells	 derive	 from	 two	 sources:	Wt1‐positive	 cells	 indigenous	 to	 the	 ovary	 and	
Gli1‐positive	 mesenchymal	 cells	 that	 migrate	 from	 the	 mesonephros.	 These	 two	 theca	
progenitor	populations	are	distinct	in	their	cell	lineage	contributions,	relative	proximity	to	
granulosa	cells,	and	their	gene	expression	profiles.	 	The	two	sources	of	theca	progenitors	
acquire	 theca	 lineage	marker	Gli1	 in	 the	ovary	 soon	after	birth,	 in	 response	 to	paracrine	
signals	 Desert	 hedgehog	 (Dhh)	 and	 Indian	 hedgehog	 (Ihh)	 from	 granulosa	 cells.	 Ovaries	
lacking	 Dhh/Ihh	 exhibited	 a	 loss	 of	 theca	 layer,	 blunted	 steroid	 production,	 arrested	
folliculogenesis,	and	failure	to	form	corpora	lutea.	Production	of	Dhh/Ihh	in	granulosa	cells	
requires	growth	differentiation	factor	9	(GDF9)	from	the	oocyte.	Gdf9	ablation	resulted	in	
diminished	expression	of	Dhh,	Ihh,	and	theca	cell‐specific	Gli1.	Conversely,	supplementation	
of	 GDF9	 to	 oocyte‐depleted	 ovaries	 reactivated	 Dhh/Ihh	 production	 and	 subsequent	
expression	 of	Gli1.	My	 studies	 provide	 the	 first	 genetic	 evidence	 for	 the	 origins	 of	 theca	
cells	and	reveal	a	novel	multicellular	interaction	via	GDF9	and	Hedgehog	signaling	critical	
for	ovarian	folliculogenesis	and	formation	of	a	functional	theca.				
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CHAPTER	1:	Literature	Review	
	
1.1	Overview	of	ovarian	organogenesis	
																The	word	“ovary”	derives	 from	the	Latin	word	“ovarium”,	 literally	“egg”	or	“nut”.	
The	mammalian	 ovary	 plays	 two	 central	 roles	 in	 female	 reproduction	 by	 acting	 as	 both	
gonads	and	reproductive	glands.	As	gonads,	 the	ovary	supplies	germ	cells	 to	produce	the	
next	generation.	While	acting	as	glands,	the	ovary	produces	hormones	controlling	a	variety	
of	aspects	of	female	development	and	physiology.		The	structural	precursor	of	the	ovary	is	
the	genital	ridge	(or	gonadal	primordium).	Genital	ridges	emerge	as	paired	thickenings	of	
the	 epithelial	 layer,	 the	 coelomic	 epithelium,	 that	 overlays	 the	 ventral	 surface	 of	 the	
mesonephros	at	10	days	post	coitum	(dpc)	in	the	mouse	embryo.	The	mechanism	by	which	
genital	ridges	are	initiated	is	unclear,	however	several	genes,	such	as	Emx2	[1],	Lhx9	[2],	Sf1	
[3],	Wt1	 [4],	 Pod1	 [5],	M33[6],	 Six1	 and	 Six4	 [7]	 have	 been	 identified	 in	 mice	 that	 play	
critical	roles	in	the	formation	or	growth	of	the	gonads.		
															The	 gonadal	 primordium	or	 genital	 ridges	 initially	 contain	no	 germ	cells.	 In	both	
sexes	 in	 mammals,	 primordial	 germ	 cells	 (PGCs)	 arise	 from	 the	 proximal	 epiblast,	 and	
migrate	through	the	dorsal	mesentery	of	the	hindgut	to	colonize	the	genital	ridge	at	around	
10.5	dpc	[8‐10].	Upon	entering	the	genital	ridge,	PGCs	proliferate	and	coalesce	with	somatic	
cells	 to	 form	 primitive	 sex	 cords.	 These	 primitive	 sex	 cords	 are	 delineated	 by	 the	
deposition	 of	 the	 basal	 lamina	 [11‐13].	 Up	 until	 this	 point,	 the	 gonadal	 development	 is	
identical	in	male	and	female	and	the	gonad	is	considered	bipotential,	or	ambisexual	stage	of	
sex	differentiation	[14].	In	further	testis	development,	primitive	sex	cords	differentiate	into	
testis	cords	as	a	result	of	the	action	of	Sertoli	cells	[15]	as	well	as	endothelial	cells	from	the	
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mesonephros	[16,	17].		In	contrast	in	the	fetal	ovary,	primitive	cords	remain	as	clusters	of	
female	germ	cells	(Germ	cell	nests)	that	are	surrounded	loosely	by	pre‐granulosa	cells.	In	
mice,	 the	 squamous	 pre‐granulosa	 cells	 break	 down	 the	 germ	 cell	 nests	 by	 enclosing	
individual	female	germ	cells	or	oocytes	at	around	time	of	birth,	leading	to	the	formation	of	
primordial	 follicles	 [11,	 18].	 Primordial	 follicle	 formation	 represents	 the	 first	 stage	 of	
folliculogenesis	and	in	mammals,	primordial	follicles	serve	as	a	resting	and	finite	source	of	
oocytes	 available	 throughout	 the	 female	 reproductive	 lifespan	 [19].	 The	 supporting	 cell	
precursors	that	comprise	each	primordial	follicle	appear	to	be	a	heterogeneous	population:	
The	pre‐granulosa	cells	in	the	fetal	gonad	contribute	to	the	first	wave	of	primordial	follicles	
in	the	medulla	of	the	ovary	immediately	after	birth.	This	population	of	primordial	follicles	
has	 long	 been	 considered,	 for	 the	most	 part,	 not	 contributing	 to	 fertility	 [20‐22].	 On	 the	
other	 hand,	 the	 supporting	 cells	 recruited	 in	 postnatal	 ovaries,	 likely	 derived	 from	 the	
surface	 epithelium,	 form	 the	 second	 wave	 of	 primordial	 follicles	 in	 the	 ovarian	 cortical	
region	[20‐22].		These	primordial	follicles	are	expected	to	be	the	follicles	that	ovulate	over	
the	 entire	 female	 reproductive	 life	 [20‐23].	 Once	 the	 growth	 of	 primordial	 follicle	 is	
activated,	 the	 primordial	 follicles	 pass	 through	 distinct	 stages	 of	 follicular	 development	
classified	 as	 primary,	 secondary,	 antral	 and	 pre‐ovulatory	 follicles.	 After	 ovulation,	 the	
follicle	 becomes	 corpus	 luteum,	 secreting	 mostly	 progesterone	 for	 the	 maintenance	 of	
pregnancy	[19,	24].			
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1.2	Current	understanding	of	the	establishment	of	the	ovarian	somatic	cell	lineages	
1.2.1	Current	understanding	on	the	establishment	of	granulosa	cells	
																The	embryonic	origins	of	ovarian	granulosa	cells	have	been	a	subject	of	debate	for	
decades.	Granulosa	 cells	 function	 to	 support	 the	growth	and	development	of	 the	oocytes	
throughout	multiple	stages	of	folliculogenesis.	Follicular	development	starts	with	a	handful	
of	granulosa	cells	 surrounding	 the	oocyte.	These	original	granulosa	cells	 then	undergo	at	
least	ten	rounds	of	cell	division	to	produce	more	than	2000	cells	of	a	full	grown	follicle	[24].		
Based	on	morphological	and	histological	observations	of	diverse	mammalian	ovary	models,	
granulosa	cell	precursors	could	arise	from	three	potential	sources:	The	somatic	precursor	
cells	in	the	genital	ridge	[25,	26];	rete	ovarii	at	the	ovary‐mesonephros	border	[27‐31],	and	
the	ovarian	surface	epithelium	[29,	32‐34].	 It	 is	possible	 that	granulosa	cells	derive	 from	
one	 or	 multiple	 sources,	 and	 species	 variation	 seems	 evident	 in	 regards	 to	 the	 cellular	
origin(s)	of	granulosa	cell	precursors.	Because	granulosa	cells	in	the	ovary	and	Sertoli	cells	
in	the	testis	are	considered	analogous	to	each	other,	their	origins	are	thought	to	stem	from	
a	 common	 somatic	 progenitor	 population	 present	 in	 the	 genital	 ridge,	 before	 the	
commitment	to	ovary	or	testis	occurs	[26,	35,	36].	 	Although	it	is	commonly	believed	that	
granulosa	 cells	 are	 derived	 from	 the	 common	 progenitor	 cells	 in	 bipotential	 gonad,	 this	
assumption	has	not	been	proven.			
																One	piece	of	evidence	 that	granulosa	cells	and	Sertoli	 cells	 stem	 from	a	common	
progenitor	 population	 came	 from	 the	 observations	 that	 granulosa	 cells	 and	 Sertoli	 cells	
have	the	potential	to	switch	their	cellular	fate.		In	mice,	loss	of	DMRT1	transcription	factor	
in	adult	Sertoli	cells	activates	FOXL2,	and	transdifferentiate	Sertoli	cells	into	granulosa	cells	
[37].	 On	 the	 contrary,	 FOXL2	 ablation	 in	 granulosa	 cells	 in	 adult	 ovary	 can	 reprogram	
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granulosa	cells	into	Sertoli	cells	[38].		Foxl2	is	a	winged‐helix/forkhead	transcription	factor.	
It	 first	 comes	 into	 picture	 due	 to	 its	 potential	 link	 to	 the	 ovary‐to‐testis	 sex	 reversal	
phenotype	 associated	 with	 Polled	 Intersex	 Syndrome	 (PIS)	 in	 XX	 goats	 [39,	 40].	 Foxl2	
exhibits	 a	 granulosa‐cell	 specific	 pattern	 in	 the	 ovary	 and	 is	 required	 for	 granulosa	 cell	
differentiation	 [41‐43].	 	 These	 findings	 altogether	 not	 only	 reveal	 the	 role	 of	 FOXL2	 in	
maintaining	granulosa	cell	identity,	but	also	lead	to	the	speculation	that	Foxl2	can	be	used	
as	a	 lineage	maker	 for	granulosa	cells.	 Indeed,	 lineage	tracing	of	Foxl2‐expressing	cells	 in	
the	 fetal	 ovary	 give	 rise	 to	 granulosa	 cell	 in	 later	 stages	 of	 ovarian	 development	 [22].	
Additionally,	 the	 Foxl2‐expressing	 cells	 in	 the	 ovary	 are	 likely	 derived	 from	 the	 surface	
epithelium	 in	 two	 distinct	 and	 sequential	 waves:	 an	 initial	 fetal	 wave	 followed	 by	 a	
neonatal	wave	[22].	 	 	Foxl2‐expressing	cells	 from	the	 initial	wave	contribute	to	granulosa	
cells	of	the	follicles	in	the	medulla	of	the	ovary	that	start	to	grow	immediately	after	birth.	
Cells	from	the	second	wave	populate	the	primordial	follicles	in	the	cortex	of	the	ovary	and	
these	follicles	are	likely	activated	later	in	adulthood	[21,	22].			
	
1.2.2		Current	understanding	of	the	establishment	of	theca	cells	
																The	 embryonic	 origins	 of	 ovarian	 theca	 cells	 are	 poorly	 understood.	 Theca	 cells	
play	diverse	roles	during	ovarian	development,	such	as	synthesizing	androgens,	which	are	
then	converted	to	estrogen	by	granulosa	cells	[44‐48];	interacting	with	granulosa	cells	and	
oocytes	during	folliculogenesis	[49‐51];	and	providing	structural	support	and	blood	supply	
for	the	developing	follicles	for	ovulation	[50,	52,	53].	In	mice,	theca	cells	are	first	observed	
around	 one	 week	 after	 birth	 in	 follicles	 with	 two	 or	 more	 layers	 of	 granulosa	 cells	
(secondary	follicles)	[19]	 .	As	the	ovarian	follicles	contribute	to	develop,	 the	theca	can	be	
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divided	 into	 two	 layers:	 theca	 interna	 and	 theca	 externa.	 Cells	 of	 the	 theca	 interna	 form	
immediately	 adjacent	 to	 the	 basal	 lamina	 of	 the	 developing	 follicle	 and	 are	 considered	
highly	 vascular	 and	 steroidogenic.	 The	 theca	 externa	 on	 the	 other	 hand,	 is	 located	 just	
outside	of	theca	interna	and	is	composed	of	non‐steroidogenic	cells	such	as	fibroblast	cells	
and	smooth	muscle	cells,	important	for	ovulation	[19].			
																Theca	cells	have	long	been	thought	to	originate	from	the	mesenchymal	cells	within	
the	ovarian	 stroma	 [48,	54‐56].	Using	neonatal	mouse	ovaries,	 putative	 thecal	 stem	cells	
were	isolated,	and	induced	to	differentiate	into	androgen‐producing	theca	cells	 in	culture	
[57].	 Because	 theca	 cells	 are	 only	 found	 in	 the	 developing	 follicle	 and	 are	 adjacent	 to	
granulosa	cells,	their	differentiation	is	considered	to	be	under	the	control	of	granulosa	cells	
[58,	 59].	 This	 concept	 is	 supported	 by	 several	 culture	 experiments	 in	 which	 cultured	
ovarian	stromal	cells	differentiate	 into	functional	 theca	cells	 in	 the	presence	of	granulosa	
cells,	 or	 in	 granulosa	 cell‐conditioned	 culture	 medium	 [58,	 60,	 61].	 Gel	 filtration	
chromatography	 further	 indicates	 that	 factors	 stimulating	 theca	differentiation	appear	 to	
be	 small‐molecular‐weight	 proteins	 ranged	 from	 20‐	 to	 24‐	 kDa	 [60].	 Other	 speculated	
sources	 for	 the	 precursor	 theca	 cells	 include	 the	 coelomic	mesothelium	which	 lines	 the	
surface	 of	 the	 ovary	 [62],	 and	 the	 mesonephros	 [63‐66].	 However	 it	 remains	 uncertain	
whether	 these	 sources	 indeed	 contribute	 to	 steroidogenic	 tissue	 of	 the	 ovary,	 as	 these	
assumptions	are	mainly	based	on	morphological	examinations	and	the	definitive	origins	of	
theca	cells	remain	veiled.		
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1.3	Current	understanding	of	the	establishment	of	the	female	germline		
																Generation	 of	 the	 female	 germline	 (or	 oogenesis)	 is	 the	 one	 of	 the	 other	 key	
functions	 of	 the	 ovary	 in	 addition	 to	 hormone	 production.	 Between	 1920	 and	 1950,	 the	
field	of	oogenesis	was	dominated	by	the	doctrine	that	the	germinal	epithelium,	or	ovarian	
surface	 epithelium	 encapsulating	 the	 ovary,	 gave	 rise	 to	 oocytes	 during	 each	 estrous	 or	
menstrual	 cycle.	This	doctrine	was	 later	 rejected	based	on	evidence	 that	a	 finite	 stock	of	
meiotic	 oocytes	 is	 present	 in	 the	 ovary	 before	 birth	 and	 no	 new	 oocytes	 are	 generated	
during	adult	life	[67].	However,	the	discovery	of	putative	germline	stem	cells	in	postnatal	
ovaries	 led	to	the	resurgence	of	 the	controversial	 idea	of	“neo‐oogenesis”	 [68‐70].	 In	 this	
chapter,	I	focus	only	on	the	establishment	of	female	germline	during	fetal	life.			
																In	the	mouse	fetal	ovary,	oocytes	start	to	form	around	13.5	dpc	when	female	germ	
cells	(or	oogonia)	stop	proliferating	and	enter	the	first	meiosis	[35].	The	oocytes	progress	
through	 leptonema,	 zygonema,	 pachynema,	 and	 diplonema	 and	 eventually	 rest	 at	 the	
dictyate	 stage	 of	 meiotic	 prophase	 I	 around	 the	 time	 of	 birth	 [71,	 72].	 Oocytes	 do	 not	
resume	meiosis	 until	 ovulation	when	 the	 female	 reaches	 sexual	maturity.	 Once	 ovulated	
from	 the	 ovary,	 oocytes	 complete	 the	 first	 meiotic	 division,	 enter	 the	 second	 meiotic	
division	and	arrest	again.	The	second	meiotic	division	is	completed	after	fertilization	[73].		
																Germ	 cells	 in	 the	 mouse	 testis	 behave	 very	 differently	 from	 their	 female	
counterparts.	 Instead	of	entering	meiosis	at	13.5	dpc,	male	germ	cells	arrest	in	mitosis	in	
fetal	 life	 and	 resume	 mitosis	 immediately	 after	 birth	 [74].	 The	 male	 germ	 cells	 or	
spermatogonia	 then	 undergo	 the	 first	 meiotic	 and	 second	 meiotic	 divisions	 to	 generate	
spermatids.	The	process	is	repeated	many	times	to	constitute	a	renewing	supply	of	mature	
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sperm	[73].	In	contrast	to	the	finite	stock	of	oocytes	at	the	time	of	birth,	spermatogonia	in	
the	testis	retain	the	ability	to	self‐renew	throughout	the	entire	reproductive	life.		
																How	germ	 cells	make	 the	decision	 to	 follow	 the	 female	 or	male	 path	has	 been	 a	
central	 focus	 of	 study	 since	 1970s.	 By	 creating	 an	 XX/XY	 chimeric	 embryo,	 researchers	
observed	that	XY	germ	cells	 in	the	ovarian	tissue	enter	meiosis	and	become	functional	Y‐
bearing	 oocytes	 [75‐77].	 By	 contrast,	 XX	 germ	 cells	 avoid	 entering	 meiosis	 if	 they	 find	
themselves	 in	a	testicular	environment	[78].	The	conclusion	was	therefore	drawn	that	all	
germ	 cells,	 regardless	 of	 their	 sex	 chromosome	 constitution,	 are	 programmed	 to	 follow	
male	or	female	pattern	of	meiosis	according	to	the	surrounding	somatic	environment	[79,	
80].	
																Byskov	 and	 others	 proposed	 that	 germ	 cell	 meiosis	 is	 controlled	 by	 meiosis‐
inducing	substance	or/and	a	meiosis‐preventing	substance	produced	by	the	somatic	cells	
in	 the	 gonads	 [81‐87].	 When	 an	 undifferentiated	 fetal	 testis	 is	 cultured	 with	 ovaries	
containing	meiotic	 germ	 cells,	 the	male	 germ	 cells	 in	 the	 testis	 are	 coaxed	 into	 entering	
meiosis	[82].	On	the	other	hand,	when	ovaries	containing	germ	cells	in	meiosis	are	cultured	
with	 fetal	 testes	 with	 well‐formed	 testicular	 structure,	 the	 oocytes	 are	 prevented	 from	
reaching	 the	diplotene	stage	of	meiotic	prophase.	Thus	 it	was	hypothesized	that	 the	 fetal	
ovary	 secretes	 a	 “meiosis‐inducing	 substance”,	which	 triggers	 the	meiotic	 entry	 of	 germ	
cells.	The	fetal	testis	instead	produces	a	“meiosis‐inhibiting	substance”	that	prevents	germ	
cells	from	entering	meiosis	[82].		
																In	 contrast	 to	 the	 hypothesis	 that	 the	 ovarian	 somatic	 environment	 secretes	
factor(s)	that	induces	germ	cell	meiosis,	McLaren	and	others	were	in	favor	of	the	concept	
that	germ	cell	entry	into	meiosis	follows	a	cell‐autonomous	or	intrinsic	program	[88,	89].	
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This	concept	was	based	on	the	observation	that	when	male	germ	cells	lose	their	way	during	
migration	and	settle	 in	nongonadal	organs	such	as	mesonephros	and	adrenal,	 these	stray	
germ	 cells	 enter	 meiosis	 following	 the	 same	 developmental	 time	 frame	 as	 their	 female	
counterparts	 in	 the	 ovary	 [89‐93].	 Likewise,	 XY	 germ	 cells	 enter	 and	 progress	 through	
meiotic	prophase	after	they	are	separated	from	Sertoli	cells	and	then	cultured	with	other	
nongonadal	 somatic	 cells	 such	 as	 embryonic	 lung	 cells	 [89].	 These	 findings	 led	 to	 the	
hypothesis	that	germ	cells	in	the	fetal	ovary	enter	meiosis	spontaneously	whereas	meiosis	
is	inhibited	in	the	testis	by	factors	produced	by	the	somatic	cells,	probably	Sertoli	cells	[89,	
94].		
																The	debate	on	how	sexually	dimorphic	pattern	of	germ	cell	meiosis	is	established	
appear	 to	 be	 resolved	 by	 the	 findings	 of	 Bowles	 et	 al.	 and	 Koubova	 et	 al.	 in	 2006.	 A	
mechanism	 involving	 retinoic	 acid	 (RA)	 and	 its	 degrading	 enzyme	CYP26B1	 is	 in	 action,	
with	both	meiosis‐inducing	(RA)	and	meiosis‐inhibiting	(CYP26B1)	properties	[95,	96].	The	
first	clue	that	RA	might	play	a	role	in	meiotic	entry	of	germ	cells	in	the	ovary	came	from	an	
expression	screen	designed	to	identify	sexually	dimorphic	genes	in	mouse	fetal	gonads.	It	
was	 found	 that	 Cyp26b1,	 the	 gene	 encoding	 a	 P450	 enzyme	 that	 degrades	 RA	[97‐100],	
shows	 a	 testis‐specific	 expression	 pattern.	 Initially	 present	 in	 gonads	 of	 both	 sexes,	
Cyp26b1	 becomes	 undetectable	 in	 female	 gonads	 after	 11.5	 dpc.	 However	 in	 the	 testis,	
Cyp26b1	 expression	 is	 maintained	 and	 reaches	 its	 maximum	 at	 13.5	 dpc	 [101].	 The	
presence	 of	 RA‐degrading	 CYP26b1	 in	 fetal	 testes	 is	 consistent	 with	 a	 significant	 lower	
level	of	RA	in	the	testis	compared	to	the	ovary	at	13.5	dpc.	This	evidence	suggests	that	a	
low	 RA	 level	 is	 necessary	 for	 preventing	 germ	 cell	 meiosis	 in	 the	 testis	 [101].	 In	 other	
words,	 a	high	RA	 level	 in	 the	 fetal	 ovary	 is	 responsible	 for	 inducing	germ	cell	 entry	 into	
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meiosis.	Indeed,	when	exogenous	RA	is	given	to	fetal	testes	in	culture,	XY	germ	cells	enter	
meiosis	 [101,	102].	 In	addition,	 treatment	of	 fetal	 testes	with	CYP26	 inhibitors	 in	culture	
induces	meiotic	entry	of	XY	germ	cells	and	an	up‐regulation	of	Stimulated	by	retinoic	acid	
gene	8	(Stra8),	which	is	required	for	premeiotic	DNA	replication	and	the	subsequent	events	
of	meiotic	prophase	in	germ	cells	of	embryonic	ovaries	[101,	103].	Finally,	exposure	of	fetal	
ovaries	 to	 RA	 antagonists	 prevents	 XX	 germ	 cells	 from	 entering	meiosis	 [101].	 These	 in	
vitro	results	were	later	substantiated	by	examination	of	the	Cyp26b1	knockout	mice.	In	the	
absence	of	 functional	Cyp26b1	genes,	RA	 levels	are	 increased	 in	embryonic	 testes	and	XY	
germ	cells	enter	meiosis	prophase	at	13.5	dpc,	similar	to	germ	cells	in	a	normal	fetal	ovary	
[101,	104].	Collectively,	this	evidence	supports	the	concept	that	high	RA	in	the	fetal	ovary	
due	 to	 lack	 of	 CYP26B1	 is	 responsible	 for	 inducing	 germ	 cell	meiosis	 [105].	 Presence	 of	
CYP26B1	in	the	fetal	testis	prevents	accumulation	of	RA	and	consequent	germ	cell	meiosis.		
																Intriguingly,	 fetal	 testes	and	ovaries	are	not	 the	source	of	RA.	Gonads	apparently	
lack	the	ability	to	synthesize	RA	because	they	do	not	express	Aldh1a2,	 the	gene	encoding	
the	 major	 enzyme	 for	 RA	 synthesis	 [101].	 Instead,	 RA	 is	 secreted	 by	 mesonephroi,	 the	
mesoderm‐derived	 tissues	 immediately	 adjacent	 to	 the	 gonads	 [101].	 	 In	 1970s,	 Byskov	
proposed	 that	 rete	 ovarii,	 the	 extending	 mesonephric	 derivative	 that	 connects	 to	 the	
ovarian	medulla,	may	be	the	source	of	“meiosis‐inducing	factor”	[27,	29,	81].	In	the	mouse	
gonads,	mesonephric	 tubules	connect	 to	 the	anterior	portion	of	 the	gonads.	 If	 indeed	 the	
“meiosis‐inducing	factor”	(or	RA)	comes	from	the	mesonephric	tubules,	one	would	expect	
that	the	RA	level	would	be	higher	at	the	anterior	end	than	at	the	posterior	end	of	the	gonad.	
This	 anterior‐to‐posterior	 gradient	 of	 RA	 in	 the	 gonads	 was	 later	 confirmed	 [101].	 This	
phenomenon	is	also	supported	by	the	fact	that	female	germ	cells	in	the	anterior	part	of	the	
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fetal	ovary	enter	meiosis	earlier	than	those	in	the	posterior	end	of	the	fetal	ovary	[106‐108].	
																Germ	cell	meiosis	in	the	fetal	ovary	is	controlled	by	not	only	the	availability	of	the	
meiosis‐inducing	 RA,	 but	 also	 the	 competence	 of	 germ	 cells	 to	 respond	 to	 RA.	 Germline	
specific	RNA‐binding	protein	DAZL	(Deleted	in	azoospermia‐like	gene)	and	NANOS2	have	
emerged	 as	 intrinsic	 factors	 in	 germ	 cells	 that	 define	 their	 ability	 to	 enter	 meiosis	 in	
response	to	RA.	When	Dazl	became	nonfunctional,	germ	cells	in	the	fetal	ovary	fail	to	enter	
meiosis.	In	addition,	male	germ	cells	in	the	Dazl	knockout	testis	lose	their	ability	to	enter	
meiosis	in	response	to	exogenous	RA	[109].	This	evidence	implies	that	the	presence	of	Dazl	
is	 a	 prerequisite	 for	 germ	 cells	 to	 gain	 the	 ability	 to	 respond	 to	 RA,	 therefore	 becoming	
meiosis‐competent.	 Nanos2,	 on	 the	 other	 hand,	 plays	 a	 role	 in	 suppressing	 germ	 cell	
meiosis.	Nanos2	is	expressed	exclusively	in	germ	cells	in	the	fetal	testis	whereas	it	is	absent	
in	female	germ	cells	[110].	Loss	of	Nanos2	in	the	fetal	testis	results	in	upregulation	of	Stra8	
and	 meiosis	 of	 male	 germ	 cells.	 Ectopic	 expression	 of	Nanos2	 in	 the	 female	 germ	 cells	
decreases	Stra8	expression	and	inhibits	germ	cell	meiosis	[111].	NANOS2	probably	inhibits	
germ	cell	meiosis	by	decreasing	Stra8	expression,	the	downstream	target	of	RA	[112].		
																Although	 the	 role	 of	 mesonephros‐derived	 RA	 in	 initiating	 the	 meiotic	 entry	 of	
germ	 cells	 seems	 evident,	 this	 concept	 is	 later	 challenged	 in	 2011	 by	 Kumar	 et	 al,	 who	
claimed	 that	 the	 sex‐specific	 timing	 of	 meiosis	 in	 mouse	 embryos	 is	 independent	 of	 RA	
signaling,	based	on	the	fact	that	germ	cells	still	enter	meiosis	in	the	RA‐deficient	fetal	ovary.	
On	the	other	hand,	inhibition	of	CYP26B1	in	RA‐deficient	testis	allows	meiosis	to	occur,	but	
only	when	 a	 RA‐deficient	mesonephros	 is	 attached.	 The	 authors	 therefore	 conclude	 that	
CYP26B1	 prevents	 the	 onset	 of	 meiosis	 by	 degrading	 a	 mesonephros‐derived	 substrate	
other	than	RA	that	initiates	meiosis	[113].		How	can	this	seemingly	contradictory	study	be	
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reconciled	with	 previous	 findings?	 The	 discrepancies	 imply	 the	 possibility	 that	multiple	
pathways	(RA	and	non‐RA)	may	play	a	role	in	controlling	the	onset	of	meiosis.		
																In	 summary,	 establishment	 of	 the	 female	 germline,	 characterized	 by	 entry	 into	
meiosis	 in	 fetal	 life,	requires	a	synchronized	action	of	both	extracellular	and	 intracellular	
factors.	Extrinsic	RA	or	non‐RA	signals,	derived	from	the	mesonephros,	serves	as	a	meiosis‐
inducing	agent	in	the	fetal	ovary.	Female	germ	cells	become	competent	to	enter	meiosis	in	
response	to	these	signals	only	after	they	are	primed	by	the	presence	of	the	intrinsic	factor	
DAZL.	 The	 fetal	 ovary	 also	 suppresses	 production	 of	 the	 meiosis‐inhibiting	 factors	
including	Cyp26b1	and	Nanos2,	clearing	the	path	for	female	germ	cells	to	differentiate	into	
oocytes.	 The	 observation	 of	 putative	 female	 germline	 stem	 cells	 in	 adult	 ovaries	 [68‐70]	
raises	 the	 question	 of	 how	 these	 putative	 germline	 stem	 cells	 escape	 from	 the	meiosis‐
inducing	 substrates	 during	 fetal	 development	 and	 re‐enter	 the	meiosis	 path	 later	 in	 life.	
Knowledge	 of	 sexually	 dimorphic	 regulation	 of	 the	 germline	 could	 have	 implications	 for	
solving	the	controversy	around	the	existence	of	female	germline	stem	cells	in	adult	ovaries.	
	
1.4	Regulation	of	folliculogenesis	
																	Formation	 of	 primordial	 follicle	 occurs	 when	 an	 individual	 female	 germ	 cell	 is	
encased	by	squamous	pre‐granulosa	cells.	This	event	is	accompanied	with	oocyte	apoptosis,	
which	results	in	two	third	of	the	perinatal	reduction	in	germ	cell	number	[114].	Deletion	of	
anti‐apoptotic	 gene	Bcl‐2	 results	 in	 fewer	 oocytes	 and	 primordial	 follicles	 [115].	 On	 the	
contrary,	mutations	of	genes	 that	promote	cell	death,	 such	as	Ahr	 [116]	and	Casp2	[117],	
resulted	in	an	increase	in	primordial	follicle	number.	These	results	altogether	suggest	the	
critical	role	of	apoptosis	in	establishing	primordial	follicle	pool.	Another	factor	that	appears	
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to	promote	primordial	 follicle	 formation	is	FIGLA	 	(factor	 in	the	germline	α),	a	germ	cell‐
specific	bHLH	transcription	factor.	Ovaries	lacking	Figla	fail	to	form	primordial	follicles	and	
consequently,	 the	 female	mice	 are	 sterile	 [118].	 	 In	 addition	 to	 FIGLA,	 the	 role	 of	Notch	
signaling	 during	 the	 formation	 of	 primordial	 follicle	 is	 evident.	 	 In	 the	 neonatal	 mouse	
ovary,	the	Notch	ligand	JAGGED1	is	expressed	in	oocytes,	and	the	NOTCH2	receptor	as	well	
as	 Notch	 target	 gene	 Hes1	 is	 expressed	 in	 nearby	 granulosa	 cells.	 Inhibition	 of	 Notch	
signaling	decreases	 primordial	 follicle	 formation,	 along	with	 a	 corresponding	 increase	 in	
the	number	of	germ	cells	that	remain	in	clusters	[119].	Further,	mice	lacking	Lunatic	Fringe	
(Lfng),	a	modulator	of	Notch	signaling	that	expresses	 in	granulosa	cells	and	theca	cells	of	
developing	 follicles,	 exhibited	 polyovular	 follicles,	 indicating	 a	 failure	 in	 germ	 cell	 nest	
breakdown	[120].		In	addition	to	the	locally	produced	factors,	circulating	steroid	hormone	
also	 appears	 to	 regulate	 germ	 cell	 cyst	 breakdown.	 Neonatal	 ovaries	 that	 exposed	 to	
genistein,	 a	 phytoestrogen,	 exhibited	 delayed	 nest	 breakdown	 [121,	 122]	 and	 developed	
multi‐oocytes	follicles	 later	 in	adulthood	[123].	 	 In	contrast,	E16.5	ovaries,	removed	from	
their	 normal	 environment	 (highly	 level	 of	 pregnancy	 hormones),	 underwent	 premature	
nest	breakdown	that	was	otherwise	prevented	by	exogenous	estrogen	[122].		
																The	transition	of	primordial	follicle	to	primary	follicle	is	defined	by	morphological	
changes	 in	granulosa	cell	 from	squamous	to	cuboidal	[19].	 	Several	key	germ	cell‐specific	
transcription	 factors,	 including	NOBOX,	 SOHLH1	 and	 SOHLH2	have	been	 identified	 to	 be	
critical	 in	 this	process.	Mice	 lacking	any	of	 these	genes	exhibit	normal	primordial	 follicle	
number	but	primary	 follicles	are	missing,	 indicating	 the	defects	 in	primordial	 to	primary	
follicle	transition	[124‐127].	In	addition	to	oocyte‐specific	transcription	factors,	transition	
from	primordial	 to	primary	 follicles	 seems	also	 require	proper	 interactions	between	KIT	
	 13
ligand	and	 the	KIT	 tyrosine	 receptor.	 In	 the	postnatal	ovary,	KIT	 is	 expressed	 in	oocytes	
and	 KIT	 ligand	 is	 expressed	 in	 the	 granulosa	 cells	 of	 developing	 follicles	 [128‐132].	
Newborn	 mice	 injected	 with	 ACK2,	 an	 antibody	 to	 KIT,	 resulting	 in	 follicle	 arrest	 at	
primordial	stage.	 	However	 this	phenotype	 is	not	observed	 if	ACK2	is	 injected	after	birth	
when	formation	of	the	primordial	follicle	already	occurred	[132].	In	contrast,	supplement	
of	 KIT	 ligand	 in	 neonatal	 ovary	 cultures	 promotes	 the	 transition	 from	 primordial	 to	
primary	 follicle,	 leading	 to	 an	 increase	 in	 the	 number	 of	 growing	 follicles	 [133].	 	 KIT	
ligand/KIT	 signaling	 appears	 to	 act	 on	 early	 folliculogenesis	 through	 the	 inactivation	 of	
forkhead	box	3	(FOXO3),	a	member	of	O	subclass	of	the	forkhead	transcription	factors	[134,	
135].	 	 Mice	 lacking	 Foxo3	 exhibit	 accelerated	 follicular	 initiation,	 evident	 by	 global	
primordial	 follicle	 activation	 that	 leads	 to	 early	 depletion	 of	 ovarian	 follicles	 and	
consequently	infertility	[136].	This	result	suggests	that	FOXO3	functions	as	an	inhibitor	of	
follicular	activation.	While	FOXO3	is	a	key	oocyte‐derived	factor	important	for	suppressing	
follicular	 activation,	 another	 member	 of	 forkhead	 family,	 forkhead	 box	 L2	 (FOXL2),	 is	
critical	for	the	morphological	changes	of	granulosa	cells	from	squamous	to	cuboidal.	FOXL2	
is	expressed	predominantly	in	pregranulosa	cells	 in	the	fetal	ovary	and	granulosa	cells	of	
the	 developing	 follicles	 [137].	 Ovaries	 deficient	 for	 Foxl2	 form	 primordial	 follicles,	 but	
further	 differentiation	 of	 granulosa	 cells	 is	 blocked,	 leading	 to	 the	 absence	 of	 secondary	
follicles	and	oocyte	atresia	[138,	139].		Loss	of	Foxl2	further	results	in	reduced	expression	
of	AMH	(anti‐Mullerian	inhibiting	substance),	the	inhibitor	of	primordial	follicle	activation	
[138].	 	AMH	is	expressed	in	granulosa	cells	from	the	primary	follicles	onward	[140,	141],	
and	 its	 expression	 from	 the	 growing	 follicles	 is	 thought	 to	 suppress	 primordial	 follicle	
activation.	Female	mice	deficient	 for	AMH	are	 fertile,	but	 the	number	of	growing	 follicles	
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significantly	 increases	 by	 4	 months	 of	 age	 along	 with	 a	 decrease	 in	 primordial	 follicle	
number	 [142].	 The	 role	 of	 AMH	 in	 repressing	 primordial	 follicle	 recruitment	 is	 further	
supported	by	 in	vitro	 studies,	 in	which	neonatal	ovaries	 treated	with	AMH	present	 fewer	
growing	follicles	[143].	Besides	AMH,	the	chemoattractive	cytokine	CXCL12	is	also	shown	
to	 suppress	 primordial	 follicle	 activation.	 Both	 CXCL12	 and	 its	 receptor	 CXCR4	 are	
dominantly	 expressed	 in	 the	 oocytes	 of	 the	 primordial	 and	 growing	 follicles	 [144].		
Neonatal	ovaries	cultured	with	recombinant	CXCL12	exhibit	lower	percentage	of	activated	
follicles,	in	contrast	to	higher	density	of	primordial	follicles	[144].		
																	The	 progression	 of	 the	 follicular	 development	 is	 tightly	 controlled	 by	
communications	 between	 oocyte	 and	 the	 somatic	 compartment	 of	 the	 follicle	 [19].	 	 The	
dominant	role	of	oocyte	in	directing	the	rate	of	follicle	growth	was	demonstrated	by	Eppig	
et	 al	 [145]	 in	 elegant	 reaggregation	 experiments,	where	mid‐sized	 oocytes	 isolated	 from	
secondary	 follicles	 mice	 were	 transferred	 back	 to	 primary	 follicles.	 The	 reaggregated	
follicles	 exhibited	 accelerated	 folliculogenesis	 with	 expedited	 differentiation	 of	 follicular	
cells	[145].	Several	growth	factors	have	been	identified	to	be	critical	for	oocyte‐somatic	cell	
interactions.	 In	 the	 absence	 of	 GDF9,	 the	 oocyte‐specific	 growth	 differentiation	 factor‐9,	
follicle	development	 is	arrested	at	primary	stage	[146].	Particularly,	 the	differentiation	of	
granulosa	 cells	 is	 disrupted	 and	 these	 granulosa	 cells	 eventually	 show	 an	 abnormal	
steroidogenic	phenotype	[147].		The	defects	in	granulosa	cell	differentiation	is	likely	due	to	
up‐regulated	expression	of	 inhibin	α,	which	could	potentially	prevent	 the	proliferation	of	
granulosa	cells	at	 the	primary	 follicle	 stage	 [147].	 	 In	 fact,	ablation	of	both	 inhibin	α	and	
GDF9	in	mice	leads	to	the	progression	of	follicle	development	beyond	primary	stage	[148].	
In	 addition	 to	GDF9,	 neurotrophins	NTF5	and	BDNF	 (Brain	 derived	neurotrophic	 factor)	
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expressed	 in	 granulosa	 cells	 appear	 to	be	 critical	during	preantral	 folliculogenesis.	NTF5	
and	BDNF	signal	via	NTRK2	on	the	oocyte	[149,	150].	Loss	of	both	NTF	and	BDNF	results	in	
a	drastic	reduction	in	the	number	of	secondary	follicles,	which	resembles	the	phenotypes	in	
Ntrk2	‐/‐	ovaries	[150].	Besides	the	paracrine	regulations	between	oocyte	and	somatic	cells,	
gap	junction‐mediated	intercellular	communications	is	also	crucial	during	folliculogenesis.	
This	 notion	 is	 supported	by	 studies	 of	mice	model	 lacking	 key	 connexins	 [151‐154].	 For	
instance,	 ovaries	deficient	 for	 connexin	43	 (CX43)	 show	 follicle	 arrest	 at	 primary	 follicle	
stage	[151,	153],	with	disrupted	granulosa	cell	differentiation	and	delayed	oocyte	growth.		
																During	 the	 secondary	 stage	 of	 follicular	 development,	 a	morphologically	 distinct	
layer	of	somatic	cells,	the	theca,	is	seen	just	outside	the	basal	membrane	of	the	developing	
follicle	 [19].	 Theca	 cells	 and	 granulosa	 cells	 interact	 through	 classical	 epithelial‐
mesenchymal	 interactions	 during	 the	 course	 of	 follicle	 development	 [155].	 The	 main	
function	of	theca	cells	is	to	produce	androgen.	Upon	the	stimulation	of	luteinizing	hormone	
(LH)	surge,	theca	cell	up‐regulates	the	expression	of	steroidogenic	enzymes	such	as	STAR,	
CYP11A1,	CYP17A1,	and	3β‐HSD	to	produce	primarily	androgens.	Androgen	produced	by	
theca	cells	then	diffuses	across	the	basal	membrane	to	granulosa	cells.			Granulosa	cells	on	
the	 other	 hand	 in	 respond	 to	 follicle‐stimulating	 hormone	 (FSH)	 by	 up‐regulating	 the	
expression	 of	 CYP19A1	 and	 HSD17B1,	 which	 convert	 androgen	 into	 estrogen	 [156].		
Preantral	granulosa	cells	later	give	rise	to	two	functionally	distinct	cell	populations	during	
antral	 folliculogenesis,	 the	mural	 granulosa	 cells	 lining	 the	 follicle	wall	 and	 the	 cumulus	
granulosa	 cells	 immediately	 surrounding	 the	 oocyte	 [19].	 These	 two	 granulosa	 cell	
populations	appear	to	be	defined	through	opposing	effect	of	oocyte‐secreted	factors	from	
within	 the	 follicle	 and	 FSH	 from	 outside,	 although	 the	 identities	 of	 the	 oocyte‐derived	
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factors	remain	to	be	determined	[157].		
																FSH	 and	 LH	 play	 crucial	 role	 in	 many	 aspects	 of	 folliculogenesis,	 including	
granulosa	 cell	 proliferation	and	apoptosis,	 follicle	 atresia,	 estradiol	production,	 ovulation	
and	 the	 formation	of	corpus	 luteum	[158‐162].	Ovaries	 lacking	LH‐β	 fail	 to	 form	corpora	
lutea	 in	 spite	 of	 the	 presence	 of	 large	 antral	 follicles,	 and	 these	 mice	 are	 sterile	 [162].	
Likewise,	FSH‐deficient	mice	are	infertile	due	to	the	absence	of	large	antral	follicles	and	a	
lack	of	corpora	lutea	(CL),	an	indicator	of	ovulation	failure.	However,	the	number	of	oocytes	
and	subsequent	formation	of	corpora	lutea	are	recovered	when	these	mice	are	treated	with	
exogenous	 PMSG	 (pregnant	 mare	 serum	 gonadotropin)	 and	 hCG	 (human	 chorionic	
gonadotropin),	 suggesting	 that	 the	 ovulation	 competence	 is	 not	 affected	 by	 FSH	 or	 LH	
deficiency	[158,	162].	In	addition,	mice	lacking	FSH	receptor	(FSHR)	exhibit	similar	ovarian	
phenotypes	and	are	also	sterile	[159,	163].			
																One	key	function	of	pituitary	gonadotropins	FSH	and	LH	is	to	act	on	granulosa	cells	
and	 theca	 cells	 for	 the	 production	 of	 estradiol.	 Mice	 lacking	 Cyp19a1,	 a	 gene	 encodes	
aromatase,	 are	 unable	 to	 produce	 estradiol	 [164].	 This	 deficiency	 of	 estrogen	 leads	 to	
female	infertility	secondary	to	abnormal	development	of	antral	follicles	and	the	absence	of	
CLs	[165,	166].	The	action	of	estrogen	on	folliculogenesis	relies	on	two	estrogen	receptors,	
ERα	 (Esr1)	 and	 ERβ	 (Esr2)	 [165].	 	 	 ERα	 is	 predominantly	 expressed	 in	 theca‐interstitial	
cells	 in	 the	 developing	 ovary	 [167].	 Ovaries	 from	 ERα‐deficient	 mice	 contain	 cystic,	
hemorrhagic	follicles	and	CLs	are	absent	[168].	 	The	cystic	follicle	phenotype	observed	in	
ERα‐deficient	 mice	 is	 similar	 to	 those	 observed	 in	 Cyp19a1‐null	 mice	 and	 in	 polycystic	
ovarian	syndrome	[169].		ERβ,	on	the	other	hand,	is	expressed	mostly	in	granulosa	cells	of	
the	developing	follicles	[167].		Mice	lacking	ERβ	are	subfertile,	producing	smaller	and	fewer	
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litters	due	to	reduced	ovulation	efficiency	[170].	 	Interestingly,	besides	being	sterile,	mice	
lacking	both	ERα	and	ERβ	(αβERKO)	presented	a	distinct	phenotype	from	each	single	ER	
knockout.	 In	addition	to	the	follicle	arrest	at	small	antral	 follicle	stage	and	the	absence	of	
CLs,	the	αβERKO	mice	exhibited	sex‐reversed	follicles,	evident	by	the	appearance	of	testis	
cords	 like	 structure	 and	 SOX9	 positive	 Sertoli‐like	 cells	 [171,	 172].	 	 In	 addition	 to	 ER	
receptors,	androgen	receptor	(AR)	also	plays	a	role	in	ovarian	folliculogenesis.	Young	and	
sexually	matured	Ar‐/‐	 female	mice	 show	 reduced	 fertility	with	 decreased	 ovulation	 rates	
and	number	of	CLs	[173,	174].	However	at	forty‐weeks	of	age,	these	mice	become	infertile	
due	to	complete	absence	of	follicles,	a	phenotype	resemble	that	of	women	with	premature	
ovarian	failure	[174,	175].			
																Only	a	subset	of	follicles	in	the	growing	pool	can	proceed	to	the	stage	of	ovulation,	
whereas	a	majority	of	follicles	will	undergo	atresia	instead.	The	mechanism	of	how	a	subset	
of	follicles	survives	to	ovulation	is	not	clear;	however,	both	in	vivo	and	in	vitro	studies	have	
suggested	 several	 factors/pathways	 critical	 for	 this	 process	 [19].	 Preovulatory	 follicles	
highly	 express	 luteinizing	 hormone/choriogonadotropin	 receptor	 (LHCGR)	 in	 mural	
granulosa	 cells	 [157],	 enabling	 them	 to	 respond	 to	 LH	 surge,	 leading	 to	 ovulation	 and	
subsequence	 formation	 of	 CLs	 [19].	 	 Mice	 deficient	 in	 Lhcgr	 are	 sterile	 [176,	 177],	 and	
mirror	 the	 histological	 defects	 observed	 in	 LH‐β‐deficient	 mice.	 However,	 exogenous	
gonadotropin	 administration	 cannot	 rescue	 the	 follicular	 defects	 in	 Lhcgr	 null	 mice,	
differed	from	the	recovery	observed	in	LH‐β‐deficient	mice	[176].		Upon	the	initiation	of	LH	
surge,	mural	 granulosa	 cells	 [157]	produce	EGF‐like	 factors	 including	Areg,	Ereg	 and	Btc	
[178],	 which	 act	 on	cumulus	 granulosa	 cells	 that	 surround	 the	 oocyte	 [179]	 to	 induce	
cumulus	expansion	and	 oocyte	maturation.	 The	 expansion	 of	 the	 cumulus	 oophorus	 is	 a	
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prerequisite	 for	 normal	 ovulation.	 Proper	 formation	 of	 the	 extracellular	 matrix	 of	 the	
cumulus	oophorus	depends	on	the	activation	of	MAPK	signaling	[180,	181],	along	with	the	
expression	of	 critical	 genes	 including	Has2,	Ptgs2,	Ptx3	and	Tnfaip6	in	 cumulus	 cells	 [182‐
186].	Activation	of	MAPK	signaling	in	cumulus	cells	requires	one	or	more	paracrine	factors	
from	 the	 oocyte	 [187,	 188].	 	 Oocytectomy	 of	 oocyte‐cumulus	 complexes	 prevents	 FSH	
induced	 cumulus	 expansion,	 whereas	 co‐culture	 of	 FSH	 stimulated	 oocytectomized	
complexes	with	denuded	oocytes	rescues	the	expansion	of	the	oocytectomized	complexes	
[189].	Similarly,	dissociated	cumulus	cells	alone	failed	to	synthesize	a	mucinous	matrix	in	
response	to	FSH,	but	the	matrix	production	is	restored	when	denuded	full‐grown	oocytes	
are	 supplemented	 in	 culture	 [190].	 Thus,	 it	 is	 postulated	 that	 oocytes	 secrete	 a	 cumulus	
expansion‐enabling	 factor	 (CEEF)	 that	 allowed	 granulosa	 cells	 to	 respond	 to	 FSH	 [191].	
One	such	potential	factor	is	GDF9,	a	member	of	the	transforming	growth	factor‐beta	(TGFβ)	
super	family.	Knockdown	of	Gdf9	in	oocytes	results	in	down‐regulated	expression	of	Has2,	
Ptgs2,	 and	 therefore	 suppresses	 cumulus	 expansion	 [192],	 whereas	 the	 supplement	 of	
recombinant	 GDF9	 in	 granulosa	 cell	 culture	 increases	 levels	 of	 Has2,	 Ptgs2	 and	 Ptx2	
expression	[193,	194].	 	Conversely,	the	response	of	granulosa	cells	to	GDF9	signaling	also	
requires	the	activation	of	MAPK	pathways,	suggesting	that	GDF9	and	MAPK	signaling	are	
cooperatively	 required	 for	 follicle	 growth	 unto	 ovulation	 [195].	 In	 addition	 to	 GDF9,	
another	member	 of	 TGFβ	 family	 BMP15,	 also	 appear	 to	 be	 involved	 in	 the	 regulation	 of	
cumulus	 expansion	 [196].	 This	 is	 because	 first,	 BMP‐15	 induces	 cumulus	 expansion	 in	
mouse	 cumulus–oocyte	 complexes	 via	 stimulating	 the	 expression	 of	 EGF‐like	 growth	
factors	 in	 vitro	 [196].	 Second,	 Gdf9+/‐	 Bmp15‐/‐	 double	 mutant	 mice	 are	 infertile	 with	
impaired	 cumulus	 expansion	 [197].	 Third,	 co‐culture	 of	 Gdf9+/‐	 Bmp15‐/‐	 oocyte	 with	
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oocytectomized	 cumulus	 complexes	 fails	 to	 cause	 FSH‐induced	 cumulus	 expansion	 along	
with	 decreased	 level	 of	 MAPK	 signaling	 [198].	 	 These	 observations	 suggest	 that	 BMP15	
signals	synergistically	with	GDF9	in	regulating	cumulus	expansions	in	mouse.		
																	Several	 transcription	 factors	 downstream	 of	 LH	 receptor	 activation	 have	 been	
demonstrated	to	be	necessary	for	ovulation	[19].	Progesterone	receptor	(PR),	a	member	of	
nuclear	receptor	subfamily,	 is	expressed	 in	 the	mural	granulosa	cells	of	 the	preovulatory	
follicles	 [199,	 200].	 PR‐deficient	 female	 mice	 are	 anovulatory	 despite	 intact	 cumulus	
expansion	in	unruptured	follicles	[201].	The	single	progesterone	receptor	gene	(Pgr)	uses	
separate	promoters	and	translational	start	sites	to	produce	two	PR	isoforms,	PR‐A	and	PR‐
B	 [202].	 To	 further	 determine	 which	 PR	 isoform	 was	 responsible	 for	 the	 anovulatory	
phenotype,	 selective	 ablation	 of	 each	 PR	 isoform	 is	 carried	 out	 and	 PR‐A,	 but	 not	 PR‐B,	
regulated	 the	ovulatory	 response	 to	 the	LH	surge	 [203,	204].	 	Other	members	of	nuclear	
receptor	 family	 involved	 in	 this	 process	 include	 LRH1	 (Nr5a2),	 SF1	 (Nr5a1)	 and	 TR4	
(Nr2c2).	Conditional	 deletion	 of	 either	 Nr5a2	or	 Nr5a1	 leads	 to	 infertility	 secondary	 to	
anovulation,	 in	 spite	 of	 different	molecular	 and	 hormonal	 changes	 in	 each	mutant	 [205,	
206].	Mice	deficient	 for	TR4	are	subfertile	with	declined	number	of	preovulatory	 follicles	
and	CLs,	likely	due	to	an	insufficient	expression	of	LH	receptor	to	respond	to	LH	surge	[207,	
208].	 In	addition	 to	 these	nuclear	receptors	aforementioned,	co‐regulators	of	 the	nuclear	
receptor	superfamily	are	also	implicated	in	the	regulation	of	ovulation.	One	such	factor	is	
nuclear‐receptor‐interacting	 protein	 1	 (NRIP1;	 encoded	 by	 the	 gene	Nrip1).	Nrip1‐/‐	mice	
are	unable	to	ovulate;	however,	luteinization	proceeds	normally,	resulting	in	the	formation	
of	 CLs	 with	 trapped	 oocytes	 [209].	 Further,	 Nrip1‐/‐	 ovaries	 exhibit	 defects	 in	 cumulus	
expansion,	indicating	the	role	of	Nrip1	in	this	process	besides	ovulation	[209,	210].	Another	
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transcription	 factor	 necessary	 for	 the	 process	 of	 ovulation	 is	 C/EBPβ	 (CCAAT‐enhancer‐
binding	protein	β,	encoded	by	Cebpb).	Cebpb	expression	is	induced	specifically	in	granulosa	
cells	 of	 preovulatory	 follicles	 following	 hCG	 administration.	 Mice	 carrying	 a	 targeted	
deletion	of	Cebpb	contain	unruptured	follicles	and	lack	CLs	[211].			
																	The	 CL	 is	 a	 highly	 differentiated	 endocrine	 structure	 required	 for	 maternal	
development	 during	 pregnancy	 and	 is	 an	 essential	 source	 of	 progesterone	 [212,	 213].	
Formation	of	CLs	requires	granulosa	cells	 to	exit	 from	the	cell	cycle	[214].	Granulosa	cell	
cycle	arrest	is	regulated	by	LH	surge‐activated	MAPK	signaling	via	up‐regulating	inhibitors	
of	cell	cycle	progression	[181].		One	such	inhibitor	is	Cyclin‐dependent	kinase	inhibitor	1B	
(CDKN1B;	also	known	as	p27Kip1)[215].		Female	mice	deficient	for	CDKN1B	are	sterile	due	
to	 granulosa	 cell	 hyperplasia	 and	 defects	 in	 CL	 formation	 [216‐218].	 Administration	 of	
gonadotropins	induces	ovulation;	however,	pregnancy	is	not	maintained	due	to	insufficient	
progesterone	level	[216].	Although	progesterone	is	considered	“the	pregnancy	hormone”,	
pituitary	 gland‐secreted	prolactin	 (PRL)	 also	 plays	 a	 critical	 role	 in	 the	 formation	 of	 CLs	
and	 the	production	of	progesterone.	Female	mice	deficient	 for	prolactin	 receptor	 (PRLR)	
are	 sterile,	 unable	 to	 support	 implantation	 and	 pregnancy	 because	 of	 insufficient	
progesterone	 production	 [219].	 The	 blunted	 progesterone	 production	 is	 likely	 due	 to	
defects	in	the	maintenance	of	CLs,	as	they	are	structurally	disorganized	and	many	of	them	
undergo	 apoptosis	 [220].	 Because	 luteinization	 occurs	 only	 after	 ovulation,	 it	 is	 then	
hypothesized	 that	 factors	 secreted	 from	 oocyte	 inhibit	 premature	 luteinization.	 It	 was	
previously	 shown	 that	 oocyte‐stimulated	 SMAD2/3	 signaling	 is	 involved	 in	 enabling	
cumulus	 expansion	 in	 vitro	 [157],	 pointing	 out	 members	 of	 TGFβ	 family	 as	 potential	
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oocyte‐derived	 inhibitors	 for	 luteinization.	 Evidence	 for	 this	 is	 seen	 in	 ovaries	 lacking	
Smad4,	which	exhibits	severe	cumulus	cell	defects	and	premature	luteinization	[221].			
	 	
1.5	Theca	cells	and	ovarian	diseases		
1.5.1	Epithelial	ovarian	cancer	
																Ovarian	 cancer	 is	 the	 fifth	 leading	 cause	 of	 cancer	 death	 among	 women	 in	 the	
Western	world	and	100,000	women	die	of	this	cancer	each	year	[222,	223].		Eighty	percent	
of	ovarian	cancers	are	epithelial	 in	origin	 [224].	Epithelial	ovarian	cancer	 is	 classified	by	
their	 genetic	 characteristics	 and	 histopathologies	 as	 serous,	 endometrioid,	 clear	 cell	 and	
mucinous	[225,	226].	High‐grade	serous	ovarian	carcinoma	is	the	most	prevalent	subtype	
and	 accounts	 for	more	 than	75%	of	mortality	 associated	with	 the	malignancy	 [222,	 227,	
228].	 In	most	 cases,	women	with	 invasive	ovarian	 cancer	 are	diagnosed	at	 an	advanced‐
stage,	when	a	cure	is	rare.	Although	epithelial	ovarian	cancer	is	considered	the	most	lethal	
gynecological	malignancy	[229],	its	pathogenesis	is	poorly	understood	[222,	223,	230].			
																Epithelial	ovarian	cancers	are	thought	to	arise	from	the	ovarian	surface	epithelium	
that	 comprises	 the	 ovarian	 surface	 [231].	 Using	 mouse	 ovary	 as	 a	 model,	 Andrea	 et	 al.	
showed	that	ovarian	surface	epithelium	at	the	hilum	region	of	the	ovary	contains	a	cancer‐
prone	 stem	 cell	 niche	 positive	 for	 stem	 cell	 marker	 ALDH1	 [232].	 Interestingly,	 ALDH1	
staining	 is	 also	 present	 in	 the	 theca	 cells	 [232].	 In	 addition,	 disorders	 of	 androgen	
production	 have	 been	 implicated	 in	 epithelium	 ovarian	 cancer	 [233]	 and	 androgen	
receptor	is	expressed	in	the	ovarian	surface	epithelial	cells	[234].	However,	 it	 is	not	clear	
whether	theca	cells	play	a	role	in	the	etiology	and	progression	of	these	cancers.	[233]	
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																In	addition	to	ovarian	surface	epithelium	as	a	source	of	epithelial	ovarian	cancer,	
recent	studies	suggest	that	many	invasive	cancers	likely	originate	from	non‐ovarian	tissues	
[235].	Possible	sites	of	origins	for	high‐grade	serous	ovarian	carcinomas	include	the	distal	
fallopian	 tube	 [236‐238]	 particularly	 in	women	with	BRCA1	 (breast	 cancer	 1)	 or	BRCA2	
(breast	 cancer	2)	mutations	 [239‐241],	 and	 the	abdominal	peritoneum	 [235].	 	Because	a	
considerable	 proportion	 of	 ovarian	 tumors	 do	 not	 arise	 from	 ovarian	 tissues,	 the	 term	
ovarian	cancer	is	therefore	for	invasive	cancers	collectively,	and	has	evolved	to	reflect	the	
possibility	of	additional	sites	of	origins	from	different	tissues	[227].		
	
1.5.2			Polycystic	ovary	syndrome	
																Polycystic	 ovarian	 syndrome	 (PCOS)	 is	 a	 common	 endocrinopathies,	 affecting	 5‐
10%	women	 of	 reproductive	 age	 [169,	 242,	 243].	 The	 symptoms	 associated	 with	 PCOS	
include	 hyperandrogenism,	 anovulation,	 and	 infertility	 as	 a	 result.	 The	 hallmark	 ovarian	
morphology	 of	 PCOS	 is	 the	 accumulation	 of	 multiple	 small	 subcortical	 follicular	 “cysts”	
embedded	 in	 enlarged	 ovaries,	 along	with	 an	 increases	 in	 ovarian	 stromal	 volume	 [244‐
246].	 	 Although	 there	 has	 been	 debate	 about	 the	 diagnostic	 criteria	 for	 PCOS,	
hyperandrogenism	and	its	symptoms	are	widely	believed	to	be	a	critical	component	of	the	
syndrome	[247‐250].		
																It	 is	 generally	 agreed	 that	 theca	 cells	 from	 the	 ovary	 are	 at	 least	 one	 primary	
source	of	excess	androgen	production	in	women	with	PCOS	[169,	250,	251].	This	notion	is	
supported	 by	 studies	 on	 isolated	 theca	 tissue	 or	 cultures	 of	 theca	 cells	 from	 PCOS	 and	
normal	women,	which	demonstrate	that	PCOS	theca	produces	greater	levels	of	androgens	
than	 that	of	normal	women	 [251‐257].	The	 rise	 in	ovarian	androgen	production	 is	 likely	
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due	to	increased	expression	of	key	enzymes	involved	in	ovarian	steroidogenesis	including	
LH	receptor,	StAR,	P450scc,	CYP11A1	and	CYP17A1	[253‐255,	257,	258].	
																Polycystic	ovary	syndrome	appears	to	be	a	familial	condition	and	a	genetic	basis	of	
PCOS	is	strongly	suggested	[259‐261].	One	line	of	evidence	that	links	theca	cells	and	PCOS	
is	a	genome‐wide	study	that	identifies	DENND1A	as	a	PCOS	candidate	locus.	It	was	shown	
that	the	spliced	form	of	DENND1A,	DENND1A.V2,	is	increasingly	expressed	in	human	PCOS	
theca	 cells.	 Overexpression	 of	 DENND1A.V2	 in	 theca	 cells	 increases	 the	 expression	 of	
steroidogenic	 genes	 that	 leads	 to	 excess	 androgen	 production.	 On	 the	 other	 hand,	
knockdown	 of	 DENND1A.V2	 resulted	 in	 decreased	 expression	 of	 genes	 involved	 in	
steroidogenesis,	and	consequently	a	reduction	in	androgen	production	[262].	Although	the	
association	 between	 theca	 cells	 and	 PCOS	 is	 apparent,	 it	 is	 yet	 unclear	 whether	
dysfunctions	of	theca	cells	contribute	to	PCOS,	or	the	consequence	of	it.		
	
1.5.3			Premature	ovarian	failure	
																Premature	ovarian	 failure	 (POF),	 also	known	as	primary	ovarian	 insufficiency	or	
premature	menopause,	 is	 the	early	decline	of	ovarian	 function	 in	women	after	seemingly	
normal	 folliculogenesis	 [263].	 	This	medical	condition	 is	affecting	1‐2%	of	women	before	
age	 40	 and	 0.1%	 of	 women	 under	 the	 age	 of	 30	 [264].	 Characteristic	 of	 POF	 include	
amenorrhoea,	hypo‐oestrogenism	and	elevated	gonadotropin	 levels	 [265].	 	Consequently,	
women	with	POF	are	infertile,	which	in	most	cases	is	due	to	follicle	depletion	[266],	and	in	
other	cases,	follicle	dysfunction	[267].			
																How	 spontaneous	 POF	 arise	 is	 largely	 unknown	 but	 several	 causes	 have	 been	
implicated,	including	mutation	of	autosomal	genes,	autoimmunity,	irritation,	chemotherapy	
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and	 X‐chromosome	 abnormalities	 such	 as	 Turner’s	 syndrome	 [265,	 266,	 268,	 269].			
Several	lines	of	evidence	have	implicated	the	role	of	theca	cells	in	the	development	of	POF.		
Mice	deficient	 in	X	 chromosome	androgen	 receptor	 (Ar)	 gene	develop	POF	phenotype	as	
they	age	[270].	This	finding	indicates	a	possible	role	of	androgen	signaling	in	the	etiology	of	
POF.		In	the	absence	of	Ar,	expression	of	Gdf9,	Bmp15	and	Hgf	are	downregulated	in	an	age‐
dependent	manner.	While	Gdf9	 and	Bmp15	 are	oocyte‐specific	 factors	critical	 for	ovarian	
folliculogenesis	 [271,	272],	Hgf	 is	produced	by	 theca	cells	and	 is	 important	 for	granulosa	
cell	function	[273].	Additionally,	in	cases	associated	with	autoimmunity,	theca	cells	appear	
to	 be	 the	 primary	 target	 of	 the	 circulating	 autoantibodies	 in	 the	 initial	 stage,	 resulting	
multifollicular	development,	reduced	estrogen	level,	and	elevated	inhibin	levels	[274].		
	
1.6	The	Hedgehog	signaling	Pathway	in	mammalian	gonad	development		
																The	origin	of	the	name	Hedgehog	(Hh)	stems	from	the	“spiked”	phenotype	of	the	
cuticle	of	the	Drosophila	 larvae.	 	Mutations	in	the	Hh	gene	result	in	the	impairment	of	the	
development	of	 the	 larval	body	patterning	 in	 flies	 [275].	Since	 its	discovery,	Hh	signaling	
has	been	implicated	in	almost	every	aspect	of	the	body	plan,	such	as	cell	fate,	growth	and	
survival,	 and	 patterning	 throughout	 the	 vertebrate	 species.	 In	 addition	 to	 the	 role	 of	Hh	
signaling	 in	 normal	 organogenesis,	 dysregulation	 of	 the	 signaling	 pathway	 is	 implied	 in	
many	diseases	 in	human	such	as	 cancers	 [276,	277].	 In	mammals,	 three	Hh	 ligands	have	
been	identified:	sonic	Hedgehog,	desert	Hedgehog	(DHH),	indian	Hedgehog	(IHH)	[276].	In	
the	absence	of	the	ligands,	the	hedgehog	receptor	Patched	(PTCH1	or	PTCH2)	inhibits	the	
activity	of	another	membrane‐bound	receptor	Smoothened	(SMO).	Binding	of	Hh	to	PTCH	
suppresses	its	activity,	releasing	the	action	of	SMO.	SMO	then	transduces	the	Hh	signals	to	
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the	 cytoplasm,	 drives	 the	 activation	 of	 zinc‐finger	 transcription	 factors	 (GLI1‐3	 in	
mammals),	and	ultimately	leads	to	the	expression	of	Hh	target	genes	[276,	278].		
																The	 role	 of	 Hh	 signaling	 in	 gonad	 development	 was	 first	 indicated	 in	 studies	
investigating	the	action	of	DHH	in	the	mouse	embryo,	as	its	expression	is	largely	restricted	
to	gonads.	In	the	fetal	testis,	Dhh	 is	the	sole	Hh	ligand	that	is	specifically	expressed	in	the	
Sertoli	cells	starting	E11.5	[279].	On	the	other	hand,	the	Hh	downstream	targets	Gli1	and	
Ptch1	are	distinctly	expressed	 in	the	 interstitium	of	 the	 fetal	 testis,	 including	 fetal	Leydig	
cells	 and	 peritubular	 myoid	 cells	 [280‐282].	 Consistent	 with	 the	 restricted	 expression	
pattern	of	Dhh	 in	the	testis,	Dhh	null	mice	are	viable	but	males	are	infertile	due	to	loss	of	
mature	 sperm	 in	 adult	 testis	 [282],	 disorganized	 testis	 cords	 [283],	 or	 Leydig	 [281]	 and	
peritubular	myoid	 cell	 defects	 [284],	 depending	 on	 the	 genetic	 background	 of	 the	mice.		
The	 role	 of	 Hh	 signaling	 on	 Leydig	 cell	 development	 is	 further	 supported	 by	 an	 in	vitro	
study,	 in	which	 the	 inhibition	 of	 the	 transcriptional	 activity	 of	 Hh	 downstream	 effectors	
GLI1	and	GLI2	results	in	the	loss	of	fetal	Leydig	cells	[280].		
																Differed	from	the	fetal	testis,	the	fetal	ovary	is	devoid	of	Hh	signaling	based	on	the	
observation	that	the	expression	of	Ptch1	and	Gli1,	 the	 indicators	of	active	Hh	signaling,	 is	
absent	in	the	ovary	during	fetal	life	[279,	280].		If	Hh	signaling	is	ectopically	activated	in	the	
fetal	ovary,	 it	 leads	to	the	appearance	of	functional	fetal	Leydig	cells	[285].	Thus,	 inactive	
state	of	Hh	signaling	seems	necessary	for	the	fetal	ovary	[278].		In	contrast	to	the	absence	
of	active	Hh	signaling	in	the	fetal	ovary,	both	Dhh	and	Ihh	are	detected	in	granulosa	cells	of	
the	developing	follicles	in	the	adult	ovary	[286,	287].	The	Hh	downstream	targets,	such	as	
Ptch1,	and	Gli1,	are	localized	specifically	in	the	mesenchymal	stromal	cells	surrounding	the	
follicles	[287].	This	unique	expression	pattern	suggests	a	potential	paracrine	regulation	of	
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DHH/IHH	signaling	on	 theca	 cell	 development.	Female	Dhh‐deficient	mice	are	 fertile	 and	
exhibit	normal	ovarian	development	 [282],	 suggesting	 that	 the	other	Hh	 ligands,	 such	as	
Ihh,	may	compensate	for	the	loss	of	Dhh	during	folliculogenesis.	Unfortunately,	most	of	the	
Ihh‐deficient	embryos	die	before	birth	[288],	therefore	precluding	the	analysis	of	the	ovary	
in	 the	 adult.	 Alternatively,	 short‐term	 culture	 of	 neonatal	 ovaries	 with	 an	 Hh	 inhibitor,	
cyclopamine,	 does	 not	 affect	 folliculogenesis	 and	 early	 secondary	 follicles	 are	 observed	
[287].	This	result	indicates	that	Hh	singling	is	likely	not	critical	in	early	folliculogenesis.	On	
the	 other	 hand,	 constitutive	 activation	 of	 the	 Hh	 signaling	 pathway	 in	 the	 ovary	 in	vivo	
disrupts	 theca	 cell	 development,	 leading	 to	 ovulation	 failure	 and	 female	 infertility	 [289].	
The	 role	 of	 Hh	 signaling	 in	 theca	 cell	 development	 is	 also	 supported	 by	 several	 in	vitro	
studies	 in	which	 the	addition	of	 recombinant	SHH	 in	 culture	 stimulates	androstenedione	
production	of	the	theca	cells	[290]	as	well	as	the	growth	of	the	follicles	[286].		
	
1.7	Summary		
																Folliculogenesis	 in	mammalian	 females	 is	 controlled	 by	 intricate	 communication	
between	oocytes,	granulosa,	and	theca	cells.	One	primary	role	of	theca	cells	 is	to	produce	
androgens	 for	 ovarian	 function	 [44‐48].	 Dysfunctions	 of	 theca	 cells	 are	 implicated	 in	
ovarian	 diseases	 such	 as	 polycystic	 ovarian	 syndrome,	 premature	 ovarian	 failure	 and	
ovarian	 cancers	 [233,	270,	 291‐294].	Despite	 their	 involvement	 in	 ovarian	 functions	 and	
pathogenesis,	 theca	 cells	 received	 much	 less	 attention	 over	 the	 years	 and	 were	 poorly	
studied	[50].			
																One	key	unanswered	question	in	ovarian	biology	is	wherefrom	and	how	theca	cells	
arise	during	ovarian	development.	 	Theca	cells	have	 long	been	 thought	 to	originate	 from	
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the	mesenchymal	 cells	within	 the	 ovarian	 stroma	 postnatally	 [48,	 54‐56].	 However,	 this	
assumption	 is	 mainly	 based	 on	morphological	 examination	 and	 the	 definitive	 origins	 of	
theca	cells	remain	unclear.	Other	possible	sources	for	the	precursor	theca	cells	include	the	
coelomic	mesothelium	which	lines	the	surface	of	the	ovary	[62],	and	the	mesonephros	[63‐
66].	However,	none	of	these	sources	have	been	tested	conclusively.		One	reason	for	this	is	
the	 lack	 of	 lineage	 markers	 exclusively	 for	 theca	 cells.	 Theca	 cell	 share	 similar	
steroidogenic	activity	and	regulation	with	their	testicular	counterpart,	the	Leydig	cells[137,	
295,	296].		Thus,	the	knowledge	gained	from	the	Leydig	cells	studies	might	be	applicable	to	
theca	 cells	 in	 the	 ovary.	 	 The	 specification	 of	 the	 fetal	 Leydig	 cells	 is	 regulated	 by	 DHH	
signaling	 from	 Sertoli	 cells,	 and	 the	 downstream	 transcription	 targets	 involved	 in	 this	
process	 include	Ptch1	 and	Gli1	[281,	283,	297].	 	 In	 the	postnatal	and	adult	ovaries,	 theca	
cells	 express	Gli1	 and	Ptch1,	 and	 the	Hh	 ligands	Dhh	 and	 Ihh	 are	 expressed	 in	 granulosa	
cells	 [287].	 These	 observations	 implicate	 a	 potential	 role	 of	 Hh	 signaling	 in	 theca	 cell	
development	 and	 suggest	 that	 GLI1	may	 be	 a	 lineage	marker	 for	 theca	 cells.	 I	 therefore	
hypothesize	that	Hh	signaling	is	playing	an	important	role	in	theca	cell	development.	This	
central	hypothesis	will	be	tested	in	three	specific	objectives.	The	first	specific	objective	of	
my	doctoral	studies	is	to	determine	whether	GLI1	can	be	used	as	a	lineage	marker	for	theca	
cells	and	from	where	theca	cells	originate.	The	second	objective	is	to	investigate	whether	
Hh	signaling	is	required	for	theca	cell	differentiation	and	ovarian	folliculogenesis.	My	third	
objective	is	to	explore	the	mechanisms	in	which	Hh	signaling	is	regulated	in	the	ovary.	My	
research	 provides	 valuable	 information	 regarding	 the	 origin(s)	 of	 theca	 cells,	 the	
mechanisms	of	their	differentiation,	and	their	impact	on	female	fertility.		
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CHAPTER	2:	The	Origins	of	Theca	Cells:	Divergent	Sources	to	a	Convergent	End	
	
2.1	Abstract	
																Theca	cells	play	essential	roles	in	not	only	steroidogenesis	but	also	folliculogenesis	
in	 the	 ovary.	 This	 ovarian	 specific	 cell	 type	 is	 thought	 to	 derive	 from	 the	 stroma	
surrounding	 the	developing	 follicles;	 however,	 their	 definitive	 origin(s)	 has	not	 yet	 been	
identified.	 Using	 Cre/loxP‐based	 lineage‐tracing	 mouse	 models,	 I	 revealed	 two	 distinct	
sources	 for	 theca	 cell	 progenitors:	 the	Wt1‐positive	 cells	 intrinsic	 to	 the	 ovary	 and	 the	
mesenchymal	Gli1‐positive	cells	that	migrate	from	the	mesonephros,	an	embryonic	tissue	
immediately	 adjacent	 to	 the	 fetal	 ovary.	 In	 addition	 to	 the	 difference	 in	 their	 spatial	
localizations,	 fetal	 ovary‐derived	Wt1‐positive	 cells	 give	 rise	 to	 the	 majority	 of	 theca‐
interstitial	cells	in	the	adult	ovary	and	represent	a	broad	mesenchymal	cell	population(s),	
whereas	 mesonephros‐derived	 Gli1‐positive	 cells	 only	 contribute	 to	 a	 small	 yet	 specific	
steroidogenic	theca	cell	population.	The	fetal	ovary‐	and	mesonephros‐derived	progenitor	
cells	converge	in	the	ovary	after	birth	and	commit	to	the	lineage	of	theca	cells	by	acquiring	
Gli1	 expression.	 To	 further	 investigate	 if	 these	 Gli1‐positive	 theca	 progenitor	 cells	 are	
important	 for	 ovarian	 functions,	 I	 developed	 a	 genetic	 model	 that	 induces	 cell	 death	
specifically	in	the	Gli1‐positive	cells	after	birth.	Ablation	of	the	Gli1‐positive	cells	resulted	in	
loss	 of	 primary	 and	 secondary	 follicles,	 decreased	 ovarian	 mass	 and	 decreased	
steroidogenic	activity.	In	summary,	these	studies	uncover	multi‐origins	of	the	progenitors	
of	theca	cell	lineage:	the	ovarian	Wt1‐positive	cells	and	the	extraovarian	Gli1‐positive	cells	
in	 the	 mesonephros.	 Furthermore,	 the	 Gli1‐positive	 theca	 cells	 are	 indispensable	 for	
normal	ovarian	function.		
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2.2	Introduction	 	
																Ovarian	morphogenesis	is	a	highly	orchestrated	process	in	which	the	follicles,	the	
basic	 unit	 of	 ovary,	 form	 and	 mature	 to	 produce	 functional	 eggs.	 The	 development	 of	
follicle	 is	 governed	 by	 intricate	 communication	 among	 oocyte,	 epithelial‐like	 granulosa	
cells	and	mesenchymal‐like	theca	cells.	Defects	in	this	process	have	dire	consequences	for	
female	 reproductive	 health	 and	 fertility.	 The	process	 of	 folliculogenesis	 starts	with	 germ	
cell	 nest	 breakdown,	 in	 which	 individual	 oocyte	 becomes	 encased	 by	 somatic	 granulosa	
cells.	As	 the	 follicle	 continues	 to	develop,	 it	 recruits	precursors	 for	 the	 theca	 cell	 lineage	
and	completes	 follicle	assembly	 [19,	24].	Theca	cells	and	granulosa	cells	 interact	 through	
classical	 epithelial‐mesenchymal	 type	 interactions	 for	 the	 progression	 of	 follicle	
development	 [155].	 Theca	 cells	 produce	 androgens	 in	 response	 to	 luteinizing	 hormone.	
The	androgens	are	subsequently	converted	to	estrogens	by	granulosa	cells	in	responses	to	
follicle‐stimulating	hormone	[19],	and	the	estrogens	in	turn	provides	a	local	feedback	loop	
in	 regulating	 androgen	 production	 [298].	 This	 “two‐cell	 two‐gonadotropin”	 theory	
establishes	 the	 significance	 of	 theca	 cells	 in	 follicular	 steroid	 production	 for	 ensured	
ovulation.		Disorders	in	theca	cell	differentiation	are	implicated	in	ovarian	diseases	such	as	
polycystic	 ovary	 syndrome	 (PCOS),	 premature	 ovarian	 failure,	 and	 ovarian	 cancers	 [233,	
270,	 292],	 therefore	 compromising	 the	 fertility.	 The	 long‐held	 assumption	 in	 the	 field	 is	
that	theca	cells	are	derived	from	the	mesenchymal	cells	within	the	ovarian	stroma	[48,	50,	
54,	 55,	 299].	 	However,	 this	 assumption	 is	mainly	 based	 on	morphological	 examinations	
and	 in	vitro	 analysis,	 and	 the	 definitive	 origins	 of	 theca	 cells	 remain	 veiled.	 The	 lack	 of	
knowledge	 on	 theca	 cell	 precursors	 hinders	 the	 investigation	 on	 the	 molecular	 basis	 of	
theca	cell	recruitment	and	differentiation.		
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																	Theca	 cells	 in	 the	mouse	 ovary	 become	morphologically	 distinguishable	 around	
one	week	after	birth	in	follicles	with	two	layers	of	granulosa	cells	(secondary	follicles)	[19].	
These	 specialized	 mesenchymal	 cells	 are	 located	 in	 the	 ovarian	 mesenchyme,	 which	 is	
separated	 from	granulosa	cells	and	oocytes	by	a	basal	membrane	 [19].	Their	histological	
proximity	to	granulosa	cells	led	to	the	hypothesis	that	recruitment	of	theca	cells	from	the	
stroma	 is	 regulated	by	 factor(s)	produced	by	 granulosa	 cells	 [137].	 	A	 candidate	 for	 this	
factor	is	Hedgehog	(Hh)	ligand,	a	morphogen	responsible	for	lineage	specification	in	many	
organs	 [276].	 In	 adult	 ovaries,	 Indian	 hedgehog	 (Ihh)	 and	 Desert	 hedgehog	 (Dhh)	 are	
detected	 in	 granulosa	 cells,	 and	 their	 downstream	 target	Gli1	 is	 expressed	 specifically	 in	
the	theca	cell	layer	[287].	While	the	role	of	Hh	signaling	in	the	ovary	is	not	clear,	it	is	known	
that	DHH	derived	 from	Sertoli	 cells	 in	 the	 testis	 regulates	 the	appearance	of	 fetal	Leydig	
cells	[281],	the	counterpart	of	putative	theca	progenitor	cells	in	the	ovary.	In	addition,	one	
of	the	Hh	effectors	involved	in	the	specification	of	fetal	Leydig	cells	is	Gli1	[280,	281].	With	
all	 these	observations,	 I	 therefore	hypothesize	 that	Gli1	 is	expressed	 in	 the	precursors	of	
theca	cell	and	might	be	used	as	a	lineage	marker	for	theca	cells	in	the	ovary.		
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2.3	Materials	and	Methods	
2.3.1	Animals	and	experimental	protocols	
																Gli1‐LacZ	(#008211),	Gli1‐CreERT2	(#007913)	[300],	Wt1‐CreERT2	(#010912),	Rosa‐
LSL‐tdTomato	 (#007905),	 Rosa‐DTA		(#006331)	 mice	 were	 purchased	 from	 the	 Jackson	
Laboratory	 (Bar	 Harbor,	 ME).	 Female	 mice	 were	 housed	 with	 male	 mice	 overnight	 and	
checked	for	the	presence	of	vaginal	plug	the	next	morning.	The	day	when	the	vaginal	plug	
was	detected	was	considered	embryonic	day	(E)	0.5.	All	animal	procedures	were	approved	
by	 the	National	 Institute	of	Environmental	Health	Sciences	(NIEHS)	Animal	Care	and	Use	
Committee	 and	 are	 in	 compliance	 with	 a	 NIEHS‐approved	 animal	 study	 proposal.	 All	
experiments	were	performed	on	at	least	three	animals	for	each	genotype.	
	
2.3.2	Tamoxifen‐induced	lineage	tracing	and	cell	ablation	experiments	
																For	lineage	tracing	and	cell	ablation	experiments,	CreERT2	activity	was	induced	by	
IP	 injection	 of	 1	 mg	 and	 5	 mg	 of	 tamoxifen	 (T‐5648,	 Sigma‐Aldrich,	 St.	 Louis,	 MO)	 per	
mouse	in	100	μl	corn	oil	(C‐8267,	Sigma‐Aldrich,	St.	Louis,	MO),	receptively.	For	the	vehicle	
control,	an	equivalent	volume	of	corn	oil	was	 injected.	Lineage	 tracing	experiments	were	
conducted	 by	 crossing	 male	 Gli1‐CreERT2,	 or	 Wt1‐CreERT2	 mice	 with	 female	 Rosa‐LSL‐
tdTomato	reporter	 mice	 to	 generate	 pups	carrying	 both	 CreERT2	and	 Rosa‐LSL‐tdTomato	
alleles.	Cell	ablation	experiments	were	conducted	by	crossing	male	Gli1‐CreERT2	mice	with	
female	 Rosa‐DTA	mice	 to	 generate	 pups	 carrying	 both	 CreERT2	and	 Rosa‐DTA	alleles.	 To	
induce	 Cre‐mediated	 recombination	 in	 neonatal	 pups	 (cell	 ablation	 experiments),	
tamoxifen	was	injected	to	the	lactating	dams.		No	overt	teratological	effects	were	observed	
after	tamoxifen	administration	under	these	conditions.		
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2.3.3	Immunohistochemistry	and	histological	analysis	
                For immunohistochemistry on frozen sections, ovaries were fixed in 4% 
paraformaldehyde in PBS at 4oC overnight, dehydrated through a sucrose gradient, embedded, 
and cryosectioned at 10 μm increments. After preincubating with 5% normal donkey serum in 
PBS for 1 hour, the sections were then incubated with primary antibodies (listed in the table 
below) in PBS-Triton X-100 solution with 5% normal donkey serum at 4oC overnight. The 
sections were then washed and incubated in the appropriate secondary antibody (1:500; 
Invitrogen, NY, USA) before mounting in Vector Mount with DAPI (Vector Labs). Slides were 
imaged under a Leica DMI4000 confocal microscope.  For paraffin-embedded tissues (regular 
samples or samples after LacZ staining), the sections were dewaxed and rehydrated in a series of 
alcohol to PBS. The slides were pretreated in 0.1 mM citric acid for 20 min in the microwave, 
then incubated with an antibody specific to anti-3HSD (listed in the table below) with the 
condition listed above. For	 histological	 analysis,	 the	 samples	 were	 fixed	 in	 4%	
paraformaldehyde	 in	PBS	 at	 4oC	overnight,	 dehydrated	 through	 an	 ethanol	 gradient,	 and	
embedded	in	paraffin	wax.	Sections	were	counterstained	with	hematoxylin	and	eosin.	
	
Primary	antibodies	 Species	 Dilution Source
FOXL2	 Rabbit	 1:500 Dr. Dagmar Wilhelm, Monash University, Australia
FOXL2	 Goat	 1:500 Imgenex,	Littleton,	CO,	USA	
PECAM-1	 Rat	 1:500 BD Biosciences, San Jose, CA, USA	
3HSD	 Rabbit	 1:500	 CosmoBio Co.Ltd, Japan	
β-galactosidase	 Chicken	 1:1000 Abcam, San Francisco CA, USA	
TRA98	 Rat	 1:1000 MBL international, Woburn, MA, USA	
WT1 Rabbit 1:300 Abcam, San Francisco CA, USA 
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DsRed Rabbit 1:1000 Clontech, Mountain View, CA, USA 
laminin	 Rabbit	 1:500 Sigma-Aldrich, St.	Louis,	MO, USA	
	
2.3.4	LacZ	staining	
																Fresh	tissues	were	stained	in	LacZ	staining	solution	at	37oC	for	3	hours.	The	LacZ	
staining	 solution	 was	 prepared	 by	 dissolving	 X‐gal	 (Invitrogen,	 Carlsbad,	 CA)	 in	
dimethylformamide	and	the	tissue	stain	base	solution	(Chemicon,	Billerica,	MA)	to	make	1	
mg/ml	working	 solution	 as	 described	 elsewhere	 [301].	 	 The	 stained	 samples	were	 then	
fixed	 in	 4%	 paraformaldehyde/PBS	 at	 4oC	 overnight.	 For	 further	 histological	 analysis,	
samples	after	LacZ	staining	were	embedded	in	paraffin	following	the	sectioning	procedure	
listed	above.	The	sections	were	counterstained	with	Fast	Red	(Sigma).		
	
2.3.5	Ovarian	transplantation	
																Ovaries	 from	 tamoxifen‐treated	 Gli1CreERT2;	 Rosa‐DTA	 or	 Rosa‐DTA	 pups	 were	
transplanted	under	the	kidney	capsule	of	ovariectomized	wild	type	recipient	mice.	A	small	
hole	was	 torn	 in	 the	 kidney	 capsule	 of	 the	 recipient	mice	 using	 a	 28G	 needle.	 A	 control	
ovary	 (Rosa‐DTA)	 was	 inserted	 into	 one	 kidney	 capsule	 and	 the	 Gli1CreERT2;	 Rosa‐DTA	
ovary	was	inserted	into	the	kidney	capsule	of	the	contralateral	ovary	in	the	same	recipient	
mouse.	 In	order	 to	 stimulate	 the	 growth	of	 the	 transplants,	 both	ovaries	 of	 the	 recipient	
mice	were	 removed	 [302].	The	 transplants	were	 collected	2	weeks	after	 transplantation,	
followed	 by	 fixation	 in	 4%	 paraformaldehyde	 in	 PBS	 and	 were	 processed	 for	
immunohistochemistry	and	histological	analysis.			
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2.3.6	Microarray	analysis		
																Gene	expression	analysis	was	conducted	using	Affymetrix	Mouse	Genome	430	2.0	
GeneChip®	arrays	(Affymetrix,	Santa	Clara,	CA).	Total	RNA	was	extracted	 in	11	μl	elution	
buffer	 using	 Arcturus®	 PicoPure®	 RNA	 isolation	 kit	 (Applied	 Biosystems	 by	 Life	
Technologies)	 following	 the	 manufacture’s	 protocol.	 Due	 to	 limited	 amount	 of	 RNA,	 the	
eluted	RNA	was	dried	 in	a	vacuum	concentrator,	 and	 re‐suspended	 in	4	μl	of	RNase‐free	
water.	The	4	μl	of	 total	RNA	was	 then	amplified	as	directed	 in	 the	WT‐Ovation	Pico	RNA	
Amplification	System	protocol,	and	labeled	with	biotin	following	the	Encore	Biotin	Module.	
Amplified	 biotin‐aRNAs	 (4.6	 μg)	 were	 fragmented	 and	 hybridized	 to	 each	 array	 for	 18	
hours	 at	 45°C	 in	 a	 rotating	 hybridization.	 Array	 slides	 were	 stained	 with	
streptavidin/phycoerythrin	 utilizing	 a	 double‐antibody	 staining	 procedure	 and	 then	
washed	 for	 antibody	 amplification	 according	 to	 the	 GeneChip	 Hybridization,	 Wash	 and	
Stain	 Kit	 and	 user	 manual	 following	 protocol	 FS450‐0004.	 Arrays	 were	 scanned	 in	 an	
Affymetrix	Scanner	3000	and	data	was	obtained	using	the	GeneChip®	Command	Console	
Software	 (AGCC;	 Version	 1.1).	 The	microarray	 raw	 data	were	 analyzed	 using	 the	 Partek	
Genomic	 Suite	 Software	 (St.	 Louis,	 Missouri).	 Two‐way	 ANOVA	 was	 performed	 to	
determine	 the	 statistical	 significance	between	 the	means.	The	 gene	 list	was	 filtered	with	
fold‐change	cutoff	of	1.4	and	an	unadjusted	p<0.05.	
	
2.3.7	Gonad	dissociation	and	cell	sorting	
																Gonadal	cells	from	Gli1‐CreERT2;	Rosa‐LSL‐tdTomato	ovaries	were	minced	and	then	
enzymatically	 dissociated	 in	 Hank’s	 balanced	 salt	 solution	 (Sigma)	 with	 1	 mg/ml	
collagenase	B	(Roche),	1.2	U/ml	Dispase	II	(Roche)	and	5	U/ml	DNAse	I	(Sigma)	for	20	min	
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at	37	oC.	To	 further	 aid	 tissue	dissociation,	 the	 solution	was	mixed	by	 repeated	pipetting	
(P1000	pipette)	[303].	Dissociated	cells	were	rinsed	and	re‐suspended	in	ice‐old	PBS,	and	
were	 subject	 to	 fluorescence‐activated	 cell	 sorting	 (FACS)	 for	 tdTomato+	 and	 tdTomato‐	
cells.	 Cell	 counts	were	 also	 obtained	 during	 FACS	 analysis.	 FACS	was	 performed	 using	 a	
FACSAria	II	 flow	cytometer	from	Becton	Dickinson	(San	Jose,	CA)	and	FACSDiVa	software	
version	6.1.3.	
	
2.3.8	Gene	expression	analysis	
																Gene	 expression	 analysis	 was	 performed	 as	 described	with	modifications	 [304].	
Total	 RNA	 was	 isolated	 from	 ovaries	 using	 the	 PicoPure	 RNA	 isolation	 kit	 (Arcturus,	
Mountain	View,	CA)	according	to	the	manufacturer’s	protocol.	The	cDNA	preparation	was	
synthesized	 using	 random	 hexamers	 and	 the	 Superscript	 II	 cDNA	 synthesis	 system	
(Invitrogen	Corp.,	Carlsbad,	CA)	following	the	manufacturer’s	instruction.	Gene	expression	
was	 analyzed	by	 real‐time	PCR	using	Bio‐Rad	CFX96TM	Real‐Time	PCR	Detection	 system.	
Taqman	 gene‐expression	 probes	 (Gli1:	 Mm00494654_m1,	 Star:	 Mm00441558_m1,	
Cyp11a1:	Mm00490735_m1,	Cyp17a1:	Mm00484040_m1,	Lhcgr:	Mm00442931_m1)	were	
used	 to	detect	 the	 fold	 changes	of	 the	 transcripts.	 Fold	 changes	 in	 gene	expression	were	
determined	by	quantitation	of	cDNA	from	target	(treated)	samples	relative	to	a	calibrator	
sample	(control).	All	real‐time	PCR	analyses	were	performed	in	duplicate,	and	the	results	
were	 reported	 from	 at	 least	 three	 independent	 experiments.	 The	 relative	 fold	 change	 of	
transcript	was	 calculated	using	 the	mathematical	model	of	Pfaffl	 as	previously	described	
[305]	and	was	normalized	to	18S	rRNA	(Mm03928990_g1)	as	an	endogenous	reference.	
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2.4	Results	 	
2.4.1	Migrating	Gli1+	cells	from	the	mesonephros	contribute	to	the	ovarian	theca	cell	
lineage	
																The	expression	of	Gli1,	indicated	by	the	presence	of	beta‐galactosidase	in	the	Gli1‐
LacZ	 reporter	mouse,	was	absent	 in	the	ovary	before	birth	(E17.5)	and	did	not	appear	 in	
the	 ovary	 until	 postnatal	 day	 2	 (P2)	 (Fig.	 2.1).	 Before	 P2,	 Gli1‐LacZ	 expression	 was	
restricted	to	the	mesenchyme	of	the	mesonephros	immediately	adjacent	to	the	ovary	(Fig.	
2.1m	&	o),	particularly	in	the	mesonephric	tubules	that	connect	the	rete	ovarii	of	the	ovary	
(Fig.	2.1b).	Between	birth	and	P2,	Gli1‐LacZ‐positive	cells	spread	from	mesonephric	tubules	
into	ovarian	interstitium	(Fig.	2.1b,	c,	g	and	k).	By	P6,	Gli1‐LacZ‐positive	cells	were	found	in	
the	 mesenchyme	 surrounding	 the	 FOXL2‐positive	 granulosa	 cells	 (Fig.	 2.1d,	 h	 and	 l)	 of	
primary	follicles	(Fig.	2.3n	&	p).	This	pattern	persisted	in	the	ovary	at	2	months	of	age	(Fig.	
2.2a)	and	some	Gli1‐positive	cells	are	positive	for	steroidogenic	marker	3βHSD	(Fig.	2.2b)	
and	steroidogenic	factor‐1	(SF‐1)	(Fig.	2.2c).	The	close	association	of	Gli1‐positive	cells	 in	
the	 mesonephros	 and	 the	 ovary	 suggests	 that	 Gli1‐positive	 cells	 from	 the	 mesonephros	
could	 be	 a	 source	 of	 theca	 progenitors.	 To	 test	 this	 hypothesis,	 I	 utilized	 a	 tamoxifen‐
induced	 Rosa‐LSL‐tdTomato	 lineage‐tracing	 model,	 in	 which	 Gli1‐positive	 cells	 in	 the	
mesonephros	 were	 labeled	 exclusively	 during	 embryogenesis	 [306].	 When	 tamoxifen	 is	
injected	 to	 the	Gli1‐CreERT2;	Rosa‐LSL‐tdTomato	 animals,	 it	 activates	 CreER	 recombinase,	
which	 then	 induces	 permanent	 expression	 of	 tdTomato	 fluorescence	 in	 the	Gli1‐positive	
cells	and	their	progeny	[300,	307].	In	addition,	the	lineage	labeling	of	the	Gli1‐positive	cells	
lasts	for	approximately	36	hr	after	tamoxifen	injection	[308,	309].	I	administered	a	single	
tamoxifen	injection	to	pregnant	mice	carrying	Gli1‐CreERT2;	Rosa‐LSL‐tdTomato	embryos	at	
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E12.5,	when	Gli1	 expression	was	 restricted	 in	 the	mesonephros	 [280].	 The	 specificity	 of	
this	model	was	confirmed	by	the	lack	of	fluorescence	in	the	tamoxifen	treated	Cre‐negative	
ovaries,	 and	 the	 oil‐treated	 Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 controls	 (Fig.	 2.3).	 During	
fetal	 life,	 the	 tdTomato‐positive	 cells	 were	 present	 specifically	 in	 the	 mesonephros	 but	
absent	in	the	ovary	(Fig.	2.4a	&	b),	consistent	with	endogenous	Gli1	expression	pattern	(Fig.	
2.1a,	e	and	i).	The	tdTomato‐positive	cells	 first	appeared	 in	the	ovary	 just	before	birth	at	
E18.5	 (Fig.	 2.4c)	 and	 a	 significant	 number	 of	 these	 cells	 were	 observed	 in	 the	 neonatal	
ovary	(Fig.	2.4d).	This	result	demonstrates	that	the	tdTomato‐positive	cells	in	the	neonatal	
ovary	were	derived	from	the	Gli1‐positive	cells	in	the	fetal	mesonephros.	At	two	months	of	
age,	 the	 mesonephros‐derived	 Gli1‐positive	 cells	 in	 the	 ovarian	 interstitium	 became	
steroidogenic	theca	cells	positive	for	3HSD	(Fig.	2.4e).		
When	 comparing	 the	 Gli1‐positive	 cells	 in	 the	 ovary	 (Fig.	 2.1d	 &	 h)	 with	 the	
contribution	 of	Gli1‐positive	 cells	 from	 the	mesonephros	 (Fig.	 2.4e),	 it	 became	 apparent	
that	the	mesonephros‐derived	Gli1‐positive	cells	represent	a	small	 fraction	of	the	ovarian	
Gli1‐positive	 cell	 population.	 To	 exclude	 the	 possibility	 that	 the	 low	 number	 of	
mesonephros‐derived	Gli1‐positive	cells	is	due	to	inefficient	labeling	of	Gli1‐positive	cells	in	
the	 mesonephros,	 I	 increased	 tamoxifen‐induced	 lineage	 labeling	 by	 administrating	
tamoxifen	to	embryos	from	E12.5	to	E14.5	for	3	consecutive	days.	The	efficiency	of	lineage	
labeling	was	validated	in	E15.5	mesonephros,	and	the	majority	of	mesenchymal	cells	in	the	
mesonephros	 were	 positive	 for	 tdTomato	 (Fig.	 2.5a‐c).	 Although	 plenty	 of	 Gli1‐positive	
cells	 in	 the	mesonephros	were	 lineage	 labeled	during	 fetal	 life,	 it	seems	that	only	a	small	
number	of	 them	actually	migrated	 into	 the	ovary	after	birth	(Fig.	2.5d‐f).	The	majority	of	
theca	cells	therefore	seem	to	come	from	the	ovarian	mesenchymal	cells	that	become	Gli1‐
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positive	(Fig.	2.1g	&	h).	This	hypothesis	was	supported	by	the	findings	that	lineage‐labeled	
ovarian	Gli1‐positive	cells	at	P2	(Fig.	2.1c,	g,	k)	became	the	majority	of	the	3HSD‐positive	
cells	in	the	theca	compartment	(Fig.	2.4f)	in	the	adult	ovary.	Notably,	ovarian	Gli1‐positive	
cells	at	P2	gave	rise	to	nearly	all	cells	in	the	theca	cell	layer	(Fig.	2.4f).	Further	quantitative	
analysis	 of	 the	 lineage‐traced	 cell	 number	 revealed	 that	 the	 mesonephros‐derived	 Gli1‐
positive	cells	only	contribute	to	about	1%	of	the	total	cells	in	the	adult	ovary,	whereas	the	
neonatal	ovary‐derived	Gli1‐positive	cells	give	rise	to	around	41%	of	the	total	cells	 in	the	
ovary	 (Table	 2.1).	 These	 results	 suggest	 that	 a	 small	 percentage	 of	 the	 theca	 cells	 in	 the	
adult	ovary	are	derived	from	the	mesonephros	whereas	the	majority	of	the	theca	cells	must	
come	from	progenitor	cells	that	originated	in	the	ovarian	mesenchyme.		
	
2.4.2	Fetal	ovary‐derived	Wt1+	cells	are	the	main	source	of	theca	cell	population	
The	 progenitor	 cells	 in	 the	 gonadal	 primordium	 are	 thought	 to	 be	 the	 bona	 fide	
source	of	gonadal	somatic	cells	[310].	When	the	somatic	cell	progenitors	first	appear	in	the	
gonad,	 they	 express	 Wilms’	 tumor	 1	 (Wt1),	 a	 transcription	 factor	 essential	 for	 gonadal	
formation	[4,	311].		To	determine	if	the	gonad‐derived	Wt1‐positive	cells	contribute	to	the	
theca	 cell	 lineage,	 I	 performed	 similar	 tamoxifen‐induced	 lineage‐tracing	 experiments	 by	
labeling	 the	Wt1‐postive	 cells	 in	Wt1‐CreERT2;	Rosa‐LSL‐tdTomato	 gonads	 at	 the	 onset	 of	
sex	 determination	 (E10.5).	 Twenty‐four	 hours	 after	 tamoxifen	 treatment	 (E11.5),	 the	
lineage‐labeled	Wt1‐positive	cells	were	present	in	the	somatic	compartment	of	fetal	ovaries,	
overlapping	with	endogenous	WT1	protein	(Fig.	2.6a	&	d).	At	E13.5	and	E18.5,	fetal	ovary‐
derived	Wt1‐positive	cells	gave	rise	to	both	FOXL2‐positive	cells	and	FOXL2‐negative	cells	
in	 the	 developing	 ovary	 (Fig.	 2.6b,	 c,	 e	 and	 f),	 and	 were	 located	 mostly	 in	 the	 ovarian	
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interstitium	delineated	by	laminin	staining	(Fig.	2.7a,	b,	d	and	e).		At	one	month	of	age,	the	
ovary‐derived	Wt1‐positive	cells	were	located	in	the	ovarian	interstitium	surrounding	the	
follicles	 and	 positive	 for	 3HSD	 (Fig.	 2.7c,	 f).	 These	 results	 indicate	 that	Wt1	 marks	 a	
specific	 pool	 of	 steroidogenic	 precursors	 in	 the	 gonadal	 primordium	 before	 sexual	
differentiation	occurs.		
To	 further	 investigate	 if	 these	 fetal	 ovary‐derived	Wt1‐positive	 cells	 become	Gli1‐
positive	theca	progenitor	cells	after	birth	(Fig.	2.1g	&	h),	I	examined	the	induction	of	Gli1‐
LacZ	expression	in	the	Wt1‐positive	cells	in	postnatal	ovaries.	When	the	fetal	ovary‐derived	
Wt1‐positive	cells	began	to	surround	the	primary	follicles	 in	the	medulla	of	 the	postnatal	
ovary,	 they	 acquired	 the	 expression	 of	 Gli1,	 indicating	 that	 they	 have	 committed	 to	 the	
theca	cell	lineage	(Fig.	2.8).	In	ovaries	from	2‐month	old	mice,	the	fetal	ovary‐derived	Wt1‐
positive	 cells	 occupied	 almost	 the	 entire	 theca	 cell	 layer	 and	 they	 were	 positive	 for	
endogenous	Gli1‐LacZ	(Fig.	2.9).		
One	thing	to	note	 is	that	 the	fetal‐ovary	derived	Wt1‐positive	cells	give	rise	to	not	
only	 FOXL2‐negtive	 population	 but	 also	 FOXL2‐positive	 population	 at	 fetal	 and	 neonatal	
stages	(Fig.	2.6	and	Fig.	2.8b).	This	observation	suggests	that	the	fetal‐ovary	derived	Wt1‐
positive	cells	should	also	give	rise	to	adult	granulosa	cells,	however,	endogenous	tdTomato	
signals	somehow	were	not	observed	 in	granulosa	cells	 in	adult	ovaries	(Fig.	2.7c	and	Fig.	
2.9d).	 To	 enhance	 the	 tdTomato	 signals,	 I	 used	 an	 antibody	 specific	 to	 tdTomato	 and	
demonstrated	 the	 presence	 of	 tdTomato	 signals	 in	 granulosa	 cells	 of	 the	 developing	
follicles	in	adult	ovary	(Fig.	2.10).	This	result	indicates	that	first,	in	addition	to	theca	cells,	
fetal	 ovary‐derived	Wt1‐positive	 cells	 also	 give	 rise	 to	 granulosa	 cells	 in	 the	 adult	ovary.	
Second,	 it	 suggests	 that	 both	 granulosa	 cells	 and	 theca	 cells	 are	 derived	 from	 the	 same	
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progenitor	 population	 (Wt1‐positive)	 in	 the	 fetal	 ovary.	 However,	 the	 mechanisms	 that	
specify	the	two	different	ovarian	somatic	cell	lineages	remain	to	be	explored.	
																	One	potential	concern	regarding	the	Wt1‐	lineage‐tracing	experiments	is	that	Wt1	
is	not	only	expressed	 in	 the	 fetal	ovary,	but	also	expressed	 in	 the	 fetal	mesonephros	and	
might	 therefore	 contribute	 to	 adult	 theca	 cells	 as	 well.	 	 To	 further	 investigate	 this	
possibility,	I	examined	the	Gli1‐LacZ	expression	in	the	lineage‐labeled	Wt1‐positive	cells	in	
the	 mesonephros.	 It	 was	 apparent	 that	 Gli1‐postive	 cells	 and	 the	 lineage‐labeled	Wt1‐
positive	 cells	 in	 the	mesonephros	 represent	almost	 the	 same	population	 (Fig.	2.11).	This	
observation	 suggests	 that,	 even	 if	 the	 lineage‐labeled	 Wt1‐positive	 cells	 in	 the	
mesonephros	were	to	migrate	into	ovary	and	became	theca	cells,	they	would	represent	the	
same	population	as	 the	mesonephros‐derived	Gli1‐positive	cells,	and	only	contribute	 to	a	
small	percentage	of	adult	theca	cell	population.	
	
2.4.3	Characterization	of	the	mesonephros‐derived	Gli1+	cells		
Fetal	ovary‐derived	Wt1‐positive	cells	and	mesonephros‐derived	Gli1‐positive	cells	
appear	 to	 represent	 two	 different	 populations	 of	 theca	 cells.	 Fetal	 ovary‐derived	Wt1‐
positive	 cells	 were	 found	 in	 the	 entire	 theca	 in	 the	 adult	 ovary	 (Fig.	 2.9),	 whereas	
mesonephros‐derived	Gli1‐positive	cells	were	located	preferentially	near	the	basal	lamina	
(Fig.	2.12),	a	region	that	contains	predominantly	steroidogenic	cells	[24].	This	observation	
leads	to	the	hypothesis	that	these	mesonephros‐derived	Gli1‐positive	cells	represent	a	pure	
population	 of	 steroidogenic	 cells.	 I	 isolated	mesonephros‐derived	Gli1‐positive	 cells	 (Fig.	
2.4e)	and	neonatal	ovary‐derived	Gli1‐positive	cells	(Fig.	2.4f)	by	FACS	from	2	month‐old	
mice,	 and	 compared	 their	 transcriptomes	 (Fig.	 2.13a).	 The	 mesonephros‐derived	 theca	
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cells	 and	 the	 ovary‐derived	 theca	 cells	 shared	 a	 common	 transcriptome	 profile	 yet	 they	
exhibit	a	gene	expression	profiling	distinct	from	each	other.	Among	45,101	tested	probes,	
4,936	were	 differentially	 expressed	 (Fig.	 2.13a).	 Among	 the	 4,936	 probes,	 2,223	 probes	
were	higher	 in	the	ovary‐derived	Gli1‐positive	cells,	 including	Esr1	(Estrogen	receptor	1),	
Wt1,	and	genes	implicated	in	cell	growth	and	proliferation.	Many	of	the	signaling	pathways	
that	 were	 activated	 are	 not	 only	 involved	 in	 cell	 growth	 and	 proliferation,	 but	 also	
associated	with	progression	of	PCOS	and	cancers	such	as	RhoA	signaling	[312,	313],	MAKP	
signaling	[314,	315],	and	Wnt/β‐catenin	signaling	[316‐318]	(Table	2.2	and	Fig.	2.13a).	On	
the	other	hand,	2,716	probes	were	enriched	in	the	mesonephros‐derived	Gli1‐positive	cells	
including	the	genes	associated	with	steroidogenesis,	such	as	Star,	Cyp11a1,	Cyp17a1,	Lhcgr	
and	 HSD17b3	 (Fig.	 2.13b	 and	 table	 2.2),	 indicating	 that	 the	 mesonephros‐derived	 Gli1‐
positive	cells	are	more	steroidogenically	active	 than	 the	ovary‐derived	Gli1‐positive	cells.		
The	 steroidogenic	 activity	 of	 these	 cells	 was	 also	 confirmed	 by	 immunostaining	 with	
3βHSD	 (Fig.	 2.14).	 These	 results	 altogether	 demonstrate	 that	 ovary‐derived	Gli1‐positive	
cells	represent	a	broad	mesenchymal	cell	population(s),	whereas	the	mesonephros‐derived	
Gli1‐positive	cells	contribute	to	the	steroidogenic	theca	cell	population.			
	
2.4.4	 Neonatal	 Gli1+	 cells	 in	 the	 ovary	 are	 functionally	 important	 for	 ovarian	
development	
																The	findings	that	two	sources	of	theca	progenitor	pools	converge	and	become	Gli1‐
positive	cells	in	the	ovary	prompted	us	to	examine	the	functional	significance	of	these	Gli1‐
positive	cells.	I	developed	a	genetic	model	(Gli1‐CreERT2;	Rosa‐DTA)	that	induces	cell	death	
specifically	in	the	Gli1‐positive	cells	of	the	ovary	after	birth.	Because	ovarian	Gli1‐positive	
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cells	consist	of	cells	both	 from	the	mesonephros	(Gli1‐positive)	and	the	 fetal	ovary	(Wt1‐
positive),	 this	 cell	 ablation	model	 induces	 cell	 death	 in	 both	 sources	 of	 theca	 progenitor	
cells.		Tamoxifen	treatment	induces	the	expression	of	DTA	(diphtheria	toxin	fragment	A)	in	
the	 Gli1‐positive	 cells,	 which	 subsequently	 undergo	 apoptosis	 [319].	 I	 administered	
tamoxifen	to	the	Gli1‐CreERT2;	Rosa‐DTA	pups	and	their	littermate	controls	via	the	milk	by	
injecting	 lactating	dam	from	PD1	to	PD4,	when	Gli1	expression	first	appears	 in	 the	ovary	
(Fig.	 2.1c,	 d,	 g	 and	 h).	 Because	Gli1	 is	 also	 expressed	 in	 essential	 organs	 such	 as	 brain,	
ablation	 of	 Gli1‐positive	 cells	 could	 negatively	 impact	 the	 general	 development	 of	 the	
animals.	To	 circumvent	 this	potential	 complication,	 I	 removed	 the	ovaries	 from	 the	pups	
after	4	days	of	 tamoxifen	 treatment,	 transplanted	 them	under	 the	kidney	capsule	of	wild	
type	 ovariectomized	mice,	 and	 examined	 the	 ovaries	 2	weeks	 after	 transplantation	 (Fig.	
2.15a).		Ablation	of	the	Gli1‐positive	cells	resulted	in	a	decrease	in	ovarian	mass	and	follicle	
numbers	and	a	complete	loss	of	primary	follicles	compared	to	the	controls	(Fig.	2.15b	&	c).	
Immunostaining	 for	 the	 steroidogenic	 marker	 3βHSD	 shows	 decreased	 expression	 of	
steroidogenic	 enzymes	 (Fig.	 2.15d	 &	 e).	 These	 results	 altogether	 indicate	 that	 the	 Gli1‐
positive	 theca	 progenitor	 cells	 in	 the	 neonatal	 ovary	 are	 indispensable	 for	 ovarian	
development.		
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2.5	Discussion		
															My	study	provided	the	first	genetic	evidence	for	the	two	origins	of	theca	progenitor	
cells	 in	 the	mouse	ovary:	mesonephros	 (Gli1‐positive)	and	somatic	precursors	within	 the	
fetal	 ovary	 (Wt1‐positive).	 	 Theca	 progenitor	 cells	 from	 divergent	 sources	 acquire	 the	
expression	of	Gli1	 during	 their	 commitment	 to	 the	 theca	 cell	 lineage	 (Fig.	 2.16).	 Further,	
genetic	ablation	of	the	neonatal	Gli1‐positive	theca	progenitor	cells	results	in	fewer	follicle	
numbers	and	renders	the	ovary	smaller	in	size.	
																Before	 P2,	 Gli1‐LacZ	 expression	 was	 restricted	 in	 the	 mesonephric	 tubules	 that	
connect	the	rete	ovarii	of	the	ovary.	The	rete	ovarii	 is	anastomosing	tubule‐like	structure	
lined	 by	 cuboidal	 or	 columnar	 epithelium	 [320],	 and	 its	 formation	 is	 thought	 to	 be	
contributed	by	cells	 from	the	mesonephros	[321].	 	This	specialized	structure	 interests	us	
because	 rete	 ovarii	 has	 been	 suggested	 an	 important	 source	 of	 granulosa	 cells	 of	 the	
developing	 follicles	 in	mammals	 such	 as	mink,	 cat,	 ferret,	 mouse	 and	 rat	 [29,	 320‐322].	
Because	Gli1‐LacZ	expression	seems	to	spread	from	mesonephros	into	ovary	via	rete‐ovarii,	
I	 therefore	 hypothesized	 that	 Gli1‐positive	 cells	 from	 mesonephros	 could	 contribute	 to	
somatic	cells	in	the	ovary.			
																In	 contrast	 to	 the	 long‐standing	 assumption	 that	 theca	 cells	 only	 derive	 from	
within	the	ovarian	stroma	[48,	54,	55,	57,	299],	my	results	reveal	an	extra‐ovarian	source	
of	Gli1‐positive	cells	from	the	mesonephros	that	contributes	to	the	adult	theca	cell	lineage.	
For	 a	 long	 time,	 the	 mesonephric	 contribution	 to	 gonadal	 morphogenesis	 has	 been	
considered	a	male‐specific	event	[295],	as	 the	migration	of	mesonephric	cells	 into	the	XY	
gonads	occurs	 from	E11.5	to	E16.5	but	 this	phenomenon	 is	never	observed	in	XX	gonads	
[323].	The	migrating	cells	in	XY	gonads	appear	to	be	exclusively	endothelial	cells,	which	are	
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essential	 for	 the	 formation	 of	 testis	 cords	 [295,	 324].	 	 My	 finding	 of	 the	 mesonephros‐
derived	Gli1‐positive	cells	contributing	to	the	theca	cell	 lineage	in	the	ovary	suggests	that	
such	migration	event	also	happens	in	the	female.	While	the	mesonephric	cells	migrate	into	
testis	 at	 E11.5	 for	 the	 formation	 of	 testis	 cords,	 the	migration	 of	mesonephric	 cells	 into	
ovary	does	not	occur	until	 right	before	birth,	when	 the	process	of	 folliculogenesis	 is	 just	
initiated.	One	seemingly	conflicting	fact	is	that	the	mesonephros‐derived	Gli1‐positive	cells	
migrate	into	the	ovary	prior	to	birth,	whereas	the	endogenous	Gli1	expression	in	the	ovary	
is	not	observed	until	after	birth.	This	 is	because	 first,	 lineage	 labeling	of	 tdTomato	to	the	
Gli1‐expressing	cells	only	occurs	at	the	time	of	tamoxifein	treatment	(E12.5),	therefore	the	
expression	 of	 tdToamto	 does	 not	 reflect	 the	 endogenous	Gli1	 expression	 later	 on	 in	 the	
ovary.	 Second,	Hh	 signaling	 is	 known	 to	be	 inactive	 in	 the	ovary	during	 fetal	 stage	 [279,	
280].	 This	 inactive	 status	 of	 Hh	 signaling	 is	 necessary	 for	 fetal	 ovary	 development,	 as	
ectopic	activation	of	Hh	signaling	in	the	fetal	ovary	leads	to	the	appearance	of	fetal	Leydig	
cells	[285].		
																My	 present	 finding	 that	 theca	 cell	 precursors	 originate	 from	 multiple‐sources	
raises	 several	 important	 questions.	 For	 instance,	 why,	 and	 for	 what	 purpose,	 are	 two	
sources	of	theca	progenitor	pools	needed	for	ovarian	function?	Furthermore,	what	induces	
the	migration	of	the	Gli1‐positive	cells	from	the	mesonephros?	Because	theca	cells	are	only	
associated	with	developing	follicles,	their	recruitment	is	probably	regulated	by	factors	from	
the	activated	primary	follicles	[50,	137].	In	agreement	with	this,	the	mesonephros‐derived	
Gli1‐positive	cells	were	seen	first	in	the	medulla	of	the	ovary	at	birth,	where	the	formation	
of	 primary	 follicle	 occurs.	 	 It	 is	 not	 clear	why	 two	 theca	 progenitor	 cell	 populations	 are	
needed	for	ovarian	development.		Because	theca	cells	are	only	associated	with	developing	
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follicles,	one	would	assume	that	the	presence	of	two	theca	progenitor	pools	is	involved	in	
follicular	development.	Interestingly,	two	classes	of	primordial	follicles	seem	to	exist	in	the	
ovary:	the	primordial	follicles	(first	wave)	activated	immediately	after	birth	in	the	medulla	
of	the	ovary,	and	the	primordial	follicles	(second	wave)	that	are	gradually	activated	later	in	
adulthood	 in	 ovarian	 cortex	 [21].	 The	 first	 wave	 of	 primordial	 follicles	 has	 long	 been	
considered,	for	the	most	part,	not	contributing	to	fertility	because	they	are	depleted	from	
the	ovary	via	atresia	[20‐22],	whereas	the	second	wave	of	primordial	follicles	are	expected	
to	be	the	follicles	that	ovulate	over	the	entire	 female	reproductive	 life	[20‐23].	 	Similarly,	
the	 granulosa	 cell	 precursors	 that	 comprise	 each	 primordial	 follicle	 also	 appear	 to	 be	 a	
heterogeneous	population.	The	pre‐granulosa	cells	 specified	during	 fetal	 stage	contribute	
to	the	first	wave	of	primordial	follicles	in	the	medulla	of	the	ovary	immediately	after	birth.	
On	the	other	hand,	the	granulosa	cells	recruited	in	the	cortex	of	postnatal	ovaries	forming	
the	 second	 wave	 of	 primordial	 follicles	 later	 in	 adulthood	 [21,	 22].	 	 Along	 the	 line	 of	
evidence,	my	finding	demonstrated	that	theca	cells	also	arise	from	two	distinct	sources.	It	
is	therefore	possible	that	the	two	sources	of	theca	progenitor	cells	are	involved	in	the	two	
waves	 of	 follicular	 development.	 In	 fact,	 the	mesonephros‐derived	Gli1‐positive	 cells	 are	
first	 seen	 in	 the	 medulla	 of	 the	 neonatal	 ovary	 where	 the	 first	 wave	 of	 follicular	
development	 occurs.	 This	 observation	 suggests	 that	 the	 mesonephros‐derived	 theca	
progenitor	cells	may	be	implicated	in	the	initiation	of	the	first	wave	of	folliculogenesis.		
																There	are	a	few	interesting	things	to	note	regarding	the	mesonephros‐derived	Gli1‐
positive	cells.	First,	they	migrate	into	ovary	at	around	time	of	birth,	concomitant	with	first	
wave	of	 follicular	development.	Second,	 these	cells	start	 in	 few	numbers.	Third,	 they	give	
rise	to	almost	exclusively	steroidogenic	theca	cells	 in	the	adult	ovary.	These	observations	
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lead	me	to	revisit	the	idea	of	the	existence	of	theca	stem	cells.	Previous	work	by	Honda	et	al	
[57]	 indicated	 that	 newborn	 mouse	 ovaries	 contain	 “putative	 theca	 stem	 cells”.	 These	
putative	stem	cells,	when	isolated	from	newborn	ovaries,	have	the	capacity	to	differentiate	
into	 androgen‐producing	 cells	 in	 culture,	with	molecular	 and	 cellular	 characteristics	 that	
resemble	steroidogenic	theca	cells.	When	injected	into	host	ovaries,	these	cells	colonized	in	
the	 interstitium	of	 the	ovary	where	 theca	 cells	 are	 located	 [57].	Although	 these	neonatal	
“theca	stem	cells”	demonstrated	great	capacity	 to	differentiate	 into	 functional	 theca	cells,	
their	true	 identify	was	never	defined,	as	these	cells	were	unexpectedly	obtained	using	an	
isolation	procedure	optimized	to	male	germline	stem	cells	from	neonatal	testes	[57].	Do	the	
mesonephros‐derived	Gli1‐positive	cells	in	the	neonatal	ovaries	represent	the	“theca	stem	
cells”	 in	vivo?	 Do	 they	 exhibit	 stem	 cell	 properties	 when	 cultured	 in	vitro?	 It	 would	 be	
interesting	 to	 investigate	 the	 stem	 cell	 aspects	 of	 the	mesonephros‐derived	Gli1‐positive	
cells	in	future	studies.		
																It	 is	 not	 clear	 whether	 mesonephros‐derived	 Gli1‐positive	 cells	 are	 functionally	
important	for	ovarian	function.	Studies	dealing	with	fetal	ovary	transplantations	provided	
us	 some	 clues.	When	 the	 fetal	 ovaries	without	mesonephroi	 attached	were	 transplanted	
under	 the	 kidney	 capsule	 of	 recipient	 female	 mice,	 the	 ovarian	 grafts	 exhibited	 the	
progression	 of	 follicle	 development	 till	 antral	 stage	 [325].	 In	 another	 study,	 the	
reaggregated	ovarian	 cells	 from	 fetal	 ovaries,	when	 transplanted	 into	 the	 recipient	mice,	
reorganized	 into	 ovarian	 tissue	with	 different	 stages	 of	 follicle	 development	 [325,	 326].		
These	 observations	 suggest	 that	 follicle	 development	 does	 not	 require	 the	 presence	 of	
mesonephros,	 although	 whether	 long‐term	 folliculogenesis	 is	 contributed	 by	 cell	 from	
mesonephros	 is	not	known.	 	 Interestingly,	when	 fetal	ovaries	without	mesonephroi	were	
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transplanted	into	female	hosts,	they	develop	into	ovotestis	at	a	much	higher	frequency	than	
the	ovaries	transplanted	with	intact	mesonephroi	attached	[327].	This	result	suggests	that	
fetal	mesonephros	somehow	prevents	the	sex‐reversal	of	the	ovarian	grafts	in	female	hosts.	
Based	 on	 these	 observations,	 I	 suspect	 that	 mesonephros‐derived	Gli1‐positive	 cells	 are	
dispensable	for	ovarian	folliculogenesis	for	at	least	short‐term	fertility;	however,	they	may	
also	 be	 critically	 involved	 in	 other	 aspects	 of	 ovarian	 functions	 other	 than	 follicular	
development.		
																When	 compare	 the	 mesonephros‐derived	 Gli1‐positive	 cells	 and	 the	 neonatal	
ovary‐derived	 Gli1‐positive	 cells,	 their	 transcriptome	 profile	 appear	 to	 be	 distinct	 from	
each	other.	Genes	involved	in	steroidogenesis	such	as	Cyp17a1	are	highly	expressed	in	the	
mesonephros‐derived	Gli1‐positive	 cells.	 	 On	 the	 other	 hand,	 the	 neonatal	 ovary‐derived	
Gli1‐positive	 cells	 enrich	 for	Esr1,	Wt1	 and	 genes	 likely	 associated	with	 cell	 proliferation	
(Table	 2.2).	 Notably,	 Esr1	 and	 Cyp17a1	 are	 both	 specifically	 expressed	 in	 the	 theca	 cell	
layer	 and	 are	 considered	 theca	 cell	markers.	My	 finding	 of	 the	 differential	 expression	 of	
Cyp17a1	and	Esr1	in	two	theca	cell	populations	suggests	that	the	heterogeneous	theca	cell	
populations	might	be	 responsive	 to	different	 regulatory	signaling.	 	 	The	difference	 in	 the	
gene	 expression	 profiling	 likely	 results	 from	 the	 distinct	 contributions	 of	 the	 two	 theca	
progenitor	 populations:	 the	 mesonephros‐derived	 Gli1‐positive	 cells	 only	 contribute	 to	
steroidogenic	 theca	 cells,	 but	 the	 ovary‐derived	Gli1‐positive	 cells	 give	 rise	 to	 almost	 all	
cells	 in	 the	 interstitium	of	 the	 adult	 ovaries	 including	 steroidogenic	 theca	 cells	 and	non‐
steroidogenic	cells.			
																One	remain	question	is	why	do	some	ovary‐derived	Gli1‐positive	cells	give	rise	to	
steroidogenic	 cells	 and	 some	 do	 not?	 This	 phenomenon	 would	 make	 more	 sense	 if	 we	
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revisit	 the	 endogenous	 Gli1	 expression	 pattern	 in	 the	 adult	 ovary.	 Although	 Gli1	 is	
specifically	 expressed	 in	 the	 theca	 cell	 layer	 in	 the	 adult	 ovary,	 Gli1‐positive	 cells	 are	
nevertheless	a	heterogeneous	population	containing	both	3βHSD‐positive	cells	and	3βHSD‐
negative	 cells.	 In	 a	 similar	 manner,	 the	 lineage‐traced	 Gli1‐positive	 cells	 from	 neonatal	
ovary	 give	 rise	 to	 both	 steroidogenic	 positive	 cells	 and	 non‐steroidogenic	 cells	 in	 adult	
ovary.	My	 interpretation	 is	 that	Gli1	marks	 a	 board	 theca	 cell	 population	 including	 both	
steroidogenic	 cells	 and	 non‐steroidogenic	 cells.	While	 the	 steroidogenic	 cells	 are	mostly	
derived	from	the	mesonephros‐derived	Gli1‐positive	cells	that	locate	immediately	adjacent	
to	 the	developing	 follicles,	 the	non‐steroidogenic	cells	are	predominantly	originated	from	
the	ovary‐derived	Wt1‐positive	cells	that	occupy	almost	the	entire	theca	layer.	This	finding	
is	 in	 tune	with	pre‐existing	knowledge	 that	 theca	 cell	 layer	 consists	of	 theca	 interna	and	
theca	 externa.	Theca	 interna	 locates	 right	next	 to	 the	 follicles	 and	 is	 highly	 vascular	 and	
steroidogenic,	 whereas	 theca	 externa	 sits	 outside	 the	 theca	 interna	 and	 is	 composed	 of	
mostly	non‐steroidogenic	cells	such	as	fibroblast	cells	and	smooth	muscle	cells	 important	
for	ovulation	[19].		
																When	the	two	sources	of	theca	progenitor	cells	are	ablated	in	the	neonatal	ovaries,	
the	ovaries	become	smaller	in	size	and	exhibit	the	lack	of	primary	follicles.	The	smaller	size	
of	the	ovary	is	expected	because	the	Gli1‐positive	theca	progenitor	cells	are	removed	from	
the	ovary	at	birth.	These	 theca	progenitor	cells	acquire	 the	expression	of	Gli1	when	 they	
start	to	surround	the	primary	follicles.	 In	this	sense,	the	ablation	of	the	Gli1‐positive	cells	
likely	disrupt	the	development	of	the	primary	follicles	so	that	primary	follicles	are	missing	
in	 the	 ovarian	 grafts	 two	 weeks	 after	 transplantation.	 Because	 the	 tamoxifen	
administration	 to	 the	 pups	 is	 potentially	 affected	 by	 multiple	 factors	 such	 as	 the	 dams’	
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metabolism	and	their	lactating	ability,	and	how	much	milk	each	pup	actually	obtained,	the	
cell	 ablation	 in	 the	 neonatal	 ovaries	 is	 not	 100%	 and	 that	 may	 explain	 the	 presence	 of	
remaining	follicles	in	the	ovarian	grafts.	It	is	not	yet	certain	whether	the	phenotypes	of	the	
ovarian	 grafts	 are	 permanent,	 or	 it	will	 be	 restored	 over	 time.	 However,	 I	 expect	 that	 if	
given	 enough	 time,	 the	 Gli1‐positive	 cell	 ablated	 ovaries	 should	 recover	 their	
folliculogenesis,	 mostly	 because	 1)	 the	 primordial	 follicles	 are	 still	 present	 in	 the	 Gli1‐
positive	cells	ablated	ovaries;	2)	the	ovarian	surface	epithelium	can	give	rise	to	granulosa	
cells	that	comprise	new	follicles	to	compensate	the	loss	of	follicles	in	the	Gli1‐positive	cells	
ablated	ovaries	 (see	Chapter	1);	3)	 the	ablation	 is	not	100%	so	 that	 the	 remaining	 theca	
progenitor	cells	might	re‐populate	over	time	and	resume	follicular	development.	
															In	 summary,	 my	 findings	 of	 two	 origins	 of	 theca	 cells	 and	 their	 distinct	
transcriptomes	provide	 important	 information	regarding	 theca	cell	development.	 I	 reveal	
that	 theca	 cells	 stem	 from	 two	 sources	 during	 development:	 precursor	 cells	 intrinsic	 to	
fetal	ovary	and	the	mesenchymal	cells	in	the	fetal	mesonephros.	Their	differences	in	origins	
and	 gene	 expression	 profiling	 provide	 developmental	 basis	 and	 genetic	 evidence	 for	 the	
heterogeneity	 and	 complex	 of	 the	 theca	 cell	 population.	 	 Disregualtion	 of	 theca	 cells	 are	
linked	to	many	ovarian	diseases	such	as	polycystic	ovarian	syndrome	and	ovarian	cancers	
[233,	270,	292].	My	discovery	of	theca	cell	origins	not	only	answers	a	fundamental	question	
in	 ovarian	 biology,	 but	 also	 assists	 in	 our	 understanding	 the	 normal	 process	 of	
development	and	how	diseases	such	as	infertility	and	ovarian	cancer	may	arise.		
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2.6	Figures	and	Tables	
Figure	2.1	
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Figure	2.1:	Time	course	analyses	of	Gli1	expression	in	the	ovary	and	mesonephros.	a‐
l,	Expression	of	Gli1‐LacZ	in	the	developing	ovaries	was	detected	by	whole	mount	beta‐
cfrgalactosidase	staining	(a‐d)	or	fluorescent	immunohistochemistry	for	Gli1‐positive	cell	
marker	LacZ,	granulosa	cell	marker	FOXL2,	and	nuclear	counterstain	DAPI	in	lower	
magnification	(e‐h)	and	higher	magnification	images	(i‐l).	Arrow,	mesonephric	tubules;	E,	
embryonic	day;	Ov,	ovary;	Ms,	mesonephros;	P,	postnatal	day.	Scale	bar:	a‐d,	500	m;	e‐l,	
25	m.	m‐p,	Transverse	sections	of	E17.5	(m,	o)	and	P6	ovary	(n,	p)	and	mesonephros	from	
Gli1‐LacZ	reporter	embryos	after	LacZ	staining	(blue)	in	lower	magnification	(m,	n)	and	
higher	magnification	(o,	p)	images.	The	sections	were	counterstained	with	nuclear	FastRed	
(red).	Ov,	ovary;	Ms,	mesonephros.	Scale	bar:	100	m.	
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Figure	 2.2:	 Expression	 of	 Gli1‐LacZ	 in	 the	 adult	 ovary.	 a‐c,	 Fluorescent	
immunohistochemistry	 for	 LacZ	 (green)	 with	 granulosa	 cell	 marker	 FOXL2	 (red)	 (a),	 or	
steroidogenic	cell	marker	3HSD	(red)	(b),	or	SF1	(red),	a	regulator	of	steroidogenesis		in	
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Gli1‐LacZ	ovaries	at	2	months	of	age.	The	inset	is	higher	magnification	of	the	outlined	area.	
Scale	bar.	25	m.	
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Figure	2.3:	Cre‐mediated	tdTomato	expression	is	not	observed	in	the	absence	of	Cre	
or	 tamoxifen.	 a‐c,	 Tamoxifen	 or	 oil	 was	 administered	 at	 E12.5	 and	 the	 ovaries	 were	
analyzed	for	tdTomato	(red)	at	birth.	tdTomato	expression	is	only	detected	in	Gli1‐CreERT2;	
Rosa‐LSL‐tdTomato	 ovaries	 that	 were	 treated	 with	 tamoxifen	 (c),	 but	 not	 in	 the	 Cre‐
negative	 control	 (b),	nor	 the	oil‐treated	 control	 (a).	Mesonephroi	were	 removed	 from	all	
ovaries	for	imaging.	Ov,	ovary;	Ms,	mesonephros.		Scale	bar:	500	m.	
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Figure	 2.4:	 Lineage‐tracing	 experiments	 for	 the	 Gli1‐positive	 cells	 in	 the	
mesonephros	and	ovary.	a‐f,	Lineage‐tracing	of	the	Gli1‐positive	cells	in	the	Gli1‐CreERT2;	
Rosa‐LSL‐tdTomato	 embryos	 was	 induced	 by	 tamoxifen	 (TM)	 administration	 at	 E12.5	
(mesonephros‐derived,	 a‐e),	 or	 at	 P2	 (neonatal	 ovary‐derived,	 f).	 The	 ovaries	 were	
examined	at	different	 stages	of	development	 for	 tdTomato,	 steroidogenic	marker	3HSD,	
and	 DAPI.	 From	 E17.5	 to	 birth,	mesonephroi	 were	 removed	 from	 the	 ovaries	 for	 better	
imaging	(b‐d).	The	staining	for	3HSD	was	observed	not	only	in	theca	cell	layer	but	also	in	
granulosa	 cells	 in	 large	 antral	 follicles	 (e	 &	 f).	 The	 insets	 in	 (e)	 and	 (f)	 are	 higher	
magnification	of	the	outlined	areas.	Ov,	ovary;	Ms,	mesonephros.		Scale	bar:	a‐d,	500	m;	e‐f,	
25	m.		
	 56
	
Figure	2.5:	Lineage‐tracing	experiments	 for	 the	mesonephros‐derived	Gli1‐positive	
cells	 in	 the	mesonephros	 and	ovary.	 a‐f,	 The	 lineage‐tracing	 of	 mesonephros‐derived	
Gli1‐positive	 cells	 in	 the	 Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 embryos	 was	 induced	 by	
tamoxifen	 administration	 from	 E12.5‐E14.5,	 and	 the	 mesonephroi	 and	 ovaries	 were	
analyzed	 at	 E15.5	 and	 P5	 for	 tdTomato	 (red),	 granulosa	 cell	 marker	 FOXL2	 (cyan)	 and	
DAPI	(Grey).	Ov,	ovary;	Ms,	mesonephros.		Scale	bar:	25	m.		
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Figure	2.6:	Lineage‐tracing	experiments	 for	the	Wt1‐positive	cells	 in	the	ovary.	a‐d,	
Lineage‐tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	in	the	Wt1‐CreERT2;	Rosa‐LSL‐
tdTomato	embryos	was	 induced	by	 tamoxifen	 (TM)	 administration	 at	 E10.5.	 The	 ovaries	
were	analyzed	at	different	stages	of	development	by	fluorescent	immunohistochemistry	for	
tdTomato,	WT1,	 germ	 cell	marker	PECAM‐1,	 granulosa	 cell	marker	 FOXL2,	 steroidogenic	
cell	marker	3HSD,	and	DAPI.	E=	embryonic	day.	e‐h,	higher	magnification	of	the	outlined	
areas	in	(a‐d).	Scale	bar:	25	m.	Arrows	indicate	fetal	ovary‐derived	Wt1‐positive	cells.		
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Figure	2.7:	Lineage‐tracing	experiments	 for	the	Wt1‐positive	cells	 in	the	ovary.	a‐b,	
Lineage‐tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	in	the	Wt1‐CreERT2;	Rosa‐LSL‐
tdTomato	embryos	was	 induced	by	 tamoxifen	 (TM)	 administration	 at	 E10.5.	 The	 ovaries	
were	analyzed	at	different	stages	of	development	by	fluorescent	immunohistochemistry	for	
tdTomato	(red),	germ	cell	marker	TRA98	(cyan),	and	laminin	that	marks	basal	membrane	
(green).	E=	embryonic	day.	c‐d,	 higher	magnification	of	 the	outlined	areas	 in	 (a‐b).	 Scale	
bar:	25	m.		
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Figure	2.8:	Fetal	ovary‐derived	Wt1‐positive	cells	acquire	 the	expression	of	Gli1	 in	
the	perinatal	ovary.	a,	Lineage	tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	in	the	
Wt1‐CreERT2;	 Rosa‐LSL‐tdTomato;	 Gli1‐LacZ	 embryos	 was	 induced	 by	 tamoxifen	 (TM)	
administration	 at	 E10.5.	 The	 ovaries	 were	 analyzed	 at	 P4	 by	 fluorescent	
immunohistochemistry	 for	 tdTomato,	 LacZ	 for	 Gli1‐positive	 cells,	 granulosa	 cell	 marker	
FOXL2,	and	DAPI.	b‐e,	higher	magnification	of	the	outlined	area	in	(a).	E=	embryonic	day;	
P=	postnatal	day.	Scale	bar:	25	m.		
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Figure	2.9:	Fetal	ovary‐derived	Wt1‐positive	cells	acquire	 the	expression	of	Gli1	 in	
the	adult	ovary.	(a‐d)	Lineage	tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	in	the	
Wt1‐CreERT2;	 Rosa‐LSL‐tdTomato;	 Gli1‐LacZ	 embryos	 was	 induced	 by	 tamoxifen	 (TM)	
administration	 at	 E10.5.	 The	 ovaries	 were	 analyzed	 at	 2	 months	 of	 age	 by	 fluorescent	
immunohistochemistry	 for	 tdTomato	 (b),	 LacZ	 for	 Gli1‐positive	 cells	 (c),	 and	 DAPI.	 E=	
embryonic	day.	Scale	bar:	25	m.		
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Figure	2.10:	Fetal	ovary‐derived	Wt1‐positive	cells	give	rise	to	granulosa	cells	in	the	
adult	ovary.	a‐c,	Lineage	tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	 in	the	Wt1‐
CreERT2;	Rosa‐LSL‐tdTomato	embryos	 was	 induced	 by	 tamoxifen	 (TM)	 administration	 at	
E10.5.	The	ovaries	were	analyzed	at	1	month	of	age	by	fluorescent	immunohistochemistry	
for	 endogenous	 tdTomato	 (red),	 DsRed	 for	 tdTomato‐positive	 cells	 (green).	 d‐f,	 higher	
magnification	of	a‐c.		E=	embryonic	day.	Scale	bar:	25	m.		
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Figure	2.11:	Fetal	ovary‐derived	Wt1‐positive	cells	are	positive	 for	Gli1	 in	 the	 fetal	
mesonephros.	a‐e,	Lineage	tracing	of	the	fetal	ovary‐derived	Wt1‐positive	cells	in	the	Wt1‐
CreERT2;	 Rosa‐LSL‐tdTomato;	 Gli1‐LacZ	 embryos	 was	 induced	 by	 tamoxifen	 (TM)	
administration	 at	 E10.5.	 The	 mesonephroi	 were	 analyzed	 at	 E15.5	 by	 fluorescent	
immunohistochemistry	for	tdTomato	(b),	LacZ	for	Gli1‐positive	cells	(c),	germ	cell	marker	
TRA98	(d),	and	DAPI	(e).	E=	embryonic	day.	Ov,	ovary;	Ms,	mesonephros.	Scale	bar:	25	m.		
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Figure	 2.12:	The	mesonephros‐derived	Gli1‐positive	 cells	 are	 located	 immediately	
adjacent	to	the	basal	membrane	in	adult	ovary.	Lineage	tracing	of	the	Gli1‐positive	cells	
in	 the	 Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 embryos	 were	 induced	 by	 tamoxifen	 (TM)	
administration	 at	 E12.5.	 The	 ovaries	 were	 examined	 at	 2	 months	 of	 age	 for	 tdTomato,	
3HSD,	and	DAPI.	Yellow	dotted	line	indicates	the	basal	membrane	that	separates	the	theca	
cell	layer	from	granulosa	cells.	
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Figure	2.13:	Characterization	of	the	mesonephros‐derived	Gli1‐positive	cells.	a,	Gene	
expression	 profiles	 of	 3	 independent	 pools	 of	 the	 mesonephros‐derived	 (Tamoxifen	 at	
E12.5,	E14.5	and	E16.5)	and	 the	neonatal	ovary‐derived	Gli1‐positive	cells	 (Tamoxifen	at	
P1‐3	 via	 lactating	 dams).	 All	 cells	 were	 isolated	 from	 the	 adult	 ovaries	 of	 Gli1‐CreERT2;	
Rosa‐LSL‐tdTomato	mice	at	2	months	of	age.	b,	qPCR	analysis	of	Gli1	and	markers	of	theca	
cell	 steroidogenesis	 (Star,	Cyp11a1,	Cyp17a1,	and	Lhcgr)	 in	 the	mesonephros‐derived	and	
the	neonatal	ovary‐derived	Gli1‐positive	cells.	*P	<	0.05.		
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Figure	2.14:	Mesonephros‐derived	Gli1‐positive	cells	are	steroidogenically	active	 in	
the	adult	ovary.	a‐c,	The	lineage‐tracing	of	the	mesonephros‐derived	Gli1‐positive	cells	in	
Gli1‐CreERT2;	Rosa‐LSL‐tdTomato	embryos	was	 induced	by	 tamoxifen	administration	 from	
E12.5‐14.5	 and	 the	 ovaries	 were	 analyzed	 at	 2	 months	 of	 age	 for	 tdTomato	 (red)	 and	
steroidogenic	cell	marker	3HSD	(green).	Scale	bar:	25	m.	
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Figure	 2.15:	 Effects	 of	 genetic	 ablation	 of	 neonatal	 Gli1‐positive	 theca	 progenitor	
cells	 on	 development	 of	 the	 ovary.	 a,	 Timeline	 of	 cell	 ablation	 experiment	 with	 time	
points	 for	 tamoxifen	 (TM)	 administration,	 transplantation,	 and	 tissue	 collection.	
PD=Postnatal	day.	b‐c,	Hematoxylin	and	eosin	staining	on	the	sections	of	control	(b)	or	Gli1‐
positive	 cells	 ablated	 ovarian	 transplants	 (c).	 d‐e,	 Immunofluorescence	 analysis	 was	
performed	on	the	sections	of	the	transplants	for	steroidogenic	cell	marker	3HSD	(green)	
and	DAPI	(grey).	Scale	bar:	100	m.		
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Figure	2.16:	Proposed	model	for	the	origins	of	theca	cells	in	the	mouse	ovary.	Theca	
cells	derive	 from	two	sources:	Wt1+	cells	 indigenous	to	the	ovary	and	Gli1+	mesenchymal	
cells	migrated	from	the	mesonephros	around	time	of	birth.	
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Table	  2.1:	  Comparison	  of	  theca	  cell	  contributions	  between	  mesonephros-­‐derived	  and	  
neonatal	   ovary-­‐derived	  Gli1-­‐positive	   cells.	  Lineage-­‐labeling	  of	  the	  Gli1-­‐positive	  cells	   in	  the	   Gli1-­‐CreERT2;	   Rosa-­‐LSL-­‐tdTomato	   embryos	   was	   induced	   by	   tamoxifen	   (TM)	  administration	   from	   E12.5-­‐E16.5	   (mesonephros-­‐derived),	   or	   from	   P1-­‐3	   (neonatal	   ovary-­‐derived).	  The	  ovaries	  from	  2	  months	  of	  mice	  were	  subjected	  to	  fluorescence-­‐activated	  cell	  sorting	  for	  the	  percentage	  of	  tdTomato+	  and	  tdTomato-­‐	  cells	  in	  the	  ovary.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
E: Embryonic day. TM: Tamoxifen 
Target'cell'type' Timing'of'lineage1labeling' Time'of'collection'
Percentage'of'tdTomato+''
cells'in'the'ovary'
Percentage'of'tdTomato1'
cells'in'the'ovary'Mesonephros)derived-
Gli1)positive-cells- TM-at-E12.5,-E14.5,-E16.5- 2-months- 1.03%- 98.97%-Ovarian-Gli1)positive-cells- TM-at-P1,-P2,-P3- 2-months- 41.07%- 58.93%-
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Genes	of	interest	
Fold	change	
(Ovary	derived	cells	vs.	mesonephros‐derived	cells)	
Pgr	 4.113	
Wt1	 2.374	
Esr1	 2.881	
Bmp2	 2.029	
Cxcl2	 3.800	
Cxcl3	 4.890	
Cxcl12	 2.487	
Foxo3	 1.869	
HSD17b3	 ‐1.549	
	
Table	2.2.	 	 Fold	 changes	 of	 genes	 of	 interest	 from	microarray	 analysis	 of	 ovary‐derived	
Gli1‐positive	 cells	 versus	 mesonephros‐derived	Gli1‐positive	 cells	 from	 2	 months	 of	 age	
mice.		
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CHAPTER	3:	Role	of	Desert/Indian	Hedgehog	Signaling	in	Theca	Cell	Development	in	
the	Murine	Ovary	
	
3.1	Abstract		
																Establishment	 of	 the	 androgen‐producing	 theca	 cell	 lineage	 is	 critical	 for	
folliculogenesis	 and	ovulation	of	 the	mammalian	ovaries.	 In	Chapter	2,	 I	 have	 found	 that	
theca	cells	derived	from	two	origins:	the	precursor	cells	(Wt1‐positive)	intrinsic	to	the	fetal	
ovary	 and	 the	 mesenchymal	 cells	 (Gli1‐positive)	 in	 the	 mesonephros.	 However,	 the	
signaling	pathway	that	directly	specify	theca	cell	lineage	is	not	clear.	One	clue	is	that	when	
the	 two	 sources	 of	 theca	 progenitor	 cells	 come	 to	 surround	 the	 primary	 follicles	 in	 the	
postnatal	ovary,	they	acquire	the	expression	of	Gli1,	 indicating	that	Gli1	 is	 involved	in	the	
specification	of	theca	cell	lineage.	To	determine	what	regulates	Gli1	expression	in	the	ovary,	
neonatal	 ovaries	 were	 cultured	 in	 the	 presence	 of	 a	 Hedgehog	 (Hh)	 signaling	 inhibitor	
cyclopamine.	 Cyclopamine	 treatment	 suppressed	 the	 expression	 of	 Gli1	 in	 the	 ovary,	
indicating	 that	 Gli1	 expression	 in	 the	 neonatal	 ovary	 is	 activated	 by	 the	 canonical	 Hh	
pathway.	The	Hh	 ligands	that	were	produced	 in	the	neonatal	ovaries	appeared	to	be	Dhh	
and	 Ihh.	To	 further	examine	what	 cell	 type(s)	 is	 responsible	 for	Hh	 ligands	production,	 I	
isolated	 granulosa	 cells	 and	 theca	 progenitor	 cells	 from	 postnatal	 ovaries.	 Dhh	 and	 Ihh	
were	highly	expressed	in	granulosa	cells,	whereas	their	downstream	targets	Gli1	and	Ptch1	
were	enriched	in	theca	progenitor	cells.	This	observation	suggests	a	novel	regulation	from	
granulosa	cells	to	theca	progenitor	cells	via	Hh	signaling.	To	investigate	whether	Dhh	and	
Ihh	play	a	functional	role	in	theca	cell	development,	I	generated	Dhh/Ihh	double	knockout	
(DKO)	 mice	 in	 which	 the	 expression	 of	Dhh	 and	 Ihh	 are	 specifically	 ablated	 in	 gonadal	
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somatic	cells.	Ovaries	lacking	Dhh/Ihh	were	smaller	in	size,	exhibiting	follicle	arrest	at	pre‐
antral	 stage	and	 the	absence	of	 corpora	 lutea.	 In	addition,	 steroidogenic	 theca	cells	were	
completely	lost,	along	with	a	significant	down‐regulation	of	steroidogenic	genes.	Consistent	
with	the	lack	of	Gli1‐positive	theca	cells	and	defects	in	follicular	development,	the	levels	of	
circulating	 hormones	 including	 dehydroepiandrosterone	 (DHEA),	 testosterone,	 and	
progesterone	 in	the	DKO	female	are	decreased.	 In	summary,	 these	studies	demonstrate	a	
critical	 role	 of	 granulosa	 cell‐derived	 DHH/IHH	 signaling	 in	 regulating	 theca	 cell	
differentiation	in	the	developing	ovary.		
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3.2	Introduction		
																Theca	 cells	 in	 the	 mouse	 ovary	 do	 not	 become	 morphologically	 distinguishable	
until	one	week	after	birth	when	the	 follicles	develop	to	secondary	stage	 [19].	These	cells	
play	diverse	roles	during	ovarian	development,	such	as	synthesizing	androgens,	which	are	
then	converted	to	estrogen	by	granulosa	cells	[44‐48];	interacting	with	granulosa	cells	and	
oocytes	during	folliculogenesis	[49‐51];	and	providing	structural	support	and	blood	supply	
for	 the	developing	 follicles	 for	ovulation	 [50,	52,	53].	 In	addition	 to	 the	 function	of	 theca	
cells	in	normal	ovarian	development,	dysfunction	of	androgen	production	are	implicated	in	
pathogenesis	 of	 many	 ovarian	 diseases,	 such	 as	 polycystic	 ovarian	 syndrome	 (PCOS),	
premature	ovarian	 failure	and	ovarian	cancers	 [233,	262,	270,	292,	328].	Although	 theca	
cells	play	such	a	critical	role	 in	ovarian	development,	 the	mechanisms	that	regulate	 their	
differentiation	remain	poorly	understood.	Because	theca	precursor	cells	do	not	express	LH	
receptors	 [329],	and	theca	 layer	still	 forms	 in	FSH‐deficient	 female	mice	 [158],	 the	 initial	
theca	cell	differentiation/recruitment	is	likely	gonadotropin‐independent.		
																The	 factors	 that	 regulate	 theca	 cell	 differentiation	 appear	 to	 be	 small‐molecular‐
weight	proteins	ranged	from	20‐	to	24‐	kDa	secreted	from	granulosa	cells	of	 the	growing	
follicles	[60].	This	is	because	that	theca	cells	are	only	associated	with	developing	follicles,	
and	their	histological	proximity	to	granulosa	cells	led	to	the	hypothesis	that	differentiation	
of	theca	cells	is	regulated	by	paracrine	factor(s)	produced	by	granulosa	cells	[137].	In	fact,	
when	 undifferentiated	 theca‐stromal	 cells	 (or	 putative	 theca	 stem	 cells),	 were	 cultured	
with	 granulosa	 cells,	 or	 granulosa	 cell‐conditioned	 culture	 medium,	 markers	 of	 theca	
differentiation,	 such	 as	 LH	 receptors	 and	 steroidogenic	 enzymes	 were	 expressed	 and	
androgens	produced	 [57,	58,	60,	61].	 Candidate	 factors	 that	may	 contribute	 to	 theca	 cell	
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differentiation	include	IGF,	KIT	ligand,	GDF9	and	Hh	ligand.	Addition	of	IGF‐I	or	KIT	ligand	
in	rat	theca	cell	culture	is	able	to	increase	expression	of	some	but	not	all	theca	cell	makers	
[330].	In	Gdf9	knockout	ovary,	the	theca	layer	is	not	formed,	yet	it	is	unclear	whether	GDF9	
regulates	 theca	 cell	 differentiation	 directly	 or	 indirectly	 through	 regulation	 of	 granulosa	
cell	 development	 [146].	 Among	 those	 potential	 factors,	 Hh	 ligand	 interests	me	 the	most	
because	of	the	role	of	DHH	in	the	development	of	fetal	Leydig	cells	in	mouse	testis	[281],	as	
Leydig	 cells	 are	 considered	 the	male	 counterpart	of	 theca	 cells	 in	 the	ovary.	Both	 in	vivo	
and	 in	vitro	 studies	have	demonstrated	 that	DHH	derived	 from	Sertoli	 cells	 regulates	 the	
specification	 and	 appearance	 of	 fetal	 Leydig	 cells	 [281],	 and	 one	 of	 the	 downstream	
effectors	 involved	 in	 this	process	 is	Gli1	 [280,	281].	 In	a	similar	pattern,	Dhh	and	 Ihh	are	
expressed	 in	 granulosa	 cells	 of	 the	 developing	 follicles	 in	 adult	mouse	 ovary	 [286,	 287],	
whereas	 their	 downstream	 targets	 Ptch1	 and	 Gli1,	 are	 localized	 specifically	 in	 the	
mesenchymal	stromal	cells	surrounding	the	follicles	[287].	Whether	Dhh	and	Ihh	together	
play	 a	 functional	 role	 during	 ovarian	 development	 is	 not	 known	 [282,	 288].	 Constitute	
activation	of	Hh	signaling	in	the	ovary	results	in	defects	in	smooth	muscle	cell	development	
and	subsequent	failure	in	ovulation,	indicating	that	appropriate	Hh	signaling	is	required	for	
proper	 ovarian	 function.	 In	 addition,	 recombinant	 SHH	 is	 able	 to	 stimulate	
androstenedione	 production	 of	 the	 bovine	 theca	 cells	 in	 culture	 [290].	 With	 all	 these	
observations	mentioned	 above,	 I	 therefore	 hypothesize	 that	 Hh	 signaling	 from	 granuosa	
cells	is	important	for	theca	cell	development	and	proper	ovarian	functions.			
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3.3	Materials	and	Methods	
3.3.1	Animals	breeding	
																Gli1‐LacZ	 (#008211),	Gli1‐CreERT2	(#007913),	 Foxl2‐CreERT2	(#015854),	Rosa‐LSL‐
tdTomato	 (#007905),	Dhh+/‐	 (#002784),	 Ihh+/‐	(#004290)	mice	were	 purchased	 from	 the	
Jackson	Laboratory	 (Bar	Harbor,	ME).	Sf1‐Cre	and	Ihh	floxed/floxed	mice	were	kind	gifts	 from	
Dr.	 Keith	 Parker	 (UT	 Southwestern	 Medical	 Center)	 and	 Dr.	 Francesco	 DeMayo	 (Baylor	
College	of	Medicine),	respectively.	Female	mice	were	housed	with	male	mice	overnight	and	
checked	for	the	presence	of	vaginal	plug	the	next	morning.	The	day	when	the	vaginal	plug	
was	detected	was	considered	embryonic	day	(E)	0.5.	All	animal	procedures	were	approved	
by	 the	National	 Institute	of	Environmental	Health	Sciences	(NIEHS)	Animal	Care	and	Use	
Committee	 and	 are	 in	 compliance	 with	 a	 NIEHS‐approved	 animal	 study	 proposal.	 All	
experiments	were	performed	on	at	least	three	animals	for	each	genotype.	
	
3.3.2	Isolation	of	granulosa	cells	and	theca	progenitor	cells		
																Cell	 lineage	 labeling	was	conducted	by	administrating	 tamoxifen	(T‐5648,	Sigma‐
Aldrich,	 St.	 Louis,	 MO)	 to	 Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 or	 Foxl2‐CreERT2;	 Rosa‐LSL‐
tdTomato	 neonatal	pups	 through	 lactating	 dams.	 The	 pups	 were	 fostered	 to	 CD‐1	 dams	
immediately	after	birth	followed	by	tamoxifen	administration.	5	mg	tamoxifen	dissolved	in	
100	μl	corn	oil	(C‐8267,	Sigma‐Aldrich,	St.	Louis,	MO)	was	injected	to	the	foster	dam	once	
per	day	for	2	consecutive	days	(PND1‐2).	No	overt	teratological	effects	were	observed	after	
tamoxifen	administration	under	these	conditions.		
																Neonatal	 ovaries	 from	 Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 or	 Foxl2‐CreERT2;	 Rosa‐
LSL‐tdTomato	 pups	 were	 minced	 and	 enzymatically	 dissociated	 in	 Hank’s	 balanced	 salt	
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solution	(Sigma)	with	1	mg/ml	collagenase	B	(Roche),	1.2	U/ml	Dispase	II	 (Roche)	and	5	
U/ml	DNAse	I	 (Sigma)	 for	20	min	at	37	oC.	To	 further	aid	tissue	dissociation,	 the	solution	
was	mixed	by	repeated	pipetting	(P1000	pipette)	[303].	Dissociated	cells	were	rinsed	and	
re‐suspended	in	ice‐old	PBS	and	were	subject	to	fluorescence‐activated	cell	sorting	(FACS)	
for	tdTomato+	and	tdTomato‐	cells.	FACS	was	performed	using	a	FACSAria	II	flow	cytometer	
from	Becton	Dickinson	(San	Jose,	CA)	and	FACSDiVa	software	version	6.1.3.			
	
3.3.3	Immunohistochemistry	and	histological	analysis	
																Immunohistochemistry	 and	 histological	 analysis	 were	 performed	 as	 described	
with	modifications[331].	Tissues	were	paraffin‐embedded	and	the	sections	were	dewaxed	
and	rehydrated	 in	a	series	of	alcohol	 to	PBS.	The	slides	were	pretreated	 in	0.1	mM	citric	
acid	 for	20	min	 in	 the	microwave,	 incubated	with	primary	antibodies	 (listed	 in	 the	 table	
below)	in	PBS‐Triton	X‐100	solution	with	5%	normal	donkey	serum	at	4°C	overnight.	The	
sections	were	 then	washed	and	 incubated	 in	 the	appropriate	secondary	antibody	(1:500;	
Invitrogen,	 USA)	 before	 mounting	 in	 Vector	 Mount	 with	 DAPI	 (Vector	 Labs).	 For	 anti‐
COUPTFII	antibody,	a	M.O.M	kit	was	used	following	the	manufacturer	protocol	(BMK‐2202,	
Vector	 labs).	 Slides	 were	 imaged	 under	 a	 Leica	 DMI4000	 confocal	 microscope.	 For	
histological	 analysis,	 the	 samples	 were	 fixed	 in	 4%	 paraformaldehyde	 in	 PBS	 at	 4°C	
overnight,	 dehydrated	 through	 an	 ethanol	 gradient,	 and	 embedded	 in	 paraffin	 wax.	
Sections	 were	 stained	 with	 hematoxylin/eosin	 or	 PAS/	 hematoxylin,	 and	 were	 scanned	
using	Aperio	ScanScope	XT	Scanner	(Aperio	Technologies,	 Inc.,	CA,	USA)	for	digital	 image	
analysis.		
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Primary	antibodies	 Species	 Dilution Source
FOXL2	 Rabbit	 1:500 Dr.	Dagmar	Wilhelm,	Monash	University,	Australia
FOXL2	 Goat	 1:500 Imgenex,	Littleton,	CO,	USA	
αSMA	 Rabbit	 1:500 Abcam,	San	Francisco	CA,	USA	
CYP17A1	 Goat	 1:100 Santa	Cruz	Biotechnology,	Texas,	USA	
COUPTFII	 Mouse	 1:200 R&D	systems.	Minneapolis,	MN,	USA	
	
3.3.4	Gene	expression	analysis	
																	Gene	 expression	 analysis	was	 performed	 as	 described	with	modifications	 [304].	
Total	 RNA	 was	 isolated	 from	 ovaries	 using	 the	 PicoPure	 RNA	 isolation	 kit	 (Arcturus,	
Mountain	View,	CA)	according	to	the	manufacturer’s	protocol.	The	cDNA	preparation	was	
synthesized	 using	 random	 hexamers	 and	 the	 Superscript	 II	 cDNA	 synthesis	 system	
(Invitrogen	Corp.,	Carlsbad,	CA)	following	the	manufacturer’s	instruction.	Gene	expression	
was	 analyzed	by	 real‐time	PCR	using	Bio‐Rad	CFX96TM	Real‐Time	PCR	Detection	 system.	
Taqman	 gene‐expression	 probes	 (Gli1:	 Mm00494654_m1,	 Ptch1:	 Mm00436026_m1,	 Ihh:	
Mm00439613_m1,	 Shh:	 Mm00436528_m1,	 Dhh:	 Mm01310203_m1,	 Foxl2:	
Mm00843544_m1,	 Star:	 Mm00441558_m1,	 Cyp11a1:	 Mm00490735_m1,	 Hsd3b1:	
Mm01261921_mH,	 Nr5a1:	 Hs01018738_m1,	 Cyp19a1:	 Mm00484049_m1)	 were	 used	 to	
detect	 the	 fold	 changes	 of	 the	 transcripts.	 Fold	 changes	 in	 gene	 expression	 were	
determined	by	quantitation	of	cDNA	from	target	(treated)	samples	relative	to	a	calibrator	
sample	(control).	All	real‐time	PCR	analyses	were	performed	in	duplicate,	and	the	results	
were	 reported	 from	 at	 least	 three	 independent	 experiments.	 The	 relative	 fold	 change	 of	
transcript	was	 calculated	using	 the	mathematical	model	of	Pfaffl	 as	previously	described	
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[305]	and	was	normalized	to	18S	rRNA	(Mm03928990_g1)	as	an	endogenous	reference.	
	
3.3.5	Microarray	analysis		
																Gene	expression	analysis	was	conducted	using	Affymetrix	Mouse	Genome	430	2.0	
GeneChip®	arrays	(Affymetrix,	Santa	Clara,	CA).	Fifty	(50)	ng	of	total	RNA	was	amplified	as	
directed	 in	 the	 WT‐Ovation	 Pico	 RNA	 Amplification	 System	 protocol,	 and	 labeling	 with	
biotin	 following	 the	 Encore	 Biotin	 Module.	 4.6	 μg	 of	 amplified	 biotin‐aRNAs	 were	
fragmented	and	hybridized	to	each	array	for	18	hours	at	45°C	in	a	rotating	hybridization.	
Array	 slides	 were	 stained	 with	 streptavidin/phycoerythrin	 utilizing	 a	 double‐antibody	
staining	procedure	and	then	washed	for	antibody	amplification	according	to	the	GeneChip	
Hybridization,	Wash	and	Stain	Kit	and	user	manual	following	protocol	FS450‐0004.	Arrays	
were	scanned	in	an	Affymetrix	Scanner	3000	and	data	was	obtained	using	the	GeneChip®	
Command	 Console	 Software	 (AGCC;	 Version	 1.1)	 using	 the	MAS5	 algorithm	 to	 generate.	
CHP	files.	The	microarray	raw	data	were	analyzed	using	the	Partek	Genomic	Suite	Software	
(St.	 Louis,	 Missouri).	 Two‐way	 Anova	 was	 performed	 to	 determine	 the	 statistical	
significance	between	 the	means.	The	 gene	 list	was	 filtered	with	 fold‐change	 cutoff	 of	 1.5	
and	an	unadjusted	p<0.05.	
	
3.3.6	Organ	culture		
																Ovaries	with	mesonephroi	attached	from	E18.5	Gli1‐LacZ	embryos	were	cultured	
for	3	days	on	Millicell‐PC	membrane	inserts	(0.4	μm	pore	size;	30	mm	diameter;	Millipore	
corp.,	Medford,	MA)	with	medium	filling	only	the	lower	chamber	[332].	8‐10	ovaries	were	
placed	on	each	membrane	insert,	with	one	drop	of	medium	on	each	ovary.	For	culture	with	
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the	Hh	inhibitor,	cyclopamine	(25	μM,	Sigma)	[333],	or	an	equal	volume	of	vehicle,	
dimethyl	sulfoxide	(DMSO),	was	added	to	the	culture	medium	at	the	beginning	of	the	
culture	for	3	days	and	the	culture	medium	was	changed	every	other	day.	The	medium	for	
organ	culture	was	DMEM/F12	(1:1)	+	L‐Glutamine	+	15mM	HEPES	(Invitrogen)	
supplemented	with	50	μg/ml	penicillin	G/streptomycin	sulfate,	and	5%	(vol/vol)	fetal	
bovine	serum	(FBS).	After	3	days	of	culture,	the	ovaries	were	collected	and	processed	for	
LacZ	staining	as	described	in	Chapter	2.		
	
3.3.7	Steroid	Hormone	Multiplex	Immunoassay	
																	Serum	samples	were	collected	at	various	 times	and	stored	at	 ‐80°C	until	 further	
analyzed.	Mice	were	not	 staged	 for	 estrus	 cycle	 at	 the	 time	 of	 sample	 collection.	 Serum	
samples	 were	 assayed	 for	 DHEA,	 Estradiol,	 Progesterone,	 and	 Testosterone	 using	 the	
Steroid	Hormone	Panel	kit	(cat	#	N45CB‐1)	from	MSD	(Meso	Scale	Discovery,	Gaithersburg,	
Maryland,	USA)	according	to	manufacturer’s	protocols.	The	Steroid	Hormone	Panel	utilizes	
a	competitive	immunoassay	format.	Briefly,	a	96	well	custom	designed	plate	that	had	been	
precoated	with	 capture	 antibodies	 on	 spatially	 distinct	 spots	was	 blocked	with	 blocking	
solution	for	1	hr.	at	room	temperature	with	constant	shaking	at	700	rpm.	After	washing	3x	
with	 PBS‐T	 buffer,	 samples	 and	 standards	were	 added	 to	 appropriate	 wells	 of	 the	MSD	
plate	and	incubated	for	2	hrs	at	RT	with	constant	shaking.	After	incubation	of	the	samples,	
a	mixture	of	MSD	SULFOTAGTM	labeled	tracers	are	added	to	each	well.	The	tracers	compete	
with	analytes	in	the	samples	for	binding	on	the	immobilized	antibodies	generating	a	signal	
for	each	assay	this	is	inversely	proportional	to	the	analyte	concentration.	After	incubating	
with	 the	 tracers,	 the	 plate	was	washed	 again	 3x	with	PBS‐T,	 pat	 dried,	 and	150	μl	 of	 1x	
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Read	 Buffer	was	 added	 to	 each	well.	 The	 plate	was	 immediately	 analyzed	 on	 the	 Sector	
Imager	2400	System	(MSD).	The	instrument	measures	intensity	of	emitted	light	to	afford	a	
quantitative	measure	 of	 DHEA,	 Estradiol,	 Progesterone,	 and	 Testosterone	 in	 the	 sample.	
Testosterone	standard	is	not	supplied	with	the	MSD	kit,	it	was	purchased	separately	from	
Steraloids	(cat	#	A6950)	(Newport,	RI,	USA)	and	used	in	the	range	from	16	ng/mL	to	0.1	
ng/mL.	All	the	samples	were	run	on	the	same	plate.	The	intra‐array	%CV	(n=7)	is	3.99	for	
DHEA,	7.63	for	testosterone	and	13.32	for	progesterone.	
	
3.3.8	Statistical	analysis	
																Data	 were	 analyzed	 using	 Prism	 (Version	 6,	 GraphPad	 Software)	 by	 two‐tailed	
Student’s	 t‐test.	Values	are	expressed	as	mean±s.e.m.	A	minimal	of	3	biological	replicates	
was	used	for	each	experiment.			
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3.4	Results		
3.4.1	Expression	of	Gli1	 in	 the	neonatal	ovary	 is	under	 the	control	of	canonical	Hh	
pathway		
																		As	presented	in	Chapter	2,	Gli1	was	a	lineage	marker	for	adult	theca	cells	and	the	
expression	 of	 Gli1	 was	 not	 present	 in	 the	 fetal	 ovary	 until	 right	 after	 birth.	 	 The	
identification	 of	 Gli1	 as	 a	 theca	 cell	 lineage	 marker	 raises	 the	 question:	 what	 signal(s)	
specify	theca	cell	lineage	and	induce	Gli1	expression?	Gli1	is	a	known	downstream	target	of	
the	Hh	pathway	[334].	I	first	examined	whether	activation	of	the	Hh	pathway	is	responsible	
for	 inducing	Gli1	expression	by	culturing	 fetal	ovaries	 in	the	presence	of	 the	Hh	 inhibitor	
cyclopamine	 [281,	 333].	 Cyclopamine	 inhibits	 Hh	 signaling	 by	 inactivating	 SMO,	 the	
downstream	Hh	 signal	 transducer	 [333].	 	 The	 ovaries	were	 cultured	 for	 3	 days	 starting	
E18.5,	before	Gli1	expression	occurred	in	the	ovary	(Fig,	3.1a).	Gli1‐LacZ	was	expressed	in	
the	ovaries	after	3	days	culture	as	expected	in	the	absence	of	cyclopamine	(Fig.	3.1b).	When	
cyclopamine	 was	 added	 in	 culture,	 the	 expression	 of	 Gli1‐LacZ	 in	 the	 ovaries	 was	
completely	abolished	(Fig.	3.1c).	These	results	 indicate	that	Gli1	expression	is	 induced	by	
the	canonical	Hh	pathway.		
	
3.4.2	Dhh	and	Ihh	are	produced	primarily	in	granulosa	cells	in	the	ovary	
																In	search	of	the	Hh	ligands	that	may	be	responsible	for	activating	the	Hh	pathway	
in	 the	 neonatal	 ovaries,	 I	 examined	mRNA	 expression	 of	Dhh,	 Ihh,	 and	 Shh	 in	 the	 ovary	
before	 (E17.5)	 and	 after	 (PND3)	 the	 appearance	 of	Gli1.	 Expression	 of	Gli1	was	 at	 basal	
level	before	birth	but	dramatically	up‐regulated	at	PND3	(Fig.	3.2a).	In	the	similar	pattern,	
expression	of	Dhh	and	Ihh	was	low	in	the	ovary	before	birth	and	significantly	increased	at	
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PND3	(Fig.	3.2a).	Notably,	expression	of	Shh	was	undetectable	in	ovaries	at	both	stages	(Fig.	
3.2b),	 suggesting	 that	 Dhh	 and	 Ihh,	 but	 not	 Shh,	 are	 responsible	 for	 the	 onset	 of	 Gli1	
expression	in	the	neonatal	ovary.	The	specificity	of	the	probes	was	validated	using	different	
tissues:	testis	(negative	for	Shh	and	positive	for	Dhh),	adrenal	(positive	for	Shh),	limb	bud	
(positive	for	Shh	and	Ihh	and	negative	for	Dhh)	(Fig.	3.2b).	
																To	 identify	 which	 somatic	 cell	 type(s)	 produce	 Dhh	 and	 Ihh,	 I	 isolated	 theca	
progenitor	cells	and	granulosa	cells	from	neonatal	ovaries	and	examined	the	expression	of	
Dhh	and	 Ihh	 in	 the	 isolated	cell	populations.	This	experiment	was	accomplished	by	using	
Gli1‐CreERT2;	 Rosa‐LSL‐tdTomato	 and	 Foxl2‐CreERT2;	 Rosa‐LSL‐tdTomato	 lineage	 tracing	
genetic	 models,	 in	 which	 ovarian	 Gli1‐positive	 cells	 were	 obtained	 for	 theca	 progenitor	
cells	and	Foxl2‐posiitve	cells	 for	granulosa	cells,	respectively.	These	ovarian	somatic	cells	
were	 labeled	with	 tdTomato	 via	 tamoxifen	 administration	 from	 PND1	 to	 PND2,	 and	 the	
ovaries	 were	 collected	 and	 processed	 for	 FACS	 at	 PND5	 (Fig.	 3.3a).	 The	 purity	 of	 the	
isolated	tdTomato‐positive	cells	was	validated	with	their	high	expression	for	Gli1	and	Foxl2,	
respectively	(Fig.	3.3a).	Notably,	tdTomato‐negative	cells	also	expressed	Gli1	and	Foxl2	but	
at	a	much	lower	level	compare	to	that	of	tdTomato‐positive	cells.	This	was	probably	due	to	
the	 fact	 that	 only	 a	 portion	 of	Gli1‐	 and	Foxl2‐positive	 cells	were	 labeled	with	 tdTomato	
through	2	days	of	tamoxifen	treatment.	 	The	remaining	unlabeled	Gli1‐	and	Foxl2‐positive	
cells	therefore	contributed	to	the	Gli1	and	Foxl2	expression	in	the	tdTomato‐negative	cells	
(Fig.	 3.3a).	 Further	 analysis	 of	 the	 isolated	 ovarian	 somatic	 cells	 revealed	 that,	 the	 Hh	
downstream	targets	Gli1	and	Ptch1	were	highly	enriched	in	theca	progenitor	cells,	whereas	
Hh	ligands	Dhh	and	Ihh	were	predominantly	expressed	in	granulosa	cells	(Fig.	3.3b).		These	
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results	implicate	a	novel	regulation	of	theca	cell	differentiation	by	granulosa	cells	through	
the	Hh	signaling	pathway.		
	
3.4.3	Loss	of	Ihh	and	Dhh	results	in	defective	folliculogenesis	in	the	ovary	
																Female	 Dhh‐deficient	 mice	 are	 fertile	 and	 exhibit	 normal	 ovarian	 development	
[282],	suggesting	that	the	other	Hh	ligands,	such	as	Ihh,	may	compensate	for	the	loss	of	Dhh	
during	folliculogenesis.	Most	of	the	Ihh‐deficient	embryos	die	before	birth	[288],	therefore	
precluding	 the	 analysis	 of	 the	 ovary	 in	 the	 adult.	 To	 investigate	 whether	 Dhh	 and	 Ihh	
together	 regulate	 theca	 cell	 development,	 I	 generated	 Dhh/Ihh	 double	 knockout	 mice	
(Hereafter	referred	as	Dhh/Ihh	DKO)	in	which	Dhh	and	Ihh	was	ablated	from	Sf1‐positive	
gonadal	somatic	cells	(Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐)	[335].	Loss	of	Dhh,	Ihh,	and	Gli1	expression	in	
the	 single	 and	 double	 KO	 ovaries	 confirmed	 the	 efficiency	 of	 the	 knockouts	 and	 the	
inactivation	of	the	Hedgehog	pathway	(Fig.	3.4).	Ovaries	deficient	in	either	Dhh	or	Ihh	alone	
appeared	 to	 exhibit	 normal	 folliculogenesis,	 evident	 by	 different	 stages	 of	 follicle	
development	 as	well	 as	 the	presence	of	 corpora	 lutea	 (CLs)	 (Fig.	 3.5a‐f).	 In	 addition,	 the	
theca	 cell	 layer	 is	 formed,	 as	 determined	 by	 immunostaining	 with	 α‐SMA,	 a	 marker	 for	
smooth	muscle	cells	in	theca	cell	 layer	(Fig.	3.5g‐i)	[289].	However,	ovaries	from	Dhh/Ihh	
DKO	female	mice	appeared	significantly	smaller	in	size	and	irregular	in	shape	compared	to	
the	control	(Fig.	3.6a	&	b).	In	contrast	to	the	normal	progression	of	folliculogenesis	and	the	
presence	of	corpora	lutea	in	adult	control	ovaries	(Fig.	3.6c),	Dhh/Ihh	DKO	ovaries	lacked	
corpora	lutea,	and	the	follicles	failed	to	progress	beyond	preantral	follicle	stage,	suggesting	
that	ovulation	did	not	occur	 (Fig.	3.6d,	 g	 and	h).	Antral	 follicles	were	 rarely	 found	 in	 the	
DKO	ovaries	and	if	they	were	present,	they	appeared	cystic	and	hemorrhagic	(Fig.	3.6e	&	f).	
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The	theca	 layer	was	almost	nonexistent	 in	ovaries	 lacking	Dhh	and	Ihh,	as	determined	by	
immunostaining	with	α‐SMA,	a	marker	for	smooth	muscle	cells	in	theca	cell	layer	(Fig.	3.7a	
&	 b)	 [289].	 Furthermore,	 the	 expression	 of	 3βHSD	 and	 CYP17A1,	 the	 key	 enzymes	 in	
androgen	 biosynthesis,	 was	 undetectable	 in	 the	 ovarian	 mesenchyme,	 confirming	 the	
absence	 of	 androgen‐producing	 theca	 cells	 (Fig.	 3.7c‐f).	 Consistent	 with	 these	 findings,	
levels	of	circulating	testosterone	and	dehydroepiandrosterone	(DHEA)	were	reduced	in	the	
absence	of	Dhh	and	Ihh	CLs	(Fig.	3.8).	In	addition,	the	level	of	circulating	progesterone	was	
also	decreased	 in	Dhh/Ihh	DKO	 female,	 likely	as	a	 result	of	 the	absence	of	CLs	 (Fig.	3.8).	
Although	the	loss	of	Dhh	and	Ihh	abolished	a	large	number	of	cells	in	the	theca	layer,	there	
were	 still	 some	 interstitial	 cells	 survived	 the	 ablation	 of	 Hh	 signaling.	 To	 examine	 their	
identify,	 I	 stained	 the	 ovarian	 section	 with	 COUP‐TFII,	 an	 orphan	 nuclear	 receptor	 with	
suggested	 roles	 in	 adult	 Leydig	 cell	 differentiation	 in	 testis	 [336,	 337].	 	 COUP‐TFII	 is	
normally	 expressed	 in	 the	 ovarian	 interstitium	 including	 the	 cells	 that	 immediately	
adjacent	to	the	follicles	(Fig.	3.9a	&	c).	In	the	absence	of	Dhh	and	Ihh,	COUP‐TFII	remained	
expressed	 in	 the	 interstitium	of	 the	ovary	 and	 in	 cells	 adjoining	 the	 granulosa	 cells	 (Fig.	
3.9b	&	d).	
																To	further	investigate	the	transcriptome	changes	in	the	DKO	ovaries,	I	performed	
microarray	 analysis	with	 DKO	 ovaries	 and	 control	 ovaries	 (Dhh	 het/Ihh	 het)	 (Fig.	 3.7a).	
Among	 1393	 differentially	 expressed	 probes,	 636	 probes	were	 up‐regulated	 in	 the	 DKO	
ovary	including	genes	involved	in	follicular	growth	and	granulosa	cell	differentiation	such	
as	Gata6,	Wt1,	Igf1	(table	3.1).		On	the	other	hand,	757	probes	were	down‐regulated	in	the	
DKO	 ovary	 and	many	 of	 the	 them	were	 associated	with	Hedgehog	 pathway	 and	 ovarian	
steroidogenesis,	 such	 as	 Nr5a1,	 Star,	 Cyp11a1,	 Hsd3b1	 and	 Cyp19a1	 (Fig.	 3.10b).	 The	
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significant	 decrease	 of	 genes	 directly	 involved	 in	 androgen	 production	 including	 Star,	
Cyp11a1	 and	 Hsd3b1	 further	 confirms	 the	 defects	 of	 theca	 cell	 steroidogenesis	 at	 the	
molecular	level	(Fig.	3.10b).		
	
	
3.5	Discussion	
																My	 studies	 demonstrated	 the	 critical	 role	 of	 Dhh	 and	 Ihh	 during	 theca	 cell	
differentiation.	Dhh	and	Ihh	are	produced	from	granulosa	cells	of	developing	follicles	soon	
after	birth,	and	the	Hh	ligand	production	in	turn	induces	Gli1	expression	in	the	interstitial	
cells	of	the	neonatal	ovary.		In	the	absence	of	Dhh	and	Ihh,	androgen‐producing	theca	cells	
are	 missing,	 follicle	 development	 are	 arrested	 at	 pre‐antral	 stage	 along	 with	 blunted	
steroid	production.		
																It	 is	 not	 clear	 why	 two	 Hh	 ligands	 are	 needed	 in	 granulosa	 cells	 for	 theca	 cell	
differentiation.	 Ovaries	 deficient	 for	 either	 Dhh	 or	 Ihh	 exhibit	 normal	 folliculogenesis,	
whereas	ovaries	deficient	 for	both	Dhh	 and	 Ihh	 show	completely	 loss	of	 functional	 theca	
cells	and	follicle	arrest.	These	observations	indicate	that	Dhh	and	Ihh	from	granulosa	cells	
play	 a	 redundant	 role	 during	 folliculogenesis.	 	 Although	 the	 role	 of	Dhh	 and	 Ihh	 during	
follicle	development	seems	redundant,	they	appear	to	have	different	capacity	in	regulating	
Gli1	expression	in	the	ovary.	In	the	absence	of	Dhh	alone,	Gli1	expression	was	unaffected,	
whereas	 loss	 of	 Ihh	 alone	 significantly	 decreased	 the	 expression	 of	 Gli1	 in	 the	 ovaries.	
These	results	suggest	that	even	though	Dhh	and	Ihh	play	a	redundant	role	during	theca	cell	
differentiation,	Ihh	might	be	a	predominant	factor	in	this	case.	In	chapter	2,	I	demonstrated	
that	theca	cells	surrounding	the	developing	follicles	are	heterogeneous	as	they	stem	from	
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two	sources:	the	somatic	precursor	cells	in	the	fetal	ovary	and	the	mesenchymal	cells	in	the	
fetal	mesonephros.	Do	the	two	Hh	ligands	play	different	roles	in	regulating	the	two	theca	
cell	populations?	Because	the	two	theca	cell	populations	(ovary‐	and	mesonephros‐derived)	
exhibit	 distinct	 transcriptomes	 in	 the	 adult	 ovary,	 a	 further	 microarray	 comparison	
between	their	gene	expression	profiling	and	the	transcriptome	changes	 in	 the	absence	of	
Dhh	and	Ihh	might	shed	light	on	the	interactions	between	the	two	Hh	ligands	and	the	two	
theca	cell	populations.	
														When	Dhh	 and	 Ihh	 were	 absent,	morphologically	 evident	 preantral	 follicles	 were	
present	yet	the	theca	cell	differentiation	failed	to	occur.	 	This	result	indicates	that	growth	
from	primordial	to	secondary	follicle	does	not	require	steroidogenic	theca	cells.	In	addition	
to	the	absence	of	functional	theca	cells,	Dhh/Ihh	DKO	ovaries	also	exhibited	a	dramatic	loss	
of	interstitial‐stroma	cells.	In	particularly,	vacuoles‐like	structure	was	found	in	the	medulla	
of	 the	 adult	 ovary	 and	 in	 the	 intra‐ovarian	 rete	 ovarii.	 These	 vacuoles	 appeared	 to	 be	
degenerated	follicles,	as	some	of	them	still	contained	oocytes	but	the	surrounding	somatic	
cells	were	absent.		The	degeneration	of	follicles	in	the	medulla	of	the	ovary	is	reminiscent	
of	the	Gli1	expression	pattern	in	the	neonatal	ovary,	as	Gli1	first	appears	in	the	center	of	the	
ovary	where	the	primary	follicles	start	to	form.	As	I	reviewed	in	Chapter	1,	 two	waves	of	
follicular	development	have	been	suggested	during	ovarian	development:	the	first	wave	of	
follicle	development	 initiates	 in	 the	medulla	of	 the	ovary	at	 time	of	birth,	and	the	second	
wave	of	follicle	development	occurs	in	the	ovarian	cortex	postnatally	with	the	cells	derived	
from	surface	epithelium	[20‐22].	Are	these	degenerated	follicles	in	the	DKO	ovary	the	ones	
from	 the	 first	wave	 of	 follicle	 development?	Are	 the	 remaining	 pre‐antral	 follicles	 in	 the	
ovarian	 cortex	 derived	 from	 the	 surface	 epithelium?	 Because	 the	 expression	 of	 Gli1	 is	
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almost	 abolished	 in	 the	 Dhh/Ihh	 DKO	 ovaries,	 one	 would	 assume	 that	 Hh	 signaling	 is	
completely	 inactivated	 in	 the	 DKO	 ovary.	 This	 observation	 raises	 up	 two	 possibilities	
concerning	 the	 remaining	 follicles	 in	 the	 cortex	 of	 the	 ovary:	 first,	 these	 follicles	 do	 not	
express	Dhh	and	Ihh	under	normal	physiological	circumstances	and	therefore	their	growth	
is	 independent	of	Hh	signaling.	However,	because	of	the	lack	of	theca‐stromal	cells,	 these	
follicles	are	unable	to	develop	further.	Second,	the	remaining	follicles	in	ovarian	cortex	do	
express	 Dhh	 and	 Ihh	 normally,	 but	 the	 Hh	 signaling	 do	 not	 become	 critical	 for	
folliculogenesis	 until	 these	 follicles	 proceed	 beyond	 pre‐antral	 stage.	 One	 following	
question	 is	 that	 if	 the	 animals	 were	 allowed	 to	 live	 longer,	 would	 the	 continual	
degeneration	of	 follicles	 lead	 to	 follicular	exhaustion	and	the	ovaries	exhibit	a	phenotype	
that	resembles	premature	ovarian	failure?	Further	analysis	of	the	DKO	ovaries	at	different	
developmental	stages	(e.g.	P5,	P21	and	6	months	of	age)	should	be	able	to	answer	at	least	
some	of	these	questions.		
																The	 defective	 folliculogenesis	 shown	 in	 the	 Dhh/Ihh	 DKO	 ovaries	 somewhat	
resemble	what	was	observed	in	Cyp19a1	KO	and	αβER	KO	(mice	lacking	both	ERα	and	ERβ)	
ovaries	[338,	339],	in	which	most	follicle	only	reach	small	antral	stage,	large	antral	follicles	
that	 remain	 are	 cystic	 and	 hemorrhagic,	 and	 CLs	 are	 absent.	 The	 ovarian	 phenotypes	 in	
Cyp19a1	KO	and	αβER	KO	ovaries	suggest	a	role	of	estrogen	signaling	on	folliculogenesis.		
In	line	with	these	findings,	the	expression	of	Cyp19a1	(necessary	for	converting	androgens	
into	estrogens)	in	the	Dhh/Ihh	DKO	ovaries	is	also	dramatically	decreased	compared	to	that	
of	 control	 ovaries.	 	This	 result	 suggests	 the	 possibility	 that	 the	 follicular	 defects	 in	 DKO	
ovary	is	at	least	partly	due	to	insufficient	estrogen	production.	This	speculation	is	probably	
true,	 given	 that	 the	 level	 of	 circulating	 androgens	 in	 the	 Dhh/Ihh	 DKO	 females	 is	 also	
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significantly	 reduced.	 Considering	 the	 low	 androgen	 level	 and	 reduced	 expression	 of	
Cyp19a1,	it	is	likely	that	the	DKO	ovary	cannot	produce	enough	estradiol	necessary	for	the	
maintenance	 of	 antral	 follicle	 and	 ovulation	 [19].	 	 Further	measurement	 of	 the	 levels	 of	
estradiol,	FSH	and	LH	in	the	DKO	female	mice	might	help	us	to	identify	the	causes	for	the	
defects	 in	 follicular	development.	 In	addition	 to	 the	 follicular	arrest	 and	 lack	of	CLs,	 sex‐
reversed	follicles	were	observed	with	the	appearance	of	Sertoli‐like	cells	in	both	Cyp19a1	
KO	and	αβER	KO	ovaries	[171,	340].	 Interestingly,	 the	expression	of	Sox9,	a	male	specific	
gene	and	a	marker	for	Sertoli	cells	in	testis	[14],	was	also	up‐regulated	in	the	DKO	ovaries	
by	microarray	analysis.		It	would	be	interesting	to	see	if	SOX9	protein	is	actually	present	in	
the	 DKO	 ovaries,	 and	 if	 seminiferous	 tubule‐like	 structures	 eventually	 develop	 in	 the	
ovaries	as	the	mice	age.			
																	Ablation	of	Dhh	and	Ihh	resulted	in	a	loss	of	a	large	number	of	interstitial	cells	but	
not	all	of	them.	It	was	shown	that	the	cells	remained	in	the	interstitium	of	DKO	ovary	were	
positive	 for	 orphan	 nuclear	 receptor	 COUP‐TFII.	 This	 observation	 is	 interesting	 to	 me	
because	disruption	of	COUP‐TFII	in	prepubertal	male	mice	results	in	arrested	adult	Leydig	
cell	differentiation	at	progenitor	cell	stage	[337].	Additionally,	in	the	fetal	testis,	COUP‐TFII	
marks	 an	 interstitial	 cell	 population	 other	 than	 fetal	 Leydig	 cells	 [336].	 These	 results	
suggest	 that	 COUP‐TFII‐positive	 cells	 in	 the	 fetal	 testis	might	 be	 the	 stem	 cells	 for	 adult	
Leydig	 cells.	 	 Although	 androgen‐producing	 theca	 cells	were	 lost	 in	 the	 DKO	 ovary,	 it	 is	
possible	that	theca	progenitor/stem	cells	were	still	present	in	the	ovarian	interstitium.	Are	
these	 remaining	 COUP‐TFII‐positive	 cells	 the	 stem	 cells	 for	 theca	 cells?	 Do	 these	 COUP‐
TFII‐positive	cells	differentiate	into	functional	theca	cells	when	isolated	in	culture?	Or,	do	
these	cells	represent	the	“third”	sub‐population	of	theca	cells?		Because	the	cells	responsive	
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to	Hh	 signaling	 should	 express	Gli1,	 one	would	 assume	 that	 these	 remaining	COUP‐TFII‐
positive	cells	are	negative	for	Gli1	and	are	independent	of	Hh	signaling.	In	Chapter	2,	Gli1	
was	shown	to	be	a	 lineage	maker	for	differentiating	theca	cells.	 If	 this	 is	the	case,	are	the	
remaining	COUP‐TFII‐positive	cells	in	an	undifferentiated	state?	This	hypothesis	brings	up	
the	possibilities	that	the	ovarian	interstitial	cells	might	have	different	developmental	status	
in	terms	of	their	differentiation	pathway.	The	first	status	is	a	naïve	state	and	the	cells	are	
not	responsive	to	extracellular	cues.	The	second	status	is	that	the	cells	become	responsive	
to	cellular	signals,	for	example,	they	acquire	Gli1	in	respond	to	Hh	signaling	in	this	case.	The	
third	status	is	that	the	cells	take	on	a	differentiation	trajectories	and	becoming	terminally	
differentiated	 cells,	 such	 as	 the	 steroidogenic	 theca	 cells.	 	 One	 concern	with	my	 current	
study	is	that,	although	I	have	shown	that	androgen‐producing	theca	cells	were	lost	 in	the	
absence	of	Hh	signaling,	I	cannot	distinguish	whether	this	is	because	Hh	signaling	directly	
regulates	 the	 process	 of	 steroidogenesis,	 or	 it	 is	 simply	 because	 the	 inactivation	 of	 Hh	
signaling	 leads	 to	 the	 cells	 being	 not	 responsive	 to	 cellular	 signals	 for	 steroidogenesis.	
Potential	strategies	to	test	if	Hh	signaling	directly	regulates	theca‐steroidogenesis	are:	1)	to	
inactivate	Hh	 signaling	 after	 theca	progenitor	 cells	 already	 acquires	Gli1	 expression,	 and	
examine	if	further	steroidogenic	differentiation	of	the	cells	require	Hh	signaling.	 	2)	Treat	
the	DKO	female	mice	with	exogenous	gonadotropins	to	examine	if	the	remaining	interstitial	
cells	differentiate	into	steroidogenic	theca	cells	in	the	absence	of	Hh	signaling.		
																In	the	absence	of	Dhh	and	Ihh,	steroidogenic	theca	cells	were	lost	and	the	follicles	
were	arrested	at	pre‐antral	stage.	Consistent	with	the	histological	observations,	microarray	
analysis	 of	 Dhh/Ihh	 DKO	 and	 the	 control	 ovaries	 showed	 down‐regulation	 of	 genes	
associated	with	theca‐steroidogenesis.	Along	the	line	with	the	lack	of	CLs	phenotype,	genes	
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involved	 in	 follicle	 development	 and	 ovulation	 were	 also	 down‐regulated,	 such	 as	 Lepr	
(Leptin	receptor)	[341],	vefga	(Vascular	endothelial	growth	factor	A)	[342‐344],	and	Cebpb	
(CCAAT/enhancer‐binding	protein‐β)	[181,	211].		Conversely,	genes	that	are	implicated	in	
granulosa	 cell	 differentiation	 appeared	 to	 be	 up‐regulated	 in	 the	 DKO	 ovaries,	 including	
Wt1	[345],	Igf1	(Insulin‐like	growth	factor	1)	[346],	Bmp6	(Bone	morphogenetic	protein	6)	
[347],	Gata6	(GATA‐binding	factor	6)	[348].	Consistent	with	these	observations,	granulosa	
cells	of	the	developing	follicles	 in	the	DKO	ovaries	appeared	to	exhibit	high	expression	of	
3βHSD,	 suggesting	 that	 granulosa	 cells	 are	 compensating	 the	 ovarian	 steroidogenesis	 by	
the	 loss	 of	 theca	 cells.	 A	 relevant	 phenomenon	 was	 observed	 in	 Gdf9‐/‐	 ovaries.	 In	 the	
absence	of	Gdf9,	the	follicles	were	arrested	at	primary	stage	along	with	a	lack	of	theca	cell	
layer,	 and	 the	 granulosa	 cells	 of	 the	 primary	 follicles	 eventually	 developed	 abnormal	
steroidogenic	phenotype	due	to	defects	in	cell	differentiation	[349].		
																In	summary,	my	 finding	provides	 the	 first	genetic	evidence	on	 the	critical	role	of	
Hh	 signaling	 during	 ovarian	 development	 using	 in	 vivo	 knockout	 models.	 While	 loss	 of	
either	Dhh	or	Ihh	alone	does	not	seem	to	affect	follicle	development,	ablation	of	both	Dhh	
and	 Ihh	 in	 the	 ovary	 results	 in	 the	 complete	 loss	 of	 steroidogenic	 theca	 cells,	 follicular	
arrest	 and	 subsequent	 lack	 of	 CLs.	 Given	 that	 disorders	 in	 theca	 cell	 differentiation	 are	
implicated	 in	 ovarian	 diseases	 such	 as	 polycystic	 ovary	 syndrome,	 premature	 ovarian	
failure	 and	 ovarian	 cancers	 [233,	 262,	 270,	 292,	 328],	 my	 discovery	 of	 the	 mechanism	
underlying	theca	cell	development	not	only	fill	a	critical	void	in	basic	ovarian	biology,	but	
also	 serve	 as	 novel	 entry	 points	 to	 understand	 how	 theca	 cell‐related	 pathology	 affects	
female	reproductive	health.	
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3.6	Figures	and	Tables	
	
	
Figure	3.1.	Effects	of	the	Hedgehog	inhibitor	cyclopamine	on	expression	of	Gli1‐LacZ	
in	the	ovary.	a‐c,	Gli1‐LacZ	ovaries	(E18.5)	were	cultured	in	the	presence	of	cyclopamine	
[333]	(25	μM),	or	an	equal	volume	of	vehicle,	for	3	days	followed	by	LacZ	staining	(blue).	
Ov=	ovary;	Ms=	mesonephros.	Scale	bar:	500	m.	
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Figure	3.2.	Dhh	and	 Ihh,	but	not	Shh,	are	produced	 in	 the	ovary	right	after	birth.	a,	
qPCR	analysis	of	Gli1,	Ihh	and	Dhh	mRNA	expression	 in	E17.5	and	PND3	ovaries.	b,	qPCR	
analysis	of	Shh,	Ihh,	and	Dhh	in	the	perinatal	ovaries,	testis	(P3),	adrenal	(P3)	and	limb	bud	
(E17.5).	Results	were	normalized	to	18S,	and	the	expression	levels	in	the	testis	were	set	as	
1	.	*P	<	0.05;	**P	<	0.01;	***P	<	0.001.	
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Figure	3.3.	Dhh	and	 Ihh	are	highly	expressed	 in	granulosa	cells	and	Gli1	and	Ptch1	
are	enriched	in	theca	progenitor	cells.	a,	qPCR	validation	of	Gli1+	theca	progenitor	cells	
and	Foxl2+	granulosa	 cells.	Results	were	 normalized	 to	18S,	 and	 the	 expression	 levels	 in	
tdTomato+	 cells	 were	 set	 as	 1.	 b,	 qPCR	 analysis	 of	 Gli1,	 Ptch1,	 Ihh,	 and	 Dhh	 mRNA	
expression	in	isolated	theca	progenitor	cells	and	granulosa	cells.		*P	<	0.05;	**P	<	0.01;	***P	
<	0.001;	****P<	0.0001.			
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Figure	3.4.	qPCR	analysis	of	Dhh,	Ihh,	and	Gli1	expression	in	ovaries	deficient	for	Dhh	
and/or	 Ihh.	 Ihh/Dhh	Dhet:	Sf1‐Cre;	Ihh	f/+;	Dhh+/‐;	 	 Ihh	 het/Dhh	KO:	Sf1‐Cre;	Ihh	f/+;	Dhh‐/‐;		
Ihh	cKO/Dhh	het:	Sf1‐Cre;	Ihh	f/‐;	Dhh+/‐;			Dhh/Ihh	DKO:	Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐.	Results	were	
normalized	to	18S,	and	the	expression	levels	in	the	Ihh/Dhh	Dhet	ovaries	were	set	as	1.	
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Figure	3.5.	Folliculogenesis	appears	normal	in	the	absence	of	either	Dhh	or	Ihh	in	the	
adult	ovary.	a‐c,	PAS/	Hematoxylin	staining	of	ovarian	sections	from	control	(Sf1‐Cre;	Ihh	
+/‐;	Dhh	+/‐),	 Ihh	 het/Dhh	KO	 (Sf1‐Cre;	Ihh	f/+;	Dhh	‐/‐)	 and	 Ihh	 cKO/Dhh	 het	 (Sf1‐Cre;	Ihh	f/‐;	
Dhh	+/‐)	ovaries	at	2	months	of	age.	Asterisks	 indicate	 the	presence	of	corpora	 lutea.	 	d‐f,	
Higher	magnification	 images	of	 corpus	 luteum.	g‐i,	 Immunofluorescence	of	α‐SMA	 in	red,	
and	FOXL2	 in	 green	 in	Dhh/Ihh	DKO	and	 control	 ovaries.	 α‐SMA	 is	 a	marker	 for	 smooth	
muscle	cell.	FOXL2	marks	granulosa	cells.	Scale	bar:	200	m.		
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Figure	3.6.	Loss	of	Dhh	and	Ihh	results	in	disrupted	folliculogenesis	in	the	ovary.	a‐b,	
Whole	mount	 light‐field	microscopic	 images.	c‐h,	histological	analysis	of	 the	ovaries	 from	
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control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐)	and	Dhh/Ihh	DKO	mice	(Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐)	at	2	month	of	
age.	(c,	d)	whole	ovarian	sections	with	different	stages	of	follicle	development.	(e,	f)	antral	
follicles	 from	 control	 and	DKO	 ovaries	 (hemorrhagic).	 (g,	 h)	 the	most	 advanced	 stage	 of	
follicle	 development	 in	 control	 (corpus	 luteum)	 and	 DKO	 ovaries	 (Pre‐antral	 follicle).		
Arrow	 indicates	 intra‐ovarian	 rete	ovarii.	Arrowhead	 indicates	 the	degenerating	 follicles.	
The	inset	is	higher	magnification	of	the	outlined	area	in	(d).	Asterisks	indicate	the	presence	
of	corpora	lutea.		Scale	bar:	200	m.		
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Figure	 3.7.	 Female	 mice	 deficient	 for	 Dhh	 and	 Ihh	 show	 defective	 theca	 cell	
differentiation	in	the	ovary.	a‐f,	Immunofluorescence	of	α‐SMA	in	red	(a,	b),	CYP17A1	in	
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magenta	(c,	d),	FOXL2	in	green	(a‐d),	3βHSD	in	red	(e,	f)	and	DAPI	in	grey	(e,	f)	in	Dhh/Ihh	
DKO	(Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐)	and	control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐)	ovaries.	α‐SMA	is	a	marker	
for	 smooth	muscle	 cell.	CYP17A1	 is	 a	marker	 for	androgen‐producing	 theca	 cells,	3βHSD	
marks	steroidogenic	cells	and	FOXL2	marks	granulosa	cells.	Asterisks	indicate	the	presence	
of	corpora	lutea.	Scale	bar:	200	m.		
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Figure	3.8.	Female	mice	deficient	for	Dhh	and	Ihh	exhibit	blunted	steroid	production.		
Serum	 levels	 of	 DHEA	 (didehydroepiandrosterone),	 testosterone	 and	 progesterone	 in	
control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐)	and	Dhh/Ihh	DKO	(Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐)	female	mice.	.	*P	<	
0.05.		
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Figure	3.9.	The	 interstitial	 cells	 in	 the	DKO	ovary	are	positive	 for	COUP‐TFII.	 	 a‐d,	
Immunofluorescence	of	COUP‐TFII	in	red	and	FOXL2	in	green	in	Dhh/Ihh	DKO	(Sf1‐Cre;	Ihh	
f/‐;	 Dhh	 ‐/‐)	 and	 control	 (Sf1‐Cre;	 Ihh	 f/+;	 Dhh+/‐)	 ovaries.	 FOXL2	 marks	 granulosa	 cells.	
Arrows	 indicate	 COUPTFII‐positive	 interstitial	 cells	 that	 are	 immediately	 adjacent	 to	 the	
granulosa	cells.	Scale	bar:	100	m.	
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Figure	3.10.	Transcriptome	changes	in	the	absence	of	Dhh	and	Ihh	in	the	adult	ovary.	
a,	Microarray	analysis	of	control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐,	n=4)	and	the	Dhh/Ihh	DKO	(Sf1‐Cre;	
Ihh	 f/‐;	Dhh	 ‐/‐,	 n=3)	 ovaries.	b,	 qPCR	 analysis	 of	 gene	 expression	 for	 Hedgehog	 signaling	
components	 (Dhh,	Ihh,	and	Gli1),	 and	 genes	 associated	with	 steroidogenesis	 (Nr5a1,	Star,	
Cyp11a1,	Hsd3b1,	Cyp19a1)	 in	 control	 and	DKO	 ovaries.	 Results	were	 normalized	 to	18S,	
and	the	expression	levels	in	the	control	ovaries	were	set	as	1.	*P	<	0.05;	**P	<	0.01;	***P	<	
0.001;	****P<	0.0001.			
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Genes	of	interest	
Fold	change	
(Dhh/Ihh	DKO	vs.	Control)	
Ehf	 3.216	
Ppargc1a	 1.926	
Bmp6	 1.842	
Wt1	 1.665	
Igf1	 1.594	
Gata6	 1.550	
Sox9	 1.548	
Lepr	 ‐4.425	
Nr2f2	 ‐2.807	
Vegfa	 ‐1.695	
Cebpb	 ‐1.645	
	
Table	3.1.		Fold	changes	of	genes	of	interest	from	microarray	analysis	of	Dhh/Ihh	DKO	(Sf1‐
Cre;	Ihh	f/‐;	Dhh	‐/‐)	ovaries	versus	control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐)	ovaries	from	2	months	of	
age	mice.		
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CHAPTER	4:		Expression	of	Theca	Cell‐Specific	Gli1	Requires	Oocyte‐Derived	GDF9	
through	Hedgehog	Signaling	from	Granulosa	Cells	
	
4.1	Abstract	
																Folliculogenesis	 is	 controlled	 by	 intricate	 communication	 between	 oocytes,	
granulosa,	and	theca	cells.	In	Chapter	2	and	3,	I	have	demonstrated	that	theca	cells	derive	
from	two	sources:	Wt1+	cells	indigenous	to	the	ovary	and	Gli1+	mesenchymal	cells	migrated	
from	the	mesonephros.	These	progenitors	acquire	theca	lineage	marker	Gli1	in	response	to	
paracrine	signals	Desert	hedgehog	(Dhh)	and	Indian	hedgehog	(Ihh)	from	granulosa	cells.	
One	 remaining	 question	 is	what	 factor(s)	 regulate	 the	 production	 of	Dhh	 and	 Ihh	 in	 the	
granulosa	 cells.	 	 Because	 the	 differentiation	 of	 granulosa	 cells	 is	 tightly	 controlled	 by	
factors	from	the	oocytes,	I	therefore	hypothesize	that	the	oocyte	plays	a	role	in	regulating	
Hh	 ligand	production	 in	 granulosa	 cells.	 In	 the	 absence	 of	 oocytes,	 the	 expression	 of	 the	
components	 of	 Hh	 signaling	 including	 Dhh,	 Ihh	 and	 Gli1	 in	 the	 ovary	 was	 significantly	
decreased,	 indicating	 that	 oocytes	 are	 necessary	 for	 the	 production	 of	 Hh	 ligands	 in	 the	
ovary.	 Next	 I	 investigated	 what	 factor(s)	 from	 the	 oocyte	 are	 responsible	 for	 Hh	 ligand	
production	in	granulosa	cells.	One	such	oocyte‐specific	candidate	is	growth	differentiation	
factor‐9	(Gdf9),	a	TGF‐beta	family	member	with	known	roles	in	the	formation	of	theca	cell	
layer.	 In	 the	 absence	 of	 Gdf9,	Dhh	and	 Ihh	 expressions	 in	 the	 granulosa	 cells	 as	 well	 as	
expression	 of	 Gli1	 in	 the	 theca	 cells	 were	 significantly	 down‐regulated.	 However,	 when	
GDF9	recombinant	protein	was	supplemented	to	an	oocyte‐depleted	ovary	 in	culture,	 the	
expression	of	Dhh,	Ihh	were	significantly	induced	as	well	as	the	subsequent	expression	of	
Gli1,	further	supporting	the	role	of	oocyte‐specific	factor	GDF9	in	regulating	Ihh	and	Dhh	in	
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the	granulosa	cells.	In	conclusion,	these	studies	reveal	novel	multicellular	interactions	via	
GDF9	 and	Hh	 signaling	 critical	 for	 ovarian	 folliculogenesis	 and	 formation	 of	 a	 functional	
theca.				
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4.2	Introduction	
																In	 Chapter	 3,	 I	 have	 demonstrated	 the	 mechanisms	 underlying	 theca	 cell	
development,	in	which	the	theca	progenitor	cells	in	the	ovary	acquired	lineage	specific	Gli1	
in	 response	 to	paracrine	DHH	and	 IHH	signaling	 from	granulosa	 cells.	 	 In	 the	 absence	of	
Dhh	and	Ihh,	theca	cells	failed	to	differentiate,	a	functional	theca	layer	was	lacking	and	the	
follicles	were	unable	to	develop	beyond	pre‐antral	stage.	These	results	establish	the	role	of	
Hedgehog	 signaling	 in	 regulating	 the	 differentiation	 of	 theca	 cells.	 	 Additionally,	 it	 was	
shown	that	constitutive	activation	of	Hh	signaling	in	the	ovary	disrupted	the	development	
of	 smooth	muscle	 cell	 in	 the	 theca	 cell	 layer	 and	 caused	 subsequent	 failure	 in	 ovulation	
[289].	 	 These	 observations	 altogether	 suggest	 that	 although	 Hh	 signaling	 is	 critical	 for	
ovarian	folliculogenesis,	it	needs	to	be	properly	regulated	for	ovarian	functions.		
																Candidate	 factor(s)	 that	 regulate	 Hh	 signaling	 in	 the	 ovary	 are	 likely	 to	 be	
originated	from	pituitary,	and/or	oocytes	within	the	ovary	through	regulation	of	granulosa	
cells	 [19].	On	one	hand,	pituitary‐derived	LH	and	FSH	control	many	aspects	of	granulosa	
cell	development	in	various	events	such	as	cell	proliferation	and	apoptosis,	follicle	atresia,	
estrogen	 production	 and	 the	 formation	 of	 CLs	 [158‐162].	 On	 the	 other	 hand,	 oocyte	 is	
considered	the	central	 regulator	of	granulosa	cell	 function	and	 thereby	play	critical	 roles	
during	the	progression	of	folliculogenesis	[350].	Many	of	the	studies	regarding	the	role	of	
oocyte	 on	 ovarian	 somatic	 cells	 were	 conducted	 in	 chicken	 and	 mice.	 In	 chicken,	 the	
germinal	 disc	 (GD)	 located	 on	 the	 surface	 of	 the	 female	 gamete	 contains	 the	 genetic	
material	and	cellular	organelles	of	the	egg,	and	is	considered	equivalent	to	the	oocyte	of	the	
mammal	[351].		Granulosa	cells	surrounding	the	oocyte	exhibit	different	phenotypes	based	
on	 their	 locations	 relative	 to	 the	GD:	 granulosa	 cells	 that	 directly	 adjacent	 to	 the	GD	are	
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more	proliferative,	whereas	 the	ones	distal	 to	 the	GD	are	more	differentiated	 [352‐354].	
This	phenomenon	is	further	explained	by	the	discovery	of	epidermal	growth	factor	(EGF)	
derived	 from	 the	 GD	 [355‐357].	 GD‐derived	 EGF	 acts	 on	 proximal	 granulosa	 cells	 and	
renders	 the	cells	more	proliferative	by	suppressing	 the	expression	of	LH	receptors	 [356‐
359].	In	contrast,	the	distal	granulosa	cells	are	less	exposed	to	EGF	and	therefore	exhibit	a	
more	differentiated	phenotype	promoted	by	LH	[358].	In	mammals,	it	was	first	proposed	in	
1970	that	the	oocyte	has	the	capacity	to	prevent	follicular	luteinization	in	rabbit	[360,	361].	
Subsequent	 studies	 dealing	 with	 co‐cultures	 of	 ovarian	 granulosa	 cells	 and	 denuded	
oocytes	 further	 establish	 the	 dominant	 role	 of	 oocytes	 in	 regulating	 granulosa	 cells	
throughout	 follicular	 development	 [362‐364].	 For	 instances,	 oocytectomy	 of	 oocyte‐
cumulus	 complexes	prevents	 FSH	 induced	 cumulus	 expansion,	whereas	 co‐culture	of	 the	
oocytectomized	 complexes	 with	 denuded	 oocytes	 rescues	 the	 expansion	 of	 the	 cumulus	
cells	 [189].	 Similarly,	 dissociated	 cumulus	 cells	 alone	 failed	 to	 synthesize	 a	 mucinous	
matrix	in	response	to	FSH,	but	the	matrix	production	is	restored	when	denuded	full‐grown	
oocytes	are	supplemented	in	culture	[190].		
																Two	oocyte‐derived	 factors	 critical	 for	 follicular	 cell	 function	 in	vivo	 are	 growth‐
differentiation	factor	9	(GDF9)	and	bone	morphogenetic	protein	15	(BMP15),	as	mutation	
of	 these	 genes	 causes	 female	 infertility	 [146,	 365].	 Both	 of	GDF9	 and	BMP15	are	 closely	
related	members	of	TGFβ	family	and	they	activate	signaling	pathways	in	granulosa	cells	to	
regulate	cellular	process	required	for	ovarian	functions	[272,	350,	363].		In	addition	to	the	
regulation	 of	 granulosa	 cells	 differentiation,	 GDF9	 also	 appears	 to	 play	 critical	 roles	 in	
theca	cell	recruitment/differentiation.	In	the	absence	Gdf9,	a	theca	layer	failed	to	develop,	
accompanied	 by	 follicle	 arrest	 at	 primary	 stage	 [146].	 However,	 whether	 GDF9	 directly	
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regulates	theca	cell	development,	or	indirectly	through	regulation	of	granulosa	cells	is	not	
known.		With	all	the	observations	aforementioned,	I	hypothesize	that	oocyte‐specific	GDF9	
indirectly	 regulates	 theca	 cell	 development	 though	 inducing	 the	 Hh	 signaling	 in	 the	
granulosa	cells.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 108
4.3	Material	and	Methods	
4.3.1	Animal	breeding	
																Gli1‐LacZ	 (#008211)	 mice	 were	 purchased	 from	 the	 Jackson	 Laboratory	 (Bar	
Harbor,	ME).	Gdf9	knockout	ovaries	were	provided	by	Dr.	Martin	Matzuk	(Baylor	College	of	
Medicine).	 Female	 mice	 were	 housed	 with	 male	 mice	 overnight	 and	 checked	 for	 the	
presence	 of	 vaginal	 plug	 the	next	morning.	 The	day	when	 the	 vaginal	 plug	was	detected	
was	 considered	 embryonic	 day	 (E)	 0.5.	 All	 animal	 procedures	 were	 approved	 by	 the	
National	 Institute	 of	 Environmental	 Health	 Sciences	 (NIEHS)	 Animal	 Care	 and	 Use	
Committee	 and	 are	 in	 compliance	 with	 a	 NIEHS‐approved	 animal	 study	 proposal.	 All	
experiments	were	performed	on	at	least	three	animals	for	each	genotype.	
	
4.3.2	Busulfan	treatment		
																Pregnant	CD‐1	females	were	injected	intraperitoneally	(IP)	at	E10.5	with	40	mg/kg	
of	busulfan	(Sigma)	dissolved	in	50%	DMSO,	or	an	equivalent	volume	of	50%	DMSO	as	the	
vehicle	 control.	 Busulfan‐treated	 pregnant	 female	 often	 undergo	 dystocia.	 	 In	 order	 to	
examine	the	expression	of	theca	progenitor	cells‐specific	Gli1	in	postnatal	ovaries	(Chapter	
2),	the	oocyte‐depleted	ovaries	were	collected	just	prior	to	birth	and	cultured	for	3	days.			
	
4.3.3	Immunohistochemistry	and	histological	analysis	
                Immunohistochemistry and histological analysis were performed as described with 
modifications[331]. For immunohistochemistry on frozen sections, ovaries were fixed in 4% 
paraformaldehyde in PBS at 4°C overnight, dehydrated through a sucrose gradient, embedded, 
and cryosectioned at 10 μm increments. After preincubating with 5% normal donkey serum in 
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PBS for 1 hour, the sections were then incubated with either anti-FOXL2 (1:500, a gift from Dr. 
Dagmar Wilhelm, Monash University, Australia) and anti-TRA98 (1:1000, MBL international, 
USA) in PBS-Triton X-100 solution with 5% normal donkey serum at 4°C overnight. The 
sections were then washed and incubated in the appropriate secondary antibody (1:500; 
Invitrogen, USA) before mounting in Vector Mount with DAPI (Vector Labs). Slides were 
imaged under a Leica DMI4000 confocal microscope.  
 
4.3.4	LacZ	staining	
																Fresh	tissues	were	stained	in	LacZ	staining	solution	at	37oC	for	3	hours.	The	LacZ	
staining	 solution	 was	 prepared	 by	 dissolving	 X‐gal	 (Invitrogen,	 Carlsbad,	 CA)	 in	
dimethylformamide	and	the	tissue	stain	base	solution	(Chemicon,	Billerica,	MA)	to	make	1	
mg/ml	working	 solution	 as	 described	 elsewhere	 [301].	 	 The	 stained	 samples	were	 then	
fixed	 in	 4%	 paraformaldehyde/PBS	 at	 4oC	 overnight.	 For	 further	 histological	 analysis,	
samples	after	LacZ	staining	were	embedded	in	paraffin	following	the	sectioning	procedure	
listed	above.	The	sections	were	counterstained	with	Fast	Red	(Sigma).		
	
4.3.5	Gene	expression	analysis	
																Gene	 expression	 analysis	 was	 performed	 as	 described	with	modifications	 [304].	
Total	 RNA	 was	 isolated	 from	 ovaries	 using	 the	 PicoPure	 RNA	 isolation	 kit	 (Arcturus,	
Mountain	View,	CA)	according	to	the	manufacturer’s	protocol.	The	cDNA	preparation	was	
synthesized	 using	 random	 hexamers	 and	 the	 Superscript	 II	 cDNA	 synthesis	 system	
(Invitrogen	Corp.,	Carlsbad,	CA)	following	the	manufacturer’s	instruction.	Gene	expression	
was	 analyzed	by	 real‐time	PCR	using	Bio‐Rad	CFX96TM	Real‐Time	PCR	Detection	 system.	
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Taqman	 gene‐expression	 probes	 (Gli1:	 Mm00494654_m1,	 Ihh:	 Mm00439613_m1,	 Dhh:	
Mm01310203_m1,	Gdf9:	Mm00433565_m1)	were	 used	 to	 detect	 the	 fold	 changes	 of	 the	
transcripts.	 Fold	 changes	 in	 gene	 expression	 were	 determined	 by	 quantitation	 of	 cDNA	
from	 target	 (treated)	 samples	 relative	 to	 a	 calibrator	 sample	 (control).	All	 real‐time	PCR	
analyses	were	performed	 in	duplicate,	 and	 the	 results	were	 reported	 from	at	 least	 three	
independent	experiments.	The	relative	 fold	change	of	 transcript	was	calculated	using	 the	
mathematical	 model	 of	 Pfaffl	 as	 previously	 described	 [305]	 and	 was	 normalized	 to	 18S	
rRNA	(Mm03928990_g1)	or	Gata4	(Mm00484689_m1)	as	an	endogenous	reference.	
	
4.3.6	Organ	culture		
																Ovaries	 from	 E18.5	 Gli1‐LacZ,	 or	 CD‐1	 embryos	 were	 cultured	 for	 3	 days	 on	
Millicell‐PC	membrane	inserts	(0.4	μm	pore	size;	30	mm	diameter;	Millipore	corp.,	Medford,	
MA)	with	medium	filling	only	the	lower	chamber	[332].	8‐10	ovaries	were	placed	on	each	
membrane,	with	one	drop	of	medium	on	each	ovary.	For	culture	with	GDF9	recombinant	
protein	(Peng	et	al.	PNAS	2013),	the	protein	(60	ng/ml),	or	an	equal	volume	of	vehicle	(TBS	
(pH8.0)	 with	 1mg/ml	 BSA),	 was	 added	 to	 the	 last	 day	 of	 culture	 24	 hours	 prior	 to	 the	
collection.	 	 The	medium	 for	 organ	 culture	was	DMEM/F12	 (1:1)	 +	 L‐Glutamine	 +	 15mM	
HEPES	 (Invitrogen)	 supplemented	 with	 50	 μg/ml	 penicillin	 G/streptomycin	 sulfate,	 and	
5%	(vol/vol)	fetal	bovine	serum	(FBS).	The	culture	medium	was	changed	every	other	day,	
and	 after	3	days	of	 culture,	 the	ovaries	were	 collected	 and	 subject	 to	RNA	extraction,	 or	
processed	for	LacZ	staining	as	described	above.		
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4.3.7	Statistical	analysis	
																Data	 were	 analyzed	 using	 Prism	 (Version	 6,	 GraphPad	 Software)	 by	 two‐tailed	
Student’s	 t‐test.	Values	are	expressed	as	mean±s.e.m.	A	minimal	of	3	biological	replicates	
was	used	for	each	experiment.			
	
4.4	Results	
4.4.1	Dhh	and	Ihh	production	in	the	granulosa	cells	is	regulated	by	factor(s)	from	the	
oocyte	
I	have	demonstrated	 that	DHH	and	 IHH	 from	granulosa	cells	were	responsible	 for	
theca	cell	differentiation	in	the	ovarian	development	(Chapter	2	&	3).	In	the	absence	of	Dhh	
and	 Ihh,	 theca	 cell	differentiation	was	abolished	and	 the	 follicles	were	unable	 to	develop	
beyond	 pre‐antral	 stage.	 	 Next	 I	 investigated	 what	 signal	 induces	 the	 production	 of	 Hh	
ligands	 in	 the	 granulosa	 cells.	 Functions	 of	 granulosa	 cells	 are	 regulated	 not	 only	
systemically	by	hormone	signals	from	the	pituitary,	but	also	locally	via	factors	produced	in	
the	 oocytes.	 Without	 the	 oocyte,	 follicle	 formation	 never	 occur	 [366].	 I	 therefore	
hypothesized	that	oocytes	may	play	a	role	in	regulating	Hh	ligand	production	in	granulosa	
cells.	 To	 test	 this	 hypothesis,	 I	 treated	 pregnant	 females	 with	 busulfan,	 a	
chemotherapeutical	 drug	 known	 to	 induce	 germ	 cell	 death	 in	 the	 embryos	 [367,	 368].	
Busulfan	was	injected	to	pregnant	Gli1‐LacZ	female	mice	at	E10.5,	when	the	germ	cells	just	
arrive	 in	 genital	 ridge	 and	 start	 proliferating	 [8‐10].	 The	 specificity	 of	 in	utero	 busulfan	
treatment	on	oocytes	was	confirmed	by	a	complete	abolishment	of	oocytes	at	E18.5	prior	
to	birth,	coincident	with	normal	establishment	of	FOXL2‐positive	granulosa	cell	population	
in	ovaries	of	busulfan‐treated	pups	(Fig.	4.1a	&	b).	 	This	result	confirms	previous	 finding	
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that	 busulfan‐induced	 germ	 cell	 depletion	 does	 not	 alter	 the	 prenatal	 establishment	 of	
ovarian	somatic	cell	types	[369].	After	birth,	Gli1‐LacZ	staining	appeared	in	the	medulla	of	
the	control	ovaries	as	expected.	However,	the	busulfan‐treated	ovaries	were	devoid	of	any	
LacZ	 staining	and	 the	ovaries	were	much	 smaller	 in	 size,	 likely	due	 to	 the	 loss	of	 female	
germ	cells	(Fig.	4.1c	&	d).		Further	analysis	of	the	ovarian	sections	revealed	an	absence	of	
follicle	 formation	 in	 the	busulfan‐treated	ovaries	 (Fig.	 4.1e	&	 f).	Gli1‐LacZ	 staining	 in	 the	
adjacent	 mesonephros	 was	 unaffected	 (Fig.	 4.1e	 &	 f),	 indicating	 that	 the	 loss	 of	 Gli1	
expression	in	the	ovary	is	due	to	the	depletion	of	oocytes,	not	a	general	effect	of	busulfan	
on	Gli1	expression.	To	further	investigate	whether	the	Hh	ligand	production	is	affected	by	
the	loss	of	oocytes,	I	examined	the	expression	of	Dhh,	Ihh,	and	Gli1	in	the	busulfan‐treated	
ovaries.	 In	 the	 absence	 of	 oocytes,	 the	 expression	 of	Gli1	mRNA	was	 significantly	 down‐
regulated,	consistent	with	the	histological	results	and	LacZ	staining	(Fig.	4.1).	Similar	to	the	
down‐regulated	 Gli1	 expression,	 expression	 of	 Dhh	 and	 Ihh	 were	 also	 significantly	
decreased	(Fig.	4.2).	These	results	indicate	that	oocyte	is	playing	a	role	in	stimulating	Dhh	
and	Ihh	production	in	granulosa	cells.		
	
4.4.2	Oocyte‐specific	GDF9	 is	 responsible	 for	Dhh	and	 Ihh	production	 in	granulosa	
cells	
Next	I	investigated	what	factor(s)	from	oocyte	are	responsible	for	Hh	production	in	
granulosa	 cells.	 	 One	 potential	 factor	 is	 GDF9,	 an	 oocyte‐specific	 factor	 essential	 for	
folliculogenesis	 and	 formation	 of	 theca	 layer	 [146].	 In	 the	 absence	 of	 Gdf9,	 follicle	
development	 is	 arrested	 at	 primary	 stage	 and	 the	 theca	 cell	 layer	 is	 missing.	 This	
observation	 suggests	 that	 GDF9	 is	 involved	 in	 theca	 cell	 development.	 I	 therefore	
	 113
hypothesize	that	GDF9	regulates	theca	cell	development	via	inducing	Hh	ligand	production	
in	the	granulosa	cells.	To	testis	this	hypothesis,	 I	 first	examined	the	expression	of	Gdf9	 in	
the	perinatal	ovaries.	Gdf9	expression	was	absent	in	the	ovary	before	birth	but	significantly	
increased	 at	 PND3	 (Fig.	 4.3a),	 in	 parallel	 with	 the	 expression	 pattern	 of	 Dhh	 and	 Ihh	
(Chapter	 3).	 	 In	 the	 PND3	 Gdf9	 knockout	 ovaries,	 expression	 of	 Dhh	 and	 Ihh	 was	
significantly	 reduced	 compared	 to	 that	 of	Gdf9	 heterozygous	ovaries	with	normal	 follicle	
development	 [146]	 (Fig.	 4.3b).	 These	 results	 indicate	 that	 GDF9	 stimulates	Dhh	 and	 Ihh	
production	 in	 granulosa	 cells.	 Additionally,	 when	 Gdf9	 expression	 was	 absent,	 Gli1	
expression	was	also	decreased	in	parallel	with	the	diminished	ligand	production	(Fig.	4.3b),	
further	confirming	the	inactivation	of	Hh	signaling.		
	
4.4.3	Exogenous	GDF9	protein	reactivates	Hh	signaling	in	the	absence	of	oocytes.		
																While	it	is	apparent	that	Gdf9	plays	a	role	in	regulating	Dhh	and	Ihh	production	in	
granulosa	 cells,	 it	 is	 not	 clear	 whether	 GDF9	 is	 capable	 of	 rescuing	 Hh	 signaling	 in	 the	
absence	of	the	oocytes.	To	test	this	possibility,	I	cultured	the	busulfan‐treated	ovaries	with	
or	 without	 mouse	 recombinant	 GDF9	 protein	 [272].	 When	 recombinant	 GDF9	 was	
supplemented	to	the	oocyte‐depleted	ovaries	(Busulfan‐treated)	in	culture,	it	significantly	
increased	mRNA	expression	of	Ihh,	Dhh,	and	Gli1	(Fig.	4.3c),	confirming	the	critical	role	of	
oocyte‐derived	 GDF9	 in	 stimulating	 Dhh	 and	 Ihh	 production	 in	 granulosa	 cells,	 and	
subsequent	 theca	progenitor	 cell‐specific	Gli1.	Additionally,	 the	 expression	of	Gdf9	 in	 the	
ovary	was	not	affected	by	the	absence	of	Dhh	and	Ihh,	not	did	its	co‐operative	factor	Bmp15	
[196,	272]	 (Fig.	4.4).	These	 results	not	only	 support	 that	GDF9	 functions	as	an	upstream	
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regulator	of	Hh	signaling,	but	also	affirms	that	the	lack	of	androgen‐producing	theca	cells	
was	specifically	due	to	loss	of	Hh	ligands,	not	decreased	Gdf9	expression.		
	
	
4.5	Discussion	
																My	findings	demonstrate	that	oocyte‐specific	 factor	GDF9	stimulates	Dhh	and	Ihh	
production	in	the	granulosa	cells.	The	Hh	ligand	production	in	granulosa	cells	then	induces	
the	expression	of	Gli1,	a	maker	for	theca	cell	 lineages	that	derived	from	both	ovarian	and	
extraovarian	origins.		
															Although	 Dhh	 and	 Ihh	 appear	 to	 be	 downstream	 targets	 of	 GDF9,	 the	 ovarian	
phenotypes	 of	Gdf9	 KO	 ovaries	 differ	 from	 those	 observed	 in	Dhh/Ihh	 DKO	 ovaries.	 The	
follicles	 in	 the	Gdf9	KO	ovaries	arrest	at	primary	stage,	whereas	 follicles	 in	Dhh/Ihh	DKO	
ovaries	develop	beyond	the	primary	stage	and	arrest	at	the	preantral	stage.	The	difference	
in	 phenotypes	 reveals	 two	 important	 findings:	 First,	 Dhh/Ihh	 signaling	 pathway	 plays	 a	
specific	 role	 in	 theca	cell	differentiation	and	second,	GDF9,	 the	 factor	 responsible	 for	 the	
production	of	Dhh	and	Ihh,	has	a	broader	function	in	follicle	development.	The	identities	of	
other	players	that	act	downstream	of	GDF9	remains	to	be	identified.	A	possible	approached	
to	address	that	question	is	to	perform	a	microarray	analysis	on	Gdf9	knockout	adult	ovaries,	
and	compare	their	transcriptome	changes	with	that	of	the	Dhh/Ihh	DKO	ovaries.			
																In	 the	 absence	 of	Gdf9,	 expression	 of	Dhh,	 Ihh	 and	Gli1	 was	 significantly	 down‐
regulated	but	not	 completely	 abolished.	This	 observation	 raises	 the	question	 as	whether	
GDF9	 is	 the	 only	 upstream	 regulator	 of	 the	Hh	 signaling.	 In	 fact,	 it	 has	 been	 shown	 that	
GDF9	 often	 signals	 synergistically	 with	 BMP15	 to	 regulate	 granulosa	 cell	 function	 [196,	
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370‐372].	 Although	 GDF9	 homodimers	 could	 modulate	 ovarian	 pathways	 in	 vitro	 [373,	
374],	GDF9:BMP15	heterodimers	are	nevertheless	much	more	potent	[272].		Thus,	in	spite	
the	 fact	 that	 GDF9	 alone	 is	 capable	 of	 inducing	 Hh	 signaling	 in	 the	 ovary,	 one	 cannot	
exclude	 the	 possibility	 that	 GDF9	 also	 forms	 a	more	 potent	 heterodimer	with	 BMP15	 to	
regulate	Hh	ligand	production	[272].	When	mouse	GDF9	recombinant	protein	was	added	to	
the	oocyte‐depleted	ovary	in	culture,	 it	significantly	induced	the	production	of	Hh	ligands	
in	 granulosa	 cells.	 	 If	 GDF9	 indeed	 works	 synergistically	 with	 BMP15	 to	 control	 Hh	
signaling	 in	vivo,	 I	 would	 expect	 to	 see	 an	 even	more	 pronounced	 increase	 of	 Hh	 ligand	
production,	 when	 both	 GDF9	 and	 BMP15	 are	 added	 to	 the	 oocyte‐depleted	 ovaries	 in	
culture.	Although	the	upstream	regulators	of	Hh	signaling	might	be	multiple,	GDF9	is	likely	
to	be	 the	dominant	growth	 factor	 in	 this	 case	at	 least	 in	mice.	This	 is	because	1)	BMP15	
homodimers	do	not	affect	granulosa	cells	differentiation	in	vitro	[272];	2)	the	level	of	Dhh	
and	Ihh	expression	are	significantly	decreased	in	the	absence	of	Gdf9;	3)	Gdf9‐/‐	female	mice	
exhibit	 major	 defects	 in	 ovarian	 folliculogenesis	 and	 they	 are	 infertile	 [146],	 whereas	
Bmp15‐/‐	 female	 mice	 are	 subfertile	 with	 minimal	 histopathological	 defects	 [197];	 	 4)	
Ovaries	 from	Gdf9+/‐	Bmp15‐/‐	 exhibited	more	severe	 fertility	defects	 than	Bmp15‐/‐	mice,	
while	ovaries	from	Gdf9‐/‐	Bmp15‐/‐	mice	are	phenotypically	resemble	Gdf9‐/‐	mutants	[197].		
																Although	 I	 have	 shown	 that	 GDF9	 acts	 on	 granulosa	 cells	 and	 indirectly	 induces	
Gli1	expression	in	the	theca	cells,	this	result	does	not	exclude	the	possibility	that	GDF9,	or	
GDF9	and	BMP15	together,	might	also	directly	regulate	theca	cells.	Work	to	date	suggests	
that	GDF9	and	BMP15	use	the	same	type	II	receptor	BMPRII	[375‐377],	but	different	type	I	
receptors.	While	GDF9	activates	TGF‐β	type	I	receptor	TGFBR1	(ALK‐5)	[378,	379],	BMP15	
appears	to	utilize	BMP	type	1b	receptor	BMPR1B	(ALK‐6)	[376].	As	a	result,	GDF9	activates	
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the	intracellular	SMAD2/3	pathway	[378,	380],	whereas	BMP15	induces	the	BMP	pathway	
via	 intracellular	 SMAD1/5/8	 signaling	 [376,	 377].	 The	GDF9:BMP15	heterodimers	 signal	
through	 BMPRII‐ALK4/5/7‐ALK/6	 receptor	 complex	 to	 stimulate	 phosphorylation	 of	
SMAD2/3	 in	mouse	and	human	granulosa	cells	 [272].	The	receptors	of	GDF9	and	BMP15	
are	 expressed	 in	 sheep,	 rat,	 pig	 and	 mouse	 granulosa	 cells	 throughout	 follicular	
development	 [381‐387],	 rendering	granulosa	cells	a	primary	 target	 for	GDF9	and	BMP15	
signaling	[19].	In	contrast	to	granulosa	cells,	the	direct	roles	of	GDF9	and	BMP15	on	theca	
cell	development	is	far	less	clear.	Several	pieces	of	evidence	suggest	that	TGFBR1	(ALK‐5)	
[387‐390]	 and	 TGFBR2	 [387,	 390,	 391]	 are	 expressed	 in	 the	 theca‐interstitial	 cells	 in	
species	 such	 as	 pig,	 sheep,	 cow	 and	 mouse.	 The	 presence	 of	 TGFBR1	 in	 the	 theca	
compartment	 suggests	 that	 theca‐interstitial	 cells	 might	 be	 a	 direct	 target	 of	 GDF9	
signaling.	This	notion	 is	 supported	by	 several	 in	vitro	 studies,	 in	which	GDF9	 suppresses	
androgen	production	of	human	[392],	bovine	[389]	and	mouse	[393]	theca‐interstitial	cells	
whereas	promotes	 androgen	biosynthesis	 in	 theca	 cells	 in	 rat	 [394],	 revealing	 important	
species‐specific	differences.		In	the	absence	of	Dhh	and	Ihh,	steroidogenic	theca	cells	were	
missing	yet	the	expression	of	Gdf9	and	Bmp15	were	unaffected,	 indicating	that	the	loss	of	
functional	theca	cells	was	not	due	to	blunted	Gdf9	and/or	Bmp15	expression.	However,	it	is	
not	yet	clear	whether	the	expression	of	the	GDF9/BMP15	receptors	such	as	TGFBR1	was	
altered	 by	 the	 loss	 of	 Hh	 signaling.	 If	 the	 expression	 of	 the	 GDF9	 receptors	 in	 the	
interstitium	of	the	ovary	were	not	affected	in	the	absence	of	Hh	signaling,	it	indicates	that	
GDF9	 does	 not	 directly	 regulate	 theca	 cells	 in	vivo.	 However,	 if	 the	 expression	 of	 GDF9	
receptors	 in	 ovarian	 interstitium	 were	 lost,	 it	 would	 be	 difficult	 to	 further	 distinguish	
whether	 the	 decreased	 receptor	 expression	 is	 the	 result	 of	 loss	 of	 theca	 cells,	 or	 it	 is	 a	
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decrease	 in	 expression	 itself.	 Alternatively,	 cultures	 of	 theca‐interstitial	 cells	 in	 the	
presence	 of	 a	 Hh	 signaling	 inhibitor	 might	 be	 able	 to	 answer	 whether	 inhibition	 of	 Hh	
signaling	affects	the	expression	of	GDF9	receptors	in	theca‐interstitial	cells.		
																The	 importance	 of	 GDF9	 in	 folliculogenesis	was	 first	 described	 by	 Dong	 et	 al	 in	
1996	[146].	When	the	expression	of	Gdf9	was	lost	in	mice,	folliculogenesis	was	arrested	at	
primary	 stage	 and	 the	 theca	 cell	 layer	 failed	 to	 form.	 One	 key	 question	 that	 remains	
puzzling	for	the	past	two	decades	is	whether	GDF9	directly	regulates	theca	cell	recruitment	
and/or	 differentiation,	 or	 indirectly	 through	 regulation	 of	 pre‐antral	 granulosa	 cell	
development.	My	findings	of	GDF9	regulating	Hh	signaling	in	granulosa	cells	bridge	the	gap	
between	loss	of	Gdf9	 in	the	oocyte	and	the	 lack	of	theca	 layer	in	the	ovarian	interstitium.	
Although	whether	GDF9	directly	regulates	 theca	cells	 is	not	clear,	 the	GDF9/Hh	signaling	
appears	to	be	the	main	regulatory	pathway	that	governs	theca	cell	differentiation,	due	to	
the	fact	that	ablation	of	Hh	signaling	resulted	in	the	loss	of	androgen‐producing	theca	cells	
despite	the	presence	of	Gdf9.	In	addition,	this	study	indicates	that	the	process	of	theca	cell	
differentiation	 is	accomplished	through	 intricate	communications	among	three	cell	 types:	
oocytes,	granulosa	cells	and	the	mesenchymal	cells	in	ovarian	interstitium.	These	findings	
not	only	answer	a	fundamental	question	in	the	field,	but	also	provide	a	model	system	that	
might	be	applicable	to	study	morphogenesis	in	other	organs.			
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4.6	Figures	
	
Figure	4.1:	Effects	of	 in	utero	busulfan	 treatment	on	oocytes	and	 the	expression	of	
Gli1	 in	 the	 ovary.	 a‐b,	 E18.5	 control	 and	 busulfan‐treated	 ovaries	 were	 analyzed	 by	
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immunofluorescence	detection	for	granulosa	cell	marker	FOXL2	(green),	germ	cell	marker	
TRA98	 (red),	 and	 nuclear	 counterstain	 DAPI	 (blue).	 	 Scale	 bar:	 100	 m.	 c‐f,	 Gli1‐LacZ	
expression	 (blue)	 in	 the	 control	 and	 busulfan‐treated	 ovaries	 (n=8‐15)	 after	 3	 days	 of	
culture	 (c	 &	 d	 are	 whole	mount)	 and	 (e	 &	 f	 are	 sections	 counterstained	with	 FastRed).		
Scale	bar:	500	m.	
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Figure	4.2:	Loss	of	oocytes	in	the	ovary	suppresses	the	expression	of	the	components	
of	Hh	signaling.	a,	qPCR	analysis	of	Gli1,	Ihh	and	Dhh	mRNA	expression	in	the	control	and	
busulfan‐treated	ovaries.	Every	 two	ovaries	were	pooled	 to	ensure	enough	RNA	yield	 for	
PCR	analysis	(n=3‐5).	Results	were	normalized	to	a	somatic	cell	gene	Gata4.		*P	<	0.05;	**P	
<	0.01;	***P	<	0.001.	
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Figure	4.3:	Hh	signaling	in	granulosa	cells	is	regulated	by	oocyte‐derived	factor	GDF9.	
a,	 qPCR	 analysis	 of	 Gdf9	 mRNA	 expression	 in	 the	 E17.5	 and	 P3	 ovaries	 (n=5).	 b,	 qPCR	
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analysis	of	Gli1,	Ihh	and	Dhh	mRNA	expression	in	control	and	Gdf9	knockout	ovaries	(n=4).	
c,	qPCR	analysis	of	Gli1,	Ihh	and	Dhh	mRNA	expression	in	the	E18.5	oocyte‐depleted	ovaries	
(busulfan‐treated)	cultured	with	or	without	recombinant	mouse	GDF9	protein	(60	ng/ml).	
Every	 two	ovaries	were	pooled	 to	 ensure	 enough	RNA	yield	 for	 PCR	 analysis	 (n=5).	The	
expression	 level	 in	oocyte‐depleted	ovaries	without	GDF9	(Control)	was	set	as	1.	Results	
were	normalized	to	18S.		*P	<	0.05;	**P	<	0.01;	***P	<	0.001.	
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Figure	4.4:	qPCR	analysis	of	Gdf9	and	Bmp15	expression	in	control	and	Dhh/Ihh	DKO	
(Sf1‐Cre;	Ihh	f/‐;	Dhh	‐/‐)	ovaries.	Results	were	normalized	to	18S,	and	the	expression	levels	
in	the	control	(Sf1‐Cre;	Ihh	f/+;	Dhh+/‐)	ovaries	were	set	as	1.	No	statistical	significance	was	
detected	by	two‐tailed	Student’s	t‐test.	
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CHAPTER	5:	Conclusions	and	Future	Directions	
	
																My	doctoral	research	has	uncovered	the	embryonic	origins	of	 theca	cells	and	the	
mechanism	 underlying	 their	 differentiation	 (Fig.	 5.1).	 Theca	 cells	 are	 derived	 from	 two	
sources:	 the	 Wt1‐positive	 precursor	 cells	 in	 the	 fetal	 ovary	 and	 the	 Gli1‐positive	
mesenchymal	cells	in	the	fetal	mesonephros,	an	embryonic	organ	immediately	adjacent	to	
the	fetal	ovary.	The	Gli1‐positive	cells	in	the	fetal	mesonephros	migrate	into	the	ovary	just	
prior	to	birth,	and	give	rise	to	a	small	percentage	of	theca	cells	in	the	adult	ovary,	whereas	
the	Wt1‐positive	cells	derived	from	fetal	ovary	contribute	to	the	majority	of	theca	cells	in	
adulthood.	While	mesonephros‐derived	Gli1‐positive	cells	give	rise	to	mostly	steroidogenic	
theca	 cell	 located	 proximal	 to	 granulosa	 cells,	 fetal	 ovary‐derived	 Wt1‐positive	 cells	
contribute	to	both	steroidogenic	theca	cells	and	non‐steroidogenic	cells	spanning	the	entire	
theca	 layer.	 In	 addition	 to	 their	 differences	 in	 cell‐lineage	 contributions	 and	 relative	
proximity	to	granulosa	cells,	the	two	sources	of	theca	cells	exhibit	distinct	gene	expression	
profiling.	These	 findings	not	only	support	 the	historical	observation	that	 theca	cells	are	a	
mixed	population	consisting	of	theca	interna	and	theca	externa,	but	also	demonstrate	that	
the	 heterogeneity	 of	 this	 population	 is	 a	 reflection	 of	 disparate	 cellular	 origins	 and	
transcriptomes.	 Although	 originated	 from	 different	 embryonic	 sources,	 the	 two	 pools	 of	
theca	progenitor	cells	acquire	the	expression	of	Gli1	when	they	commit	to	theca	cell	lineage	
in	the	ovary	soon	after	birth.	The	expression	of	Gli1	in	theca	progenitor	cells	is	induced	by	
Dhh	and	Ihh	produced	by	granulosa	cells,	and	the	Hh	ligand	production	in	granulosa	cells	is	
then	 regulated	 by	 oocyte‐specific	 factor	 GDF9.	 In	 the	 absence	 of	 Dhh	 and	 Ihh,	 theca	
progenitor	 cells	 fail	 to	 differentiate	 into	 androgen‐producing	 theca	 cells,	 and	 the	
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folliculogenesis	 is	arrested	at	preantral	stage	along	with	blunted	steroid	productions	and	
lack	 of	 CLs.	 Although	 I	 have	 identified	 the	 origins	 of	 theca	 cells	 and	 characterized	 the	
mechanism	underlying	 theca	 cell	differentiation,	 there	 remain	many	aspects	of	 theca	 cell	
development	to	be	explored.	In	order	to	gain	a	deeper	insight	into	theca	cell	development	
and	regulation,	I	propose	the	following	future	experiments:		
	
1.	What	is	the	source	of	signal(s)	that	trigger	the	migration	of	Gli1‐positive	cells	from	
the	mesonephros	into	the	ovary?	
																I	have	found	that	theca	cell	progenitors	originate	from	two	sources:	Wt1‐positive	
cells	 in	 the	 fetal	 ovary	 and	 Gli1‐positve	 cells	 in	 the	 mesonephros.	 The	 appearance	 of	
mesonephros‐derived	Gli1‐positive	cells	in	the	ovary	suggests	that	signal(s)	from	the	ovary	
induce	 the	migration	 of	 the	Gli1‐positive	 cells	 into	 the	 ovary.	 Based	 on	 the	 fact	 that	 the	
mesonephros‐derived	theca	cells	first	appear	in	the	medulla	of	the	neonatal	ovary	and	are	
located	 adjacent	 to	 primary	 follicles,	 I	 therefore	 hypothesize	 that	 factor(s)	 from	 the	
primary	 follicles	 trigger	 the	 migration.	 To	 test	 if	 the	 developing	 follicles	 play	 a	 role	 in	
triggering	the	migration	of	mesonephric	Gli1‐positive	cells,	I	plan	to	disrupt	the	formation	
of	the	follicle	in	the	ovary	and	examine	if	the	Gli1‐positive	cells	from	the	mesonephros	still	
migrate.	 I	expect	 that	 the	mesonephros‐derived	Gli1‐positive	cells	 fail	 to	migrate	 into	 the	
ovary	in	the	absence	of	the	primary	follicle.	If	so,	I	will	then	conduct	experiments	to	further	
identify	what	 factor(s)	 from	the	primary	follicle	 triggers	migration.	Based	on	my	findings	
that	theca	cell	differentiation	is	regulated	indirectly	by	oocyte‐specific	factor	GDF9	through	
Dhh	and	Ihh	in	the	granulosa	cells,	I	speculate	that	oocyte‐derived	GDF9	and/or	granulosa	
cell‐derived	Hh	ligands	might	be	the	migration‐inducing	agents.	To	test	if	this	is	the	case,	I	
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plan	to	culture	busulfan‐treated	Gli1‐lineage	tracing	ovaries	(with	mesonephros	attached)	
with	recombinant	GDF9	and/or	DHH/IHH	proteins.	If	neither	GDF9	nor	Dhh/Ihh	is	able	to	
induce	migration,	 I	will	 use	mass	 spectrometry	 to	 screen	 for	 potential	 chemoattractants	
produced	by	the	follicles	and	perform	the	migration	assay.		
	
2.	Does	loss	of	Dhh	and	Ihh	impair	the	fertility	of	female	mice?	
																I	have	shown	that	in	the	absence	of	Dhh	and	Ihh,	the	theca	layer	is	barely	present,	
and	 the	 androgen‐producing	 theca	 cells	 were	 missing	 along	 with	 blunted	 circulating	
androgens	 and	 progesterone.	 In	 addition,	 the	 ovaries	 exhibited	 many	 defects	 including	
follicle	 arrest	 at	 the	 preantral	 stage	 and	 a	 lack	 of	 corpora	 lutea,	 indicative	 of	 ovulation	
failure.	 Together	 these	 results	 prompt	me	 to	 examine	whether	 the	Dhh/Ihh	 DKO	 female	
mice	are	infertile,	and	whether	the	defective	folliculogenesis	is	a	result	of	loss	of	functional	
theca	cells.	 I	will	generate	Dhh/Ihh	DKO	mice	and	 their	 littermate	control.	 I	will	examine	
the	fertility	of	the	female	mice	by	addressing	the	following	questions:	
a.	Are	the	Dhh/Ihh	female	mice	able	to	produce	offspring?		
																Control	and	Dhh/Ihh	DKO	female	mice	will	be	bred	with	fertile	males	to	examine	
the	fertility	of	the	female.		Because	the	DKO	females	exhibited	ovarian	follicle	arrest	in	the	
preantral	 follicle	 stage,	 I	 expect	 that	 the	 estrous	 cycle	 in	 the	 Dhh/Ihh	 DKO	 female	 is	
abnormal,	which	leads	to	the	absence	of	vaginal	plug.	In	addition,	I	expect	that	the	females	
will	be	completely	infertile	because	of	the	absence	of	corpora	lutea.		
b.	Do	exogenous	gonadotropins	induce	ovulation	in	the	Dhh/Ihh	DKO	ovaries?			
																Ovaries	lacking	Dhh	and	Ihh	exhibited	disrupted	folliculogenesis	with	the	absence	
of	 corpora	 lutea,	 indicating	 that	 ovulation	did	 not	 occur.	 To	 gain	 further	 insight	 into	 the	
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fertility	problems	as	well	as	 the	defects	 in	 folliculogenesis,	 I	will	 investigate	the	ability	of	
the	DKO	female	to	ovulate	by	performing	the	superovulation	procedure.	 I	expect	that	the	
exogenous	 gonadotropins	 will	 have	 very	 minimal	 effects	 on	 follicle	 development	 and	
ovulation	 since	 functional	 theca	 cells	 are	 absent.	 Because	 exogenous	 gonadotropins	will	
have	 minimal	 effects	 on	 ovulation,	 I	 therefore	 expect	 that	 no	 corpus	 lutea,	 or	 very	 few	
corpora	lutea	will	be	present	in	the	DKO	ovaries.		
c.	Does	exogenous	testosterone	stimulate	preantral	follicles	to	progress	to	ovulation?		
																The	most	dramatic	defect	in	the	Dhh/Ihh	DKO	ovaries	was	a	lack	of	theca	layer.	The	
defects	in	theca	cell	differentiation	result	in	reduced	level	of	circulating	testosterone.	These	
observation	 leads	 to	 the	 hypothesis	 that	 the	 arrest	 in	 follicular	 development	 in	 the	DKO	
ovary	 is	 due	 to	 defects	 in	 theca	 cell	 development	 and	 possibly	 insufficient	 testosterone	
production.	To	test	this	hypothesis,	I	will	provide	testosterone	supplement	to	prepubertal	
Dhh/Ihh	 DKO	 female	 mice	 to	 see	 if	 it	 rescues	 follicle	 development.	 I	 expect	 that	 the	
testosterone	 supplement	 will	 allow	 the	 follicles	 to	 grow	 to	 at	 least	 antral	 follicle	 stage;	
however,	 the	 follicles	 won’t	 be	 ovulated	 as	 a	 result	 of	 a	 lack	 of	 theca	 externa,	 which	
contains	 smooth	 muscle	 layer	 important	 for	 ovulation	 [289].	 Consistently	 with	 these,	 I	
expect	 that	 the	 level	 of	 circulating	 testosterone	 and	 estradiol	 will	 be	 increased	 but	 the	
progesterone	level	will	remain	low	due	to	a	lack	of	ovulation	and	production	of	CL.		
	
3.	Identifying	signaling	pathways	downstream	of	GDF9	in	folliculogenesis	
																My	findings	suggest	that	theca	cell	differentiation	is	indirectly	regulated	by	oocyte‐
derived	 factor	GDF9	 through	Hedgehog	signaling	 from	granulosa	cells.	Although	Dhh	 and	
Ihh	appear	to	be	downstream	targets	of	GDF9,	the	ovarian	phenotypes	in	the	Gdf9	KO	and	
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Ihh/Dhh	DKO	are	quite	different.	Both	Gdf9	KO	ovaries	and	Dhh/Ihh	DKO	ovaries	exhibited	
a	lack	of	theca	cell	layer.	However,	follicles	in	the	Gdf9	KO	ovaries	arrest	at	primary	stage	in	
contrast	to	the	preantral	stage	in	the	Dhh/Ihh	DKO	ovaries.	The	differences	in	phenotypes	
reveal	 two	 important	 findings:	 first,	 Dhh/Ihh	 signaling	 pathway	 plays	 a	 specific	 role	 in	
theca	 cell	 differentiation	 and	 second,	 GDF9,	 the	 factor	 responsible	 for	 the	 production	 of	
Dhh	 and	 Ihh,	 has	 a	 broader	 function	 in	 follicle	 development.	 In	 this	 aim,	 I	 will	 use	 our	
knowledge	on	Dhh/Ihh	to	gain	insight	into	folliculogenesis	under	the	control	of	GDF9.		
1.	Does	activation	of	Hedgehog	signaling	ameliorate	the	phenotypes	in	Gdf9	KO	ovaries?	
																Loss	 of	 Gdf9	 leads	 to	 defects	 in	 folliculogenesis	 including	 an	 arrest	 of	 follicle	
development	at	primary	stage,	 inactivation	of	 the	Hh	pathway,	and	consequent	 failure	 in	
the	formation	of	theca	layer.	To	investigate	whether	the	inactivation	of	the	Hh	pathway	is	
completely	or	partially	responsible	for	the	follicular	defects	in	the	absence	of	Gdf9,	I	plan	to	
ectopically	activate	 the	Hh	pathway	 in	 the	Gdf9	KO	ovary	by	 culturing	pieces	of	Gdf9	KO	
ovary	 [395]	 with	 IHH	 and	 DHH,	 and	 examine	 if	 the	 activation	 of	 Hedgehog	 pathway	
facilitates	 further	 development	 of	 the	 follicles	 in	 the	 absence	 of	 Gdf9.	 I	 expect	 that	 the	
presence	of	IHH/DHH	will	allow	the	Gdf9	KO	follicles	to	develop	beyond	the	primary	stage.	
Because	GDF9	appears	 to	have	a	boarder	 function	 in	 follicle	development	 than	DHH	and	
IHH,	I	do	not	expect	the	presence	of	DHH/IHH	is	able	to	fully	rescue	the	phenotypes	of	Gdf9	
KO	ovaries.		
2.	What	other	factors,	in	addition	to	DHH	and	IHH,	act	downstream	of	GDF9?	
																To	answer	this	question,	I	plan	to	perform	microarray	analyses	on	Gdf9	KO	ovaries	
and	Dhh/Ihh	DKO	ovaries.	By	comparing	 the	mRNA	transcriptomes	 from	the	 two	mutant	
models	at	different	time	points,	I	will	be	able	to	obtain	a	list	of	genes	that	are	differentially	
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expressed	 in	 the	 absence	 of	 Gdf9	 but	 are	 unaffected	 by	 the	 loss	 of	 Dhh	 and	 Ihh.	 I	 will	
confirm	the	gene	list	by	real	time	PCR	and	search	the	literature	for	known	functions	of	the	
genes	on	the	list.	I	will	then	exclude	the	genes	with	known	functions	and	focus	on	the	novel	
genes	in	the	future.		
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5.1	Figures	
	
Figure	5.1	Proposed	model	 for	the	origins	and	differentiation	of	theca	cells	 in	the	mouse	
ovary.	
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